{"subnetworks": [{"diseases": ["INSOMNIA", "PAIN", "PRURITUS", "SCOLIOSIS", "SICKLE CELL ANEMIA", "TINNITUS", "EPILEPSY", "PROSTATE CARCINOMA", "ALCOHOL DEPENDENCE", "CARPAL TUNNEL SYNDROME", "NEUROPATHIC PAIN", "PREMATURE BIRTH", "FIBROMYALGIA", "LUMBAR DISC DEGENERATION", "NEOPLASM", "PARTIAL EPILEPSY", "CIRRHOSIS OF LIVER", "NICOTINE DEPENDENCE", "SPONTANEOUS ABORTION", "DRUG DEPENDENCE", "OPIOID DEPENDENCE", "VOMITING", "PSYCHOSIS", "DIABETIC NEUROPATHY", "NEUROPATHY", "RESTLESS LEGS SYNDROME", "SEIZURES", "ABNORMALITY OF REFRACTION", "GENERALIZED TONIC-CLONIC SEIZURES", "IRRITABLE BOWEL SYNDROME", "CHRONIC PANCREATITIS", "BONE FRACTURE", "DRY EYE SYNDROME", "SQUAMOUS CELL CARCINOMA", "COUGH", "GENICULATE HERPES ZOSTER", "OVERACTIVE BLADDER", "PREGNANCY", "MARIJUANA DEPENDENCE", "REFLEX SYMPATHETIC DYSTROPHY", "MIGRAINE DISORDER", "ANXIETY", "RENAL INSUFFICIENCY", "INFERTILITY", "CARDIOVASCULAR DISEASE", "BRAIN ANEURYSM", "STROKE", "SUBARACHNOID HEMORRHAGE", "ANAL FISSURE", "KIDNEY STONE", "PARKINSON'S DISEASE", "BIPOLAR DISORDER", "CONSTIPATION", "SKIN DISEASE", "ANGINA PECTORIS", "HYPERTENSION", "INTRACEREBRAL HEMORRHAGE", "CORONARY ARTERY DISEASE", "PROTEINURIA", "PRINZMETAL'S ANGINA", "MYOCARDIAL INFARCTION", "ATRIAL FIBRILLATION", "LIVER DISEASE", "UNIPOLAR DEPRESSION", "CANCER", "INJURY", "INFLUENZA INFECTION", "POSTENCEPHALITIC PARKINSON DISEASE", "INFECTION", "SECONDARY PARKINSON DISEASE", "CEREBRAL ATHEROSCLEROSIS", "GAMBLING BEHAVIOUR", "SUICIDAL IDEATION", "COCAINE DEPENDENCE", "OBSESSIVE-COMPULSIVE DISORDER", "SCHIZOPHRENIA", "ALCOHOL DRINKING", "CONGENITAL HEART DISEASE", "METAMPHETAMINE DEPENDENCE", "OBESITY", "SMOKING CESSATION", "PRADER-WILLI SYNDROME", "CEREBRAL ISCHEMIA", "TORTICOLLIS", "ESSENTIAL TREMOR", "ALZHEIMERS DISEASE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "COGNITIVE IMPAIRMENT", "PANIC DISORDER", "POST-TRAUMATIC STRESS DISORDER", "ALCOHOL WITHDRAWAL", "MOVEMENT DISORDER", "GLIOBLASTOMA MULTIFORME", "FEVER", "AUTISM SPECTRUM DISORDER", "DIABETIC RETINOPATHY"], "links": [{"source": "ENSG00000006116", "target": "ENSG00000006283"}, {"source": "ENSG00000006116", "target": "ENSG00000067191"}, {"source": "ENSG00000006116", "target": "ENSG00000075429"}, {"source": "ENSG00000006116", "target": "ENSG00000075461"}, {"source": "ENSG00000006116", "target": "ENSG00000081248"}, {"source": "ENSG00000006116", "target": "ENSG00000102001"}, {"source": "ENSG00000006116", "target": "ENSG00000105605"}, {"source": "ENSG00000006116", "target": "ENSG00000108878"}, {"source": "ENSG00000006116", "target": "ENSG00000116032"}, {"source": "ENSG00000006116", "target": "ENSG00000120251"}, {"source": "ENSG00000006116", "target": "ENSG00000130433"}, {"source": "ENSG00000006116", "target": "ENSG00000142408"}, {"source": "ENSG00000006116", "target": "ENSG00000148408"}, {"source": "ENSG00000006116", "target": "ENSG00000151062"}, {"source": "ENSG00000006116", "target": "ENSG00000151067"}, {"source": "ENSG00000006116", "target": "ENSG00000152578"}, {"source": "ENSG00000006116", "target": "ENSG00000153956"}, {"source": "ENSG00000006116", "target": "ENSG00000155511"}, {"source": "ENSG00000006116", "target": "ENSG00000157388"}, {"source": "ENSG00000006116", "target": "ENSG00000165995"}, {"source": "ENSG00000006116", "target": "ENSG00000166862"}, {"source": "ENSG00000006116", "target": "ENSG00000167535"}, {"source": "ENSG00000006116", "target": "ENSG00000176884"}, {"source": "ENSG00000006116", "target": "ENSG00000182389"}, {"source": "ENSG00000006116", "target": "ENSG00000183454"}, {"source": "ENSG00000006116", "target": "ENSG00000196557"}, {"source": "ENSG00000006116", "target": "ENSG00000198216"}, {"source": "ENSG00000006116", "target": "ENSG00000198785"}, {"source": "ENSG00000006283", "target": "ENSG00000067191"}, {"source": "ENSG00000006283", "target": "ENSG00000081248"}, {"source": "ENSG00000006283", "target": "ENSG00000100346"}, {"source": "ENSG00000006283", "target": "ENSG00000102001"}, {"source": "ENSG00000006283", "target": "ENSG00000105605"}, {"source": "ENSG00000006283", "target": "ENSG00000108878"}, {"source": "ENSG00000006283", "target": "ENSG00000130433"}, {"source": "ENSG00000006283", "target": "ENSG00000142408"}, {"source": "ENSG00000006283", "target": "ENSG00000148408"}, {"source": "ENSG00000006283", "target": "ENSG00000151062"}, {"source": "ENSG00000006283", "target": "ENSG00000151067"}, {"source": "ENSG00000006283", "target": "ENSG00000153956"}, {"source": "ENSG00000006283", "target": "ENSG00000157388"}, {"source": "ENSG00000006283", "target": "ENSG00000165995"}, {"source": "ENSG00000006283", "target": "ENSG00000166862"}, {"source": "ENSG00000006283", "target": "ENSG00000167535"}, {"source": "ENSG00000006283", "target": "ENSG00000182389"}, {"source": "ENSG00000006283", "target": "ENSG00000196557"}, {"source": "ENSG00000006283", "target": "ENSG00000198216"}, {"source": "ENSG00000007402", "target": "ENSG00000067191"}, {"source": "ENSG00000007402", "target": "ENSG00000108878"}, {"source": "ENSG00000007402", "target": "ENSG00000141837"}, {"source": "ENSG00000007402", "target": "ENSG00000182389"}, {"source": "ENSG00000067191", "target": "ENSG00000075461"}, {"source": "ENSG00000067191", "target": "ENSG00000081248"}, {"source": "ENSG00000067191", "target": "ENSG00000100346"}, {"source": "ENSG00000067191", "target": "ENSG00000102001"}, {"source": "ENSG00000067191", "target": "ENSG00000105605"}, {"source": "ENSG00000067191", "target": "ENSG00000108878"}, {"source": "ENSG00000067191", "target": "ENSG00000130433"}, {"source": "ENSG00000067191", "target": "ENSG00000141837"}, {"source": "ENSG00000067191", "target": "ENSG00000142408"}, {"source": "ENSG00000067191", "target": "ENSG00000148408"}, {"source": "ENSG00000067191", "target": "ENSG00000151062"}, {"source": "ENSG00000067191", "target": "ENSG00000151067"}, {"source": "ENSG00000067191", "target": "ENSG00000153956"}, {"source": "ENSG00000067191", "target": "ENSG00000157388"}, {"source": "ENSG00000067191", "target": "ENSG00000165995"}, {"source": "ENSG00000067191", "target": "ENSG00000166862"}, {"source": "ENSG00000067191", "target": "ENSG00000167535"}, {"source": "ENSG00000067191", "target": "ENSG00000182389"}, {"source": "ENSG00000067191", "target": "ENSG00000196557"}, {"source": "ENSG00000067191", "target": "ENSG00000198216"}, {"source": "ENSG00000075429", "target": "ENSG00000075461"}, {"source": "ENSG00000075429", "target": "ENSG00000105605"}, {"source": "ENSG00000075429", "target": "ENSG00000116032"}, {"source": "ENSG00000075429", "target": "ENSG00000120251"}, {"source": "ENSG00000075429", "target": "ENSG00000142408"}, {"source": "ENSG00000075429", "target": "ENSG00000152578"}, {"source": "ENSG00000075429", "target": "ENSG00000155511"}, {"source": "ENSG00000075429", "target": "ENSG00000166862"}, {"source": "ENSG00000075429", "target": "ENSG00000176884"}, {"source": "ENSG00000075429", "target": "ENSG00000183454"}, {"source": "ENSG00000075429", "target": "ENSG00000198785"}, {"source": "ENSG00000075461", "target": "ENSG00000105605"}, {"source": "ENSG00000075461", "target": "ENSG00000108878"}, {"source": "ENSG00000075461", "target": "ENSG00000116032"}, {"source": "ENSG00000075461", "target": "ENSG00000120251"}, {"source": "ENSG00000075461", "target": "ENSG00000142408"}, {"source": "ENSG00000075461", "target": "ENSG00000152578"}, {"source": "ENSG00000075461", "target": "ENSG00000153956"}, {"source": "ENSG00000075461", "target": "ENSG00000155511"}, {"source": "ENSG00000075461", "target": "ENSG00000157388"}, {"source": "ENSG00000075461", "target": "ENSG00000166862"}, {"source": "ENSG00000075461", "target": "ENSG00000176884"}, {"source": "ENSG00000075461", "target": "ENSG00000183454"}, {"source": "ENSG00000075461", "target": "ENSG00000198785"}, {"source": "ENSG00000081248", "target": "ENSG00000100346"}, {"source": "ENSG00000081248", "target": "ENSG00000102001"}, {"source": "ENSG00000081248", "target": "ENSG00000105605"}, {"source": "ENSG00000081248", "target": "ENSG00000108878"}, {"source": "ENSG00000081248", "target": "ENSG00000130433"}, {"source": "ENSG00000081248", "target": "ENSG00000142408"}, {"source": "ENSG00000081248", "target": "ENSG00000148408"}, {"source": "ENSG00000081248", "target": "ENSG00000151062"}, {"source": "ENSG00000081248", "target": "ENSG00000151067"}, {"source": "ENSG00000081248", "target": "ENSG00000153956"}, {"source": "ENSG00000081248", "target": "ENSG00000157388"}, {"source": "ENSG00000081248", "target": "ENSG00000165995"}, {"source": "ENSG00000081248", "target": "ENSG00000166862"}, {"source": "ENSG00000081248", "target": "ENSG00000167535"}, {"source": "ENSG00000081248", "target": "ENSG00000182389"}, {"source": "ENSG00000081248", "target": "ENSG00000196557"}, {"source": "ENSG00000081248", "target": "ENSG00000198216"}, {"source": "ENSG00000100346", "target": "ENSG00000151067"}, {"source": "ENSG00000100346", "target": "ENSG00000157388"}, {"source": "ENSG00000100346", "target": "ENSG00000165995"}, {"source": "ENSG00000100346", "target": "ENSG00000167535"}, {"source": "ENSG00000100346", "target": "ENSG00000182389"}, {"source": "ENSG00000100346", "target": "ENSG00000196557"}, {"source": "ENSG00000102001", "target": "ENSG00000105605"}, {"source": "ENSG00000102001", "target": "ENSG00000108878"}, {"source": "ENSG00000102001", "target": "ENSG00000130433"}, {"source": "ENSG00000102001", "target": "ENSG00000142408"}, {"source": "ENSG00000102001", "target": "ENSG00000148408"}, {"source": "ENSG00000102001", "target": "ENSG00000151062"}, {"source": "ENSG00000102001", "target": "ENSG00000151067"}, {"source": "ENSG00000102001", "target": "ENSG00000153956"}, {"source": "ENSG00000102001", "target": "ENSG00000157388"}, {"source": "ENSG00000102001", "target": "ENSG00000165995"}, {"source": "ENSG00000102001", "target": "ENSG00000166862"}, {"source": "ENSG00000102001", "target": "ENSG00000167535"}, {"source": "ENSG00000102001", "target": "ENSG00000182389"}, {"source": "ENSG00000102001", "target": "ENSG00000196557"}, {"source": "ENSG00000102001", "target": "ENSG00000198216"}, {"source": "ENSG00000105464", "target": "ENSG00000152578"}, {"source": "ENSG00000105464", "target": "ENSG00000155511"}, {"source": "ENSG00000105464", "target": "ENSG00000161509"}, {"source": "ENSG00000105464", "target": "ENSG00000176884"}, {"source": "ENSG00000105464", "target": "ENSG00000183454"}, {"source": "ENSG00000105605", "target": "ENSG00000108878"}, {"source": "ENSG00000105605", "target": "ENSG00000116032"}, {"source": "ENSG00000105605", "target": "ENSG00000120251"}, {"source": "ENSG00000105605", "target": "ENSG00000130433"}, {"source": "ENSG00000105605", "target": "ENSG00000142408"}, {"source": "ENSG00000105605", "target": "ENSG00000148408"}, {"source": "ENSG00000105605", "target": "ENSG00000151062"}, {"source": "ENSG00000105605", "target": "ENSG00000151067"}, {"source": "ENSG00000105605", "target": "ENSG00000152578"}, {"source": "ENSG00000105605", "target": "ENSG00000153956"}, {"source": "ENSG00000105605", "target": "ENSG00000155511"}, {"source": "ENSG00000105605", "target": "ENSG00000157388"}, {"source": "ENSG00000105605", "target": "ENSG00000165995"}, {"source": "ENSG00000105605", "target": "ENSG00000166862"}, {"source": "ENSG00000105605", "target": "ENSG00000167535"}, {"source": "ENSG00000105605", "target": "ENSG00000176884"}, {"source": "ENSG00000105605", "target": "ENSG00000182389"}, {"source": "ENSG00000105605", "target": "ENSG00000183454"}, {"source": "ENSG00000105605", "target": "ENSG00000196557"}, {"source": "ENSG00000105605", "target": "ENSG00000198216"}, {"source": "ENSG00000105605", "target": "ENSG00000198785"}, {"source": "ENSG00000105737", "target": "ENSG00000120251"}, {"source": "ENSG00000105737", "target": "ENSG00000163873"}, {"source": "ENSG00000105737", "target": "ENSG00000164418"}, {"source": "ENSG00000108878", "target": "ENSG00000130433"}, {"source": "ENSG00000108878", "target": "ENSG00000142408"}, {"source": "ENSG00000108878", "target": "ENSG00000148408"}, {"source": "ENSG00000108878", "target": "ENSG00000151062"}, {"source": "ENSG00000108878", "target": "ENSG00000151067"}, {"source": "ENSG00000108878", "target": "ENSG00000153956"}, {"source": "ENSG00000108878", "target": "ENSG00000157388"}, {"source": "ENSG00000108878", "target": "ENSG00000165995"}, {"source": "ENSG00000108878", "target": "ENSG00000166862"}, {"source": "ENSG00000108878", "target": "ENSG00000167535"}, {"source": "ENSG00000108878", "target": "ENSG00000182389"}, {"source": "ENSG00000108878", "target": "ENSG00000196557"}, {"source": "ENSG00000108878", "target": "ENSG00000198216"}, {"source": "ENSG00000116032", "target": "ENSG00000120251"}, {"source": "ENSG00000116032", "target": "ENSG00000142408"}, {"source": "ENSG00000116032", "target": "ENSG00000152578"}, {"source": "ENSG00000116032", "target": "ENSG00000155511"}, {"source": "ENSG00000116032", "target": "ENSG00000166862"}, {"source": "ENSG00000116032", "target": "ENSG00000176884"}, {"source": "ENSG00000116032", "target": "ENSG00000183454"}, {"source": "ENSG00000116032", "target": "ENSG00000198785"}, {"source": "ENSG00000120251", "target": "ENSG00000142408"}, {"source": "ENSG00000120251", "target": "ENSG00000152578"}, {"source": "ENSG00000120251", "target": "ENSG00000155511"}, {"source": "ENSG00000120251", "target": "ENSG00000164418"}, {"source": "ENSG00000120251", "target": "ENSG00000166862"}, {"source": "ENSG00000120251", "target": "ENSG00000176884"}, {"source": "ENSG00000120251", "target": "ENSG00000183454"}, {"source": "ENSG00000120251", "target": "ENSG00000198785"}, {"source": "ENSG00000130433", "target": "ENSG00000142408"}, {"source": "ENSG00000130433", "target": "ENSG00000148408"}, {"source": "ENSG00000130433", "target": "ENSG00000151062"}, {"source": "ENSG00000130433", "target": "ENSG00000151067"}, {"source": "ENSG00000130433", "target": "ENSG00000153956"}, {"source": "ENSG00000130433", "target": "ENSG00000157388"}, {"source": "ENSG00000130433", "target": "ENSG00000165995"}, {"source": "ENSG00000130433", "target": "ENSG00000166862"}, {"source": "ENSG00000130433", "target": "ENSG00000167535"}, {"source": "ENSG00000130433", "target": "ENSG00000182389"}, {"source": "ENSG00000130433", "target": "ENSG00000196557"}, {"source": "ENSG00000130433", "target": "ENSG00000198216"}, {"source": "ENSG00000141837", "target": "ENSG00000151062"}, {"source": "ENSG00000141837", "target": "ENSG00000153956"}, {"source": "ENSG00000141837", "target": "ENSG00000165995"}, {"source": "ENSG00000141837", "target": "ENSG00000167535"}, {"source": "ENSG00000141837", "target": "ENSG00000182389"}, {"source": "ENSG00000142408", "target": "ENSG00000148408"}, {"source": "ENSG00000142408", "target": "ENSG00000151062"}, {"source": "ENSG00000142408", "target": "ENSG00000151067"}, {"source": "ENSG00000142408", "target": "ENSG00000152578"}, {"source": "ENSG00000142408", "target": "ENSG00000153956"}, {"source": "ENSG00000142408", "target": "ENSG00000155511"}, {"source": "ENSG00000142408", "target": "ENSG00000157388"}, {"source": "ENSG00000142408", "target": "ENSG00000165995"}, {"source": "ENSG00000142408", "target": "ENSG00000166862"}, {"source": "ENSG00000142408", "target": "ENSG00000167535"}, {"source": "ENSG00000142408", "target": "ENSG00000176884"}, {"source": "ENSG00000142408", "target": "ENSG00000182389"}, {"source": "ENSG00000142408", "target": "ENSG00000183454"}, {"source": "ENSG00000142408", "target": "ENSG00000196557"}, {"source": "ENSG00000142408", "target": "ENSG00000198216"}, {"source": "ENSG00000142408", "target": "ENSG00000198785"}, {"source": "ENSG00000148408", "target": "ENSG00000151062"}, {"source": "ENSG00000148408", "target": "ENSG00000151067"}, {"source": "ENSG00000148408", "target": "ENSG00000153956"}, {"source": "ENSG00000148408", "target": "ENSG00000157388"}, {"source": "ENSG00000148408", "target": "ENSG00000165995"}, {"source": "ENSG00000148408", "target": "ENSG00000166862"}, {"source": "ENSG00000148408", "target": "ENSG00000167535"}, {"source": "ENSG00000148408", "target": "ENSG00000182389"}, {"source": "ENSG00000148408", "target": "ENSG00000196557"}, {"source": "ENSG00000148408", "target": "ENSG00000198216"}, {"source": "ENSG00000149403", "target": "ENSG00000164418"}, {"source": "ENSG00000151062", "target": "ENSG00000151067"}, {"source": "ENSG00000151062", "target": "ENSG00000153956"}, {"source": "ENSG00000151062", "target": "ENSG00000157388"}, {"source": "ENSG00000151062", "target": "ENSG00000165995"}, {"source": "ENSG00000151062", "target": "ENSG00000166862"}, {"source": "ENSG00000151062", "target": "ENSG00000167535"}, {"source": "ENSG00000151062", "target": "ENSG00000182389"}, {"source": "ENSG00000151062", "target": "ENSG00000196557"}, {"source": "ENSG00000151062", "target": "ENSG00000198216"}, {"source": "ENSG00000151067", "target": "ENSG00000153956"}, {"source": "ENSG00000151067", "target": "ENSG00000157388"}, {"source": "ENSG00000151067", "target": "ENSG00000165995"}, {"source": "ENSG00000151067", "target": "ENSG00000166862"}, {"source": "ENSG00000151067", "target": "ENSG00000167535"}, {"source": "ENSG00000151067", "target": "ENSG00000182389"}, {"source": "ENSG00000151067", "target": "ENSG00000196557"}, {"source": "ENSG00000151067", "target": "ENSG00000198216"}, {"source": "ENSG00000152578", "target": "ENSG00000155511"}, {"source": "ENSG00000152578", "target": "ENSG00000166862"}, {"source": "ENSG00000152578", "target": "ENSG00000176884"}, {"source": "ENSG00000152578", "target": "ENSG00000183454"}, {"source": "ENSG00000152578", "target": "ENSG00000198785"}, {"source": "ENSG00000153956", "target": "ENSG00000157388"}, {"source": "ENSG00000153956", "target": "ENSG00000165995"}, {"source": "ENSG00000153956", "target": "ENSG00000166862"}, {"source": "ENSG00000153956", "target": "ENSG00000167535"}, {"source": "ENSG00000153956", "target": "ENSG00000182389"}, {"source": "ENSG00000153956", "target": "ENSG00000196557"}, {"source": "ENSG00000153956", "target": "ENSG00000198216"}, {"source": "ENSG00000155511", "target": "ENSG00000161509"}, {"source": "ENSG00000155511", "target": "ENSG00000164418"}, {"source": "ENSG00000155511", "target": "ENSG00000166862"}, {"source": "ENSG00000155511", "target": "ENSG00000176884"}, {"source": "ENSG00000155511", "target": "ENSG00000183454"}, {"source": "ENSG00000155511", "target": "ENSG00000198785"}, {"source": "ENSG00000157388", "target": "ENSG00000165995"}, {"source": "ENSG00000157388", "target": "ENSG00000166862"}, {"source": "ENSG00000157388", "target": "ENSG00000167535"}, {"source": "ENSG00000157388", "target": "ENSG00000182389"}, {"source": "ENSG00000157388", "target": "ENSG00000196557"}, {"source": "ENSG00000157388", "target": "ENSG00000198216"}, {"source": "ENSG00000161509", "target": "ENSG00000176884"}, {"source": "ENSG00000161509", "target": "ENSG00000183454"}, {"source": "ENSG00000163873", "target": "ENSG00000166862"}, {"source": "ENSG00000164418", "target": "ENSG00000166862"}, {"source": "ENSG00000164418", "target": "ENSG00000171189"}, {"source": "ENSG00000164418", "target": "ENSG00000176884"}, {"source": "ENSG00000165995", "target": "ENSG00000166862"}, {"source": "ENSG00000165995", "target": "ENSG00000167535"}, {"source": "ENSG00000165995", "target": "ENSG00000182389"}, {"source": "ENSG00000165995", "target": "ENSG00000196557"}, {"source": "ENSG00000165995", "target": "ENSG00000198216"}, {"source": "ENSG00000166862", "target": "ENSG00000167535"}, {"source": "ENSG00000166862", "target": "ENSG00000171189"}, {"source": "ENSG00000166862", "target": "ENSG00000176884"}, {"source": "ENSG00000166862", "target": "ENSG00000182389"}, {"source": "ENSG00000166862", "target": "ENSG00000183454"}, {"source": "ENSG00000166862", "target": "ENSG00000196557"}, {"source": "ENSG00000166862", "target": "ENSG00000198216"}, {"source": "ENSG00000166862", "target": "ENSG00000198785"}, {"source": "ENSG00000167535", "target": "ENSG00000182389"}, {"source": "ENSG00000167535", "target": "ENSG00000196557"}, {"source": "ENSG00000167535", "target": "ENSG00000198216"}, {"source": "ENSG00000171189", "target": "ENSG00000176884"}, {"source": "ENSG00000171189", "target": "ENSG00000182771"}, {"source": "ENSG00000176884", "target": "ENSG00000183454"}, {"source": "ENSG00000176884", "target": "ENSG00000198785"}, {"source": "ENSG00000182389", "target": "ENSG00000196557"}, {"source": "ENSG00000182389", "target": "ENSG00000198216"}, {"source": "ENSG00000183454", "target": "ENSG00000198785"}, {"source": "ENSG00000196557", "target": "ENSG00000198216"}], "drugs": [{"indications": [{"efo_term": "FIBROMYALGIA", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "NEUROPATHIC PAIN", "stage": 4}, {"efo_term": "NEUROPATHY", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "RESTLESS LEGS SYNDROME", "stage": 3}, {"efo_term": "GENERALIZED TONIC-CLONIC SEIZURES", "stage": 3}, {"efo_term": "LUMBAR DISC DEGENERATION", "stage": 3}, {"efo_term": "BONE FRACTURE", "stage": 3}, {"efo_term": "CIRRHOSIS OF LIVER", "stage": 3}, {"efo_term": "GENICULATE HERPES ZOSTER", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 2}, {"efo_term": "CHRONIC PANCREATITIS", "stage": 2}, {"efo_term": "DRY EYE SYNDROME", "stage": 2}, {"efo_term": "OVERACTIVE BLADDER", "stage": 2}, {"efo_term": "REFLEX SYMPATHETIC DYSTROPHY", "stage": 2}, {"efo_term": "ABNORMALITY OF REFRACTION", "stage": 1}, {"efo_term": "SQUAMOUS CELL CARCINOMA", "stage": 1}, {"efo_term": "COUGH", "stage": 1}, {"efo_term": "PREGNANCY", "stage": 1}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 0}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 0}], "max_phase": 4, "name": "PREGABALIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1059", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNG3", "CACNA1G", "CACNA2D2", "CACNB1", "CACNG5", "CACNG4", "CACNA1S", "CACNA1I", "CACNA1F", "CACNG7", "CACNG1", "CACNG6", "CACNA1A", "CACNG8", "CACNA1B", "CACNA2D4", "CACNA1C", "CACNA2D1", "CACNA1D", "CACNB2", "CACNG2", "CACNB3", "CACNB4", "CACNA1H", "CACNA1E"], "type": "Small molecule", "diseases": ["FIBROMYALGIA", "NEUROPATHY", "PAIN", "PARTIAL EPILEPSY", "RESTLESS LEGS SYNDROME", "SEIZURES", "ABNORMALITY OF REFRACTION", "ALCOHOL DEPENDENCE", "EPILEPSY", "GENERALIZED TONIC-CLONIC SEIZURES", "IRRITABLE BOWEL SYNDROME", "NEUROPATHIC PAIN", "LUMBAR DISC DEGENERATION", "CHRONIC PANCREATITIS", "NICOTINE DEPENDENCE", "BONE FRACTURE", "DRY EYE SYNDROME", "SQUAMOUS CELL CARCINOMA", "CIRRHOSIS OF LIVER", "COUGH", "GENICULATE HERPES ZOSTER", "DIABETIC NEUROPATHY", "OVERACTIVE BLADDER", "PREGNANCY", "MARIJUANA DEPENDENCE", "REFLEX SYMPATHETIC DYSTROPHY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "INSOMNIA", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "SCOLIOSIS", "stage": 3}, {"efo_term": "CARPAL TUNNEL SYNDROME", "stage": 3}, {"efo_term": "FIBROMYALGIA", "stage": 3}, {"efo_term": "LUMBAR DISC DEGENERATION", "stage": 3}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "CIRRHOSIS OF LIVER", "stage": 3}, {"efo_term": "VOMITING", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 2}, {"efo_term": "TINNITUS", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "SPONTANEOUS ABORTION", "stage": 2}, {"efo_term": "OPIOID DEPENDENCE", "stage": 2}, {"efo_term": "PRURITUS", "stage": 1}, {"efo_term": "NEUROPATHIC PAIN", "stage": 1}, {"efo_term": "PREMATURE BIRTH", "stage": 1}, {"efo_term": "DRUG DEPENDENCE", "stage": 1}, {"efo_term": "PSYCHOSIS", "stage": 1}], "max_phase": 4, "name": "GABAPENTIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL940", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNG3", "CACNA1G", "CACNA2D2", "CACNB1", "CACNG5", "CACNG4", "CACNA1S", "CACNA1I", "CACNA1F", "CACNG7", "CACNG1", "CACNG6", "CACNA1A", "CACNG8", "CACNA1B", "CACNA2D4", "CACNA1C", "CACNA2D1", "CACNA1D", "CACNB2", "CACNG2", "CACNB3", "CACNB4", "CACNA1H", "CACNA1E"], "type": "Small molecule", "diseases": ["INSOMNIA", "PAIN", "PRURITUS", "SCOLIOSIS", "SICKLE CELL ANEMIA", "TINNITUS", "EPILEPSY", "PROSTATE CARCINOMA", "ALCOHOL DEPENDENCE", "CARPAL TUNNEL SYNDROME", "NEUROPATHIC PAIN", "PREMATURE BIRTH", "FIBROMYALGIA", "LUMBAR DISC DEGENERATION", "NEOPLASM", "PARTIAL EPILEPSY", "CIRRHOSIS OF LIVER", "NICOTINE DEPENDENCE", "SPONTANEOUS ABORTION", "DRUG DEPENDENCE", "OPIOID DEPENDENCE", "VOMITING", "PSYCHOSIS", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "OBESITY", "stage": 3}, {"efo_term": "SMOKING CESSATION", "stage": 3}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 3}, {"efo_term": "PRADER-WILLI SYNDROME", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "ALCOHOL DRINKING", "stage": 2}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 2}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "CEREBRAL ISCHEMIA", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 1}, {"efo_term": "CONGENITAL HEART DISEASE", "stage": 1}], "max_phase": 4, "name": "TOPIRAMATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492", "mechanisms": ["Glutamate receptor ionotropic kainate antagonist", "Glutamate receptor ionotropic AMPA antagonist"], "genes": ["GRIK5", "GRIA2", "GRIK4", "GRIA4", "GRIA1", "GRIK3", "GRIK2", "GRIK1"], "type": "Small molecule", "diseases": ["COCAINE DEPENDENCE", "EPILEPSY", "ALCOHOL DRINKING", "BIPOLAR DISORDER", "MIGRAINE DISORDER", "ALCOHOL DEPENDENCE", "CONGENITAL HEART DISEASE", "METAMPHETAMINE DEPENDENCE", "GAMBLING BEHAVIOUR", "OBESITY", "SMOKING CESSATION", "NICOTINE DEPENDENCE", "MARIJUANA DEPENDENCE", "PRADER-WILLI SYNDROME", "CEREBRAL ISCHEMIA"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "PANIC DISORDER", "stage": 3}, {"efo_term": "ALCOHOL WITHDRAWAL", "stage": 3}, {"efo_term": "SUBARACHNOID HEMORRHAGE", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "MOVEMENT DISORDER", "stage": 3}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "COGNITIVE IMPAIRMENT", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 2}, {"efo_term": "ESSENTIAL TREMOR", "stage": 1}, {"efo_term": "STROKE", "stage": 1}], "max_phase": 4, "name": "LEVETIRACETAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1286", "mechanisms": ["Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["CACNA1B"], "type": "Small molecule", "diseases": ["EPILEPSY", "SEIZURES", "COGNITIVE IMPAIRMENT", "ALZHEIMERS DISEASE", "ESSENTIAL TREMOR", "PANIC DISORDER", "POST-TRAUMATIC STRESS DISORDER", "ALCOHOL WITHDRAWAL", "SUBARACHNOID HEMORRHAGE", "ALCOHOL DEPENDENCE", "MOVEMENT DISORDER", "PARTIAL EPILEPSY", "STROKE", "GLIOBLASTOMA MULTIFORME"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 4}, {"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "PRINZMETAL'S ANGINA", "stage": 4}, {"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 4}, {"efo_term": "STROKE", "stage": 4}, {"efo_term": "PROTEINURIA", "stage": 3}], "max_phase": 4, "name": "AMLODIPINE BESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200402", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["HYPERTENSION", "CORONARY ARTERY DISEASE", "PROTEINURIA", "ANGINA PECTORIS", "PRINZMETAL'S ANGINA", "MYOCARDIAL INFARCTION", "STROKE"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "INFLUENZA INFECTION", "stage": 4}, {"efo_term": "POSTENCEPHALITIC PARKINSON DISEASE", "stage": 4}, {"efo_term": "INFECTION", "stage": 4}, {"efo_term": "SECONDARY PARKINSON DISEASE", "stage": 4}, {"efo_term": "CEREBRAL ATHEROSCLEROSIS", "stage": 4}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "INJURY", "stage": 2}], "max_phase": 4, "name": "AMANTADINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1569", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "CANCER", "INJURY", "INFLUENZA INFECTION", "POSTENCEPHALITIC PARKINSON DISEASE", "INFECTION", "SECONDARY PARKINSON DISEASE", "CEREBRAL ATHEROSCLEROSIS"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "SEIZURES", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}, {"efo_term": "ESSENTIAL TREMOR", "stage": 2}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 2}, {"efo_term": "TORTICOLLIS", "stage": 1}], "max_phase": 4, "name": "PERAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1214124", "mechanisms": ["Glutamate receptor ionotropic AMPA antagonist"], "genes": ["GRIA2", "GRIA4", "GRIA1"], "type": "Small molecule", "diseases": ["EPILEPSY", "PARKINSON'S DISEASE", "SEIZURES", "TORTICOLLIS", "NEUROPATHIC PAIN", "MIGRAINE DISORDER", "ESSENTIAL TREMOR", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "SUBARACHNOID HEMORRHAGE", "stage": 3}, {"efo_term": "INFERTILITY", "stage": 2}, {"efo_term": "STROKE", "stage": 2}, {"efo_term": "BRAIN ANEURYSM", "stage": 1}], "max_phase": 4, "name": "NIMODIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1428", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["INFERTILITY", "CARDIOVASCULAR DISEASE", "BRAIN ANEURYSM", "STROKE", "SUBARACHNOID HEMORRHAGE"]}, {"indications": [{"efo_term": "RESTLESS LEGS SYNDROME", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}], "max_phase": 4, "name": "GABAPENTIN ENACARBIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1628502", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNG3", "CACNA1G", "CACNA2D2", "CACNB1", "CACNG5", "CACNG4", "CACNA1S", "CACNA1I", "CACNA1F", "CACNG7", "CACNG1", "CACNG6", "CACNA1A", "CACNG8", "CACNA1B", "CACNA2D4", "CACNA1C", "CACNA2D1", "CACNA1D", "CACNB2", "CACNG2", "CACNB3", "CACNB4", "CACNA1H", "CACNA1E"], "type": "Small molecule", "diseases": ["RESTLESS LEGS SYNDROME", "EPILEPSY", "ALCOHOL DEPENDENCE", "MIGRAINE DISORDER"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "PREMATURE BIRTH", "stage": 3}, {"efo_term": "KIDNEY STONE", "stage": 3}, {"efo_term": "ANAL FISSURE", "stage": 2}], "max_phase": 4, "name": "NIFEDIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["ANAL FISSURE", "PREMATURE BIRTH", "KIDNEY STONE", "CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "BIPOLAR DISORDER", "stage": 2}, {"efo_term": "OPIOID DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "ISRADIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1648", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "BIPOLAR DISORDER", "CARDIOVASCULAR DISEASE", "OPIOID DEPENDENCE"]}, {"indications": [{"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "ANAL FISSURE", "stage": 3}, {"efo_term": "CONSTIPATION", "stage": 1}, {"efo_term": "SKIN DISEASE", "stage": 1}], "max_phase": 4, "name": "DILTIAZEM HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1697", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["CONSTIPATION", "ANAL FISSURE", "SKIN DISEASE", "ANGINA PECTORIS"]}, {"indications": [{"efo_term": "SUICIDAL IDEATION", "stage": 3}, {"efo_term": "INJURY", "stage": 3}, {"efo_term": "BIPOLAR DISORDER", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "KETAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1714", "mechanisms": ["Glutamate [NMDA] receptor negative allosteric modulator"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "SUICIDAL IDEATION", "COCAINE DEPENDENCE", "INJURY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "REFLEX SYMPATHETIC DYSTROPHY", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 1}], "max_phase": 4, "name": "ETHOSUXIMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL696", "mechanisms": ["Voltage-gated T-type calcium channel blocker"], "genes": ["CACNA1G", "CACNA1I", "CACNA1H"], "type": "Small molecule", "diseases": ["EPILEPSY", "MIGRAINE DISORDER", "REFLEX SYMPATHETIC DYSTROPHY"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 3}, {"efo_term": "SCOLIOSIS", "stage": 2}], "max_phase": 4, "name": "CLEVIDIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237132", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["HYPERTENSION", "SCOLIOSIS", "CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "MIGRAINE DISORDER", "stage": 2}, {"efo_term": "SEIZURES", "stage": 2}, {"efo_term": "TINNITUS", "stage": 2}], "max_phase": 2, "name": "Selurampanel", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545042", "mechanisms": ["Glutamate receptor ionotropic kainate antagonist", "Glutamate receptor ionotropic AMPA antagonist"], "genes": ["GRIK5", "GRIA2", "GRIK4", "GRIA4", "GRIA1", "GRIK3", "GRIK2", "GRIK1"], "type": "Small molecule", "diseases": ["MIGRAINE DISORDER", "SEIZURES", "TINNITUS"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 3}, {"efo_term": "RENAL INSUFFICIENCY", "stage": 1}], "max_phase": 3, "name": "IMAGABALIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103836", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNG3", "CACNA1G", "CACNA2D2", "CACNB1", "CACNG5", "CACNG4", "CACNA1S", "CACNA1I", "CACNA1F", "CACNG7", "CACNG1", "CACNG6", "CACNA1A", "CACNG8", "CACNA1B", "CACNA2D4", "CACNA1C", "CACNA2D1", "CACNA1D", "CACNB2", "CACNG2", "CACNB3", "CACNB4", "CACNA1H", "CACNA1E"], "type": "Small molecule", "diseases": ["ANXIETY", "RENAL INSUFFICIENCY"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "INTRACEREBRAL HEMORRHAGE", "stage": 3}], "max_phase": 4, "name": "NICARDIPINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200326", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["HYPERTENSION", "INTRACEREBRAL HEMORRHAGE"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "ESKETAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL395091", "mechanisms": ["Glutamate [NMDA] receptor negative allosteric modulator"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["LIVER DISEASE", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "CANCER", "stage": 3}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 2}], "max_phase": 4, "name": "MEMANTINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1699", "mechanisms": ["Glutamate [NMDA] receptor negative allosteric modulator"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["GAMBLING BEHAVIOUR", "CANCER"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 3, "name": "RALFINAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107771", "mechanisms": ["Glutamate [NMDA] receptor antagonist", "Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["GRIN2D", "GRIN3B", "CACNA1B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["PAIN", "NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 2}], "max_phase": 3, "name": "RAPASTINEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544917", "mechanisms": ["Glutamate [NMDA] receptor partial agonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Protein", "diseases": ["OBSESSIVE-COMPULSIVE DISORDER", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "NRX-1074", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545230", "mechanisms": ["Glutamate [NMDA] receptor partial agonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "NEUROPATHIC PAIN", "stage": 1}], "max_phase": 2, "name": "AV-101", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545351", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "FARAMPATOR", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1276138", "mechanisms": ["Glutamate receptor ionotropic AMPA positive allosteric modulator"], "genes": ["GRIA2", "GRIA4", "GRIA1"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "MK-8777", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707401", "mechanisms": ["Glutamate receptor ionotropic AMPA positive allosteric modulator"], "genes": ["GRIA2", "GRIA4", "GRIA1"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "FEVER", "stage": 4}, {"efo_term": "PAIN", "stage": 4}], "max_phase": 4, "name": "ZICONOTIDE ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1795072", "mechanisms": ["Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["CACNA1B"], "type": "Protein", "diseases": ["FEVER", "PAIN"]}, {"indications": [{"efo_term": "DIABETIC RETINOPATHY", "stage": 1}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}], "max_phase": 4, "name": "DEXTROMETHORPHAN HYDROBROMIDE MONOHYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256818", "mechanisms": ["Glutamate [NMDA] receptor subunit epsilon 1 antagonist"], "genes": ["GRIN2A"], "type": "Small molecule", "diseases": ["DIABETIC RETINOPATHY", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 2}], "max_phase": 2, "name": "ATAGABALIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL593430", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNG3", "CACNA1G", "CACNA2D2", "CACNB1", "CACNG5", "CACNG4", "CACNA1S", "CACNA1I", "CACNA1F", "CACNG7", "CACNG1", "CACNG6", "CACNA1A", "CACNG8", "CACNA1B", "CACNA2D4", "CACNA1C", "CACNA2D1", "CACNA1D", "CACNB2", "CACNG2", "CACNB3", "CACNB4", "CACNA1H", "CACNA1E"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "TRIMETHADIONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL695", "mechanisms": ["Voltage-gated T-type calcium channel blocker"], "genes": ["CACNA1G", "CACNA1I", "CACNA1H"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "METHSUXIMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL697", "mechanisms": ["Voltage-gated T-type calcium channel blocker"], "genes": ["CACNA1G", "CACNA1I", "CACNA1H"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "PHENSUXIMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL797", "mechanisms": ["Voltage-gated T-type calcium channel blocker"], "genes": ["CACNA1G", "CACNA1I", "CACNA1H"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "PARAMETHADIONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1100", "mechanisms": ["Voltage-gated T-type calcium channel blocker"], "genes": ["CACNA1G", "CACNA1I", "CACNA1H"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}], "max_phase": 4, "name": "FELODIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1480", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}], "max_phase": 4, "name": "NISOLDIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1726", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "ATRIAL FIBRILLATION", "stage": 4}], "max_phase": 4, "name": "DRONEDARONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201729", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION"]}, {"indications": [{"efo_term": "ATRIAL FIBRILLATION", "stage": 2}], "max_phase": 2, "name": "AZD1305", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545169", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "FELBAMATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1094", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}], "max_phase": 4, "name": "ORPHENADRINE (CHLORIDE)", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201023", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "NICOTINE DEPENDENCE", "stage": 2}], "max_phase": 2, "name": "GW468816", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1207366", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["NICOTINE DEPENDENCE"]}, {"indications": [{"efo_term": "TINNITUS", "stage": 3}], "max_phase": 3, "name": "NERAMEXANE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2106798", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["TINNITUS"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "LANICEMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107647", "mechanisms": ["Glutamate [NMDA] receptor blocker"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "PAIN", "stage": 1}], "max_phase": 4, "name": "ESKETAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2364609", "mechanisms": ["Glutamate [NMDA] receptor negative allosteric modulator"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 2, "name": "Indantadol", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707400", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "MIGRAINE DISORDER", "stage": 2}], "max_phase": 2, "name": "TEZAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14935", "mechanisms": ["Glutamate receptor ionotropic kainate antagonist", "Glutamate receptor ionotropic AMPA antagonist"], "genes": ["GRIK5", "GRIA2", "GRIK4", "GRIA4", "GRIA1", "GRIK3", "GRIK2", "GRIK1"], "type": "Small molecule", "diseases": ["MIGRAINE DISORDER"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}], "max_phase": 2, "name": "MIBAMPATOR", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1277001", "mechanisms": ["Glutamate receptor ionotropic AMPA positive allosteric modulator"], "genes": ["GRIA2", "GRIA4", "GRIA1"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}], "max_phase": 2, "name": "PF-04958242", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707379", "mechanisms": ["Glutamate receptor ionotropic AMPA positive allosteric modulator"], "genes": ["GRIA2", "GRIA4", "GRIA1"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "DIABETIC NEUROPATHY", "stage": 2}], "max_phase": 2, "name": "CNV2197944", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545172", "mechanisms": ["Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["CACNA1B"], "type": "Small molecule", "diseases": ["DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 2, "name": "Radiprodil", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL182066", "mechanisms": ["Glutamate NMDA receptor; GRIN1/GRIN2B antagonist"], "genes": ["GRIN1"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "CERC-301", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2068839", "mechanisms": ["Glutamate NMDA receptor; GRIN1/GRIN2B antagonist"], "genes": ["GRIN1"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 2}], "max_phase": 4, "name": "DEXTROMETHORPHAN POLISTIREX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201461", "mechanisms": ["Glutamate [NMDA] receptor subunit epsilon 1 antagonist"], "genes": ["GRIN2A"], "type": "Small molecule", "diseases": ["AUTISM SPECTRUM DISORDER"]}, {"indications": [], "max_phase": 4, "name": "BEPRIDIL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200382", "mechanisms": ["Voltage-gated calcium channel blocker"], "genes": ["CACNG3", "CACNA1G", "CACNA2D2", "CACNB1", "CACNG5", "CACNG4", "CACNA1S", "CACNA1I", "CACNA1F", "CACNG7", "CACNG1", "CACNG6", "CACNA1A", "CACNG8", "CACNA1B", "CACNA2D4", "CACNA1C", "CACNA2D1", "CACNA1D", "CACNB2", "CACNG2", "CACNB3", "CACNB4", "CACNA1H", "CACNA1E"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MIBEFRADIL DIHYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1534525", "mechanisms": ["Voltage-gated T-type calcium channel blocker"], "genes": ["CACNA1G", "CACNA1I", "CACNA1H"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "MIROGABALIN BESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545257", "mechanisms": ["Voltage-gated calcium channel alpha2/delta subunit 2 modulator", "Voltage-gated calcium channel alpha2/delta subunit 1 modulator"], "genes": ["CACNA2D2", "CACNA2D1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "ELPETRIGINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29919", "mechanisms": ["Voltage-gated L-type calcium channel blocker", "Voltage-gated P/Q-type calcium channel alpha-1A subunit blocker", "Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1A", "CACNA1B", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "VERAPAMIL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1280", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DILTIAZEM MALATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200805", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "AMLODIPINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200984", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "CNS-5161", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41306", "mechanisms": ["Glutamate [NMDA] receptor blocker"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ORPHENADRINE CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200395", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "NEBOGLAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1255840", "mechanisms": ["Glutamate [NMDA] receptor positive allosteric modulator"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ACAMPROSATE CALCIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2068724", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "DELUCEMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2110814", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "AZD8108", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707355", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "IRAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29741", "mechanisms": ["Glutamate receptor ionotropic AMPA antagonist"], "genes": ["GRIA2", "GRIA4", "GRIA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "ZONAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL119625", "mechanisms": ["Glutamate receptor ionotropic AMPA antagonist"], "genes": ["GRIA2", "GRIA4", "GRIA1"], "type": "Protein", "diseases": []}, {"indications": [], "max_phase": 0, "name": "DASOLAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103869", "mechanisms": ["Glutamate receptor ionotropic AMPA antagonist", "Glutamate receptor ionotropic kainate 1 antagonist"], "genes": ["GRIA2", "GRIA4", "GRIA1", "GRIK1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "BECAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107735", "mechanisms": ["Glutamate receptor ionotropic AMPA antagonist"], "genes": ["GRIA2", "GRIA4", "GRIA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "CX1739", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707399", "mechanisms": ["Glutamate receptor ionotropic AMPA positive allosteric modulator"], "genes": ["GRIA2", "GRIA4", "GRIA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Z160", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL604710", "mechanisms": ["Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["CACNA1B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "TRAXOPRODIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17350", "mechanisms": ["Glutamate NMDA receptor; GRIN1/GRIN2B antagonist"], "genes": ["GRIN1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "EVT-101", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545349", "mechanisms": ["Glutamate NMDA receptor; GRIN1/GRIN2B antagonist"], "genes": ["GRIN1"], "type": "Small molecule", "diseases": []}], "heat": 0.9759071, "nodes": [{"assoc": 1.0, "id": "ENSG00000006116", "label": "CACNG3"}, {"assoc": 1.0, "id": "ENSG00000006283", "label": "CACNA1G"}, {"assoc": 1.0, "id": "ENSG00000007402", "label": "CACNA2D2"}, {"assoc": 1.0, "id": "ENSG00000067191", "label": "CACNB1"}, {"assoc": 1.0, "id": "ENSG00000075429", "label": "CACNG5"}, {"assoc": 1.0, "id": "ENSG00000075461", "label": "CACNG4"}, {"assoc": 1.0, "id": "ENSG00000081248", "label": "CACNA1S"}, {"assoc": 1.0, "id": "ENSG00000100346", "label": "CACNA1I"}, {"assoc": 1.0, "id": "ENSG00000102001", "label": "CACNA1F"}, {"assoc": 1.0, "id": "ENSG00000105464", "label": "GRIN2D"}, {"assoc": 1.0, "id": "ENSG00000105605", "label": "CACNG7"}, {"assoc": 1.0, "id": "ENSG00000105737", "label": "GRIK5"}, {"assoc": 1.0, "id": "ENSG00000108878", "label": "CACNG1"}, {"assoc": 1.0, "id": "ENSG00000116032", "label": "GRIN3B"}, {"assoc": 1.0, "id": "ENSG00000120251", "label": "GRIA2"}, {"assoc": 1.0, "id": "ENSG00000130433", "label": "CACNG6"}, {"assoc": 1.0, "id": "ENSG00000141837", "label": "CACNA1A"}, {"assoc": 1.0, "id": "ENSG00000142408", "label": "CACNG8"}, {"assoc": 1.0, "id": "ENSG00000148408", "label": "CACNA1B"}, {"assoc": 1.0, "id": "ENSG00000149403", "label": "GRIK4"}, {"assoc": 1.0, "id": "ENSG00000151062", "label": "CACNA2D4"}, {"assoc": 1.0, "id": "ENSG00000151067", "label": "CACNA1C"}, {"assoc": 1.0, "id": "ENSG00000152578", "label": "GRIA4"}, {"assoc": 1.0, "id": "ENSG00000153956", "label": "CACNA2D1"}, {"assoc": 1.0, "id": "ENSG00000155511", "label": "GRIA1"}, {"assoc": 1.0, "id": "ENSG00000157388", "label": "CACNA1D"}, {"assoc": 1.0, "id": "ENSG00000161509", "label": "GRIN2C"}, {"assoc": 1.0, "id": "ENSG00000163873", "label": "GRIK3"}, {"assoc": 1.0, "id": "ENSG00000164418", "label": "GRIK2"}, {"assoc": 1.0, "id": "ENSG00000165995", "label": "CACNB2"}, {"assoc": 1.0, "id": "ENSG00000166862", "label": "CACNG2"}, {"assoc": 1.0, "id": "ENSG00000167535", "label": "CACNB3"}, {"assoc": 1.0, "id": "ENSG00000171189", "label": "GRIK1"}, {"assoc": 1.0, "id": "ENSG00000176884", "label": "GRIN1"}, {"assoc": 1.0, "id": "ENSG00000182389", "label": "CACNB4"}, {"assoc": 0.036284, "id": "ENSG00000182771", "label": "GRID1"}, {"assoc": 1.0, "id": "ENSG00000183454", "label": "GRIN2A"}, {"assoc": 1.0, "id": "ENSG00000196557", "label": "CACNA1H"}, {"assoc": 1.0, "id": "ENSG00000198216", "label": "CACNA1E"}, {"assoc": 1.0, "id": "ENSG00000198785", "label": "GRIN3A"}], "size": 40}, {"diseases": ["INSOMNIA", "OBSESSIVE-COMPULSIVE DISORDER", "EPILEPSY", "SEIZURES", "ANXIETY", "PAIN", "HEART DISEASE", "INJURY", "DRUG DEPENDENCE", "NEUROPATHIC PAIN", "MARIJUANA DEPENDENCE", "LEUKEMIA", "MIGRAINE DISORDER", "MORBID OBESITY", "RESPIRATORY INSUFFICIENCY", "HYPERTENSION", "SUBARACHNOID HEMORRHAGE", "HYPOTENSION", "CORONARY ARTERY DISEASE", "PREMATURE BIRTH", "OBSTRUCTIVE SLEEP APNEA", "UNIPOLAR DEPRESSION", "INFLAMMATION", "DEMENTIA", "ANXIETY DISORDER", "ALZHEIMERS DISEASE", "ALCOHOL DEPENDENCE", "COCAINE DEPENDENCE", "PANIC DISORDER", "POST-TRAUMATIC STRESS DISORDER", "STROKE", "DRAVET SYNDROME", "LENNOX-GASTAUT SYNDROME", "OPIOID DEPENDENCE", "INGUINAL HERNIA", "FEVER", "CANCER", "ALCOHOL DRINKING", "BIPOLAR DISORDER", "CONGENITAL HEART DISEASE", "METAMPHETAMINE DEPENDENCE", "GAMBLING BEHAVIOUR", "OBESITY", "SMOKING CESSATION", "NICOTINE DEPENDENCE", "PRADER-WILLI SYNDROME", "CEREBRAL ISCHEMIA", "ACUTE RESPIRATORY DISTRESS SYNDROME", "ACUTE KIDNEY INJURY", "POST-OPERATIVE SIGN OR SYMPTOM", "COLORECTAL ADENOCARCINOMA", "AUTISM SPECTRUM DISORDER", "IRRITABLE BOWEL SYNDROME", "CONSTIPATION", "HIV INFECTION", "PORTAL HYPERTENSION"], "links": [{"source": "ENSG00000022355", "target": "ENSG00000109158"}, {"source": "ENSG00000022355", "target": "ENSG00000113327"}, {"source": "ENSG00000022355", "target": "ENSG00000145863"}, {"source": "ENSG00000022355", "target": "ENSG00000145864"}, {"source": "ENSG00000022355", "target": "ENSG00000151834"}, {"source": "ENSG00000022355", "target": "ENSG00000163288"}, {"source": "ENSG00000022355", "target": "ENSG00000166206"}, {"source": "ENSG00000022355", "target": "ENSG00000182256"}, {"source": "ENSG00000022355", "target": "ENSG00000186297"}, {"source": "ENSG00000109158", "target": "ENSG00000113327"}, {"source": "ENSG00000109158", "target": "ENSG00000145863"}, {"source": "ENSG00000109158", "target": "ENSG00000145864"}, {"source": "ENSG00000109158", "target": "ENSG00000151834"}, {"source": "ENSG00000109158", "target": "ENSG00000163288"}, {"source": "ENSG00000109158", "target": "ENSG00000166206"}, {"source": "ENSG00000109158", "target": "ENSG00000182256"}, {"source": "ENSG00000109158", "target": "ENSG00000186297"}, {"source": "ENSG00000109738", "target": "ENSG00000145888"}, {"source": "ENSG00000113327", "target": "ENSG00000145863"}, {"source": "ENSG00000113327", "target": "ENSG00000145864"}, {"source": "ENSG00000113327", "target": "ENSG00000151834"}, {"source": "ENSG00000113327", "target": "ENSG00000163288"}, {"source": "ENSG00000113327", "target": "ENSG00000166206"}, {"source": "ENSG00000113327", "target": "ENSG00000182256"}, {"source": "ENSG00000113327", "target": "ENSG00000186297"}, {"source": "ENSG00000145863", "target": "ENSG00000145864"}, {"source": "ENSG00000145863", "target": "ENSG00000151834"}, {"source": "ENSG00000145863", "target": "ENSG00000163288"}, {"source": "ENSG00000145863", "target": "ENSG00000166206"}, {"source": "ENSG00000145863", "target": "ENSG00000182256"}, {"source": "ENSG00000145863", "target": "ENSG00000186297"}, {"source": "ENSG00000145864", "target": "ENSG00000151834"}, {"source": "ENSG00000145864", "target": "ENSG00000163288"}, {"source": "ENSG00000145864", "target": "ENSG00000166206"}, {"source": "ENSG00000145864", "target": "ENSG00000182256"}, {"source": "ENSG00000145864", "target": "ENSG00000186297"}, {"source": "ENSG00000151834", "target": "ENSG00000163288"}, {"source": "ENSG00000151834", "target": "ENSG00000166206"}, {"source": "ENSG00000151834", "target": "ENSG00000182256"}, {"source": "ENSG00000151834", "target": "ENSG00000186297"}, {"source": "ENSG00000163288", "target": "ENSG00000166206"}, {"source": "ENSG00000163288", "target": "ENSG00000182256"}, {"source": "ENSG00000163288", "target": "ENSG00000186297"}, {"source": "ENSG00000166206", "target": "ENSG00000182256"}, {"source": "ENSG00000166206", "target": "ENSG00000186297"}, {"source": "ENSG00000182256", "target": "ENSG00000186297"}, {"source": "ENSG00000109738", "type": "manual", "target": "ENSG00000171723"}, {"source": "ENSG00000171723", "type": "manual", "target": "ENSG00000163288"}, {"source": "ENSG00000109738", "type": "manual", "target": "ENSG00000114859"}, {"source": "ENSG00000114859", "type": "manual", "target": "ENSG00000022355"}, {"source": "ENSG00000145888", "type": "manual", "target": "ENSG00000109738"}, {"source": "ENSG00000094755", "type": "manual", "target": "ENSG00000139112"}, {"source": "ENSG00000139112", "type": "manual", "target": "ENSG00000163288"}, {"source": "ENSG00000094755", "type": "manual", "target": "ENSG00000115896"}, {"source": "ENSG00000115896", "type": "manual", "target": "ENSG00000163288"}, {"source": "ENSG00000094755", "type": "manual", "target": "ENSG00000170296"}, {"source": "ENSG00000170296", "type": "manual", "target": "ENSG00000163288"}, {"source": "ENSG00000094755", "type": "manual", "target": "ENSG00000073969"}, {"source": "ENSG00000073969", "type": "manual", "target": "ENSG00000163288"}, {"source": "ENSG00000094755", "type": "manual", "target": "ENSG00000034713"}, {"source": "ENSG00000034713", "type": "manual", "target": "ENSG00000163288"}, {"source": "ENSG00000094755", "type": "manual", "target": "ENSG00000171723"}, {"source": "ENSG00000094755", "type": "manual", "target": "ENSG00000115993"}, {"source": "ENSG00000115993", "type": "manual", "target": "ENSG00000163288"}, {"source": "ENSG00000187730", "type": "manual", "target": "ENSG00000139112"}, {"source": "ENSG00000187730", "type": "manual", "target": "ENSG00000115896"}, {"source": "ENSG00000187730", "type": "manual", "target": "ENSG00000170296"}, {"source": "ENSG00000187730", "type": "manual", "target": "ENSG00000073969"}, {"source": "ENSG00000187730", "type": "manual", "target": "ENSG00000034713"}, {"source": "ENSG00000187730", "type": "manual", "target": "ENSG00000171723"}, {"source": "ENSG00000187730", "type": "manual", "target": "ENSG00000115993"}, {"source": "ENSG00000187730", "type": "manual", "target": "ENSG00000114859"}, {"source": "ENSG00000163285", "type": "manual", "target": "ENSG00000139112"}, {"source": "ENSG00000163285", "type": "manual", "target": "ENSG00000115896"}, {"source": "ENSG00000163285", "type": "manual", "target": "ENSG00000170296"}, {"source": "ENSG00000163285", "type": "manual", "target": "ENSG00000073969"}, {"source": "ENSG00000163285", "type": "manual", "target": "ENSG00000034713"}, {"source": "ENSG00000163285", "type": "manual", "target": "ENSG00000171723"}, {"source": "ENSG00000163285", "type": "manual", "target": "ENSG00000115993"}, {"source": "ENSG00000102287", "type": "manual", "target": "ENSG00000139112"}, {"source": "ENSG00000102287", "type": "manual", "target": "ENSG00000115896"}, {"source": "ENSG00000102287", "type": "manual", "target": "ENSG00000170296"}, {"source": "ENSG00000102287", "type": "manual", "target": "ENSG00000073969"}, {"source": "ENSG00000102287", "type": "manual", "target": "ENSG00000034713"}, {"source": "ENSG00000102287", "type": "manual", "target": "ENSG00000171723"}, {"source": "ENSG00000102287", "type": "manual", "target": "ENSG00000115993"}], "drugs": [{"indications": [{"efo_term": "PAIN", "stage": 3}, {"efo_term": "RESPIRATORY INSUFFICIENCY", "stage": 3}, {"efo_term": "HYPERTENSION", "stage": 3}, {"efo_term": "SUBARACHNOID HEMORRHAGE", "stage": 3}, {"efo_term": "EPILEPSY", "stage": 3}, {"efo_term": "INJURY", "stage": 3}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "LEUKEMIA", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}, {"efo_term": "MORBID OBESITY", "stage": 2}, {"efo_term": "HYPOTENSION", "stage": 2}, {"efo_term": "OBSTRUCTIVE SLEEP APNEA", "stage": 2}, {"efo_term": "INSOMNIA", "stage": 1}, {"efo_term": "PREMATURE BIRTH", "stage": 1}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}, {"efo_term": "INFLAMMATION", "stage": 1}], "max_phase": 4, "name": "PROPOFOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL526", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["LEUKEMIA", "MIGRAINE DISORDER", "MORBID OBESITY", "PAIN", "RESPIRATORY INSUFFICIENCY", "HYPERTENSION", "SUBARACHNOID HEMORRHAGE", "HYPOTENSION", "EPILEPSY", "INJURY", "CORONARY ARTERY DISEASE", "INSOMNIA", "PREMATURE BIRTH", "OBSTRUCTIVE SLEEP APNEA", "UNIPOLAR DEPRESSION", "INFLAMMATION"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "OBESITY", "stage": 3}, {"efo_term": "SMOKING CESSATION", "stage": 3}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 3}, {"efo_term": "PRADER-WILLI SYNDROME", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "ALCOHOL DRINKING", "stage": 2}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 2}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "CEREBRAL ISCHEMIA", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 1}, {"efo_term": "CONGENITAL HEART DISEASE", "stage": 1}], "max_phase": 4, "name": "TOPIRAMATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492", "mechanisms": ["GABA-A receptor; anion channel positive modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["COCAINE DEPENDENCE", "EPILEPSY", "ALCOHOL DRINKING", "BIPOLAR DISORDER", "MIGRAINE DISORDER", "ALCOHOL DEPENDENCE", "CONGENITAL HEART DISEASE", "METAMPHETAMINE DEPENDENCE", "GAMBLING BEHAVIOUR", "OBESITY", "SMOKING CESSATION", "NICOTINE DEPENDENCE", "MARIJUANA DEPENDENCE", "PRADER-WILLI SYNDROME", "CEREBRAL ISCHEMIA"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 4}, {"efo_term": "ANXIETY DISORDER", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "DEMENTIA", "stage": 1}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 1}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 1}, {"efo_term": "DRUG DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "LORAZEPAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL580", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["ANXIETY", "DEMENTIA", "EPILEPSY", "UNIPOLAR DEPRESSION", "ANXIETY DISORDER", "ALZHEIMERS DISEASE", "ALCOHOL DEPENDENCE", "DRUG DEPENDENCE", "COCAINE DEPENDENCE"]}, {"indications": [{"efo_term": "CANCER", "stage": 3}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "OBESITY", "stage": 2}, {"efo_term": "ACUTE KIDNEY INJURY", "stage": 2}, {"efo_term": "MORBID OBESITY", "stage": 2}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "CONGENITAL HEART DISEASE", "stage": 2}, {"efo_term": "POST-OPERATIVE SIGN OR SYMPTOM", "stage": 1}, {"efo_term": "INFLAMMATION", "stage": 1}, {"efo_term": "HEART DISEASE", "stage": 0}], "max_phase": 4, "name": "SEVOFLURANE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200694", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator", "Glycine receptor (alpha-1/beta) positive modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GLRB", "GABRG2", "GABRA6", "GABRB2", "GLRA1", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["OBESITY", "ACUTE KIDNEY INJURY", "CANCER", "MORBID OBESITY", "POST-OPERATIVE SIGN OR SYMPTOM", "HEART DISEASE", "INJURY", "CORONARY ARTERY DISEASE", "INFLAMMATION", "CONGENITAL HEART DISEASE"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 4}, {"efo_term": "DRAVET SYNDROME", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "LENNOX-GASTAUT SYNDROME", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 1}], "max_phase": 4, "name": "CLOBAZAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL70418", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["ANXIETY", "DRAVET SYNDROME", "NEUROPATHIC PAIN", "PAIN", "LENNOX-GASTAUT SYNDROME"]}, {"indications": [{"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 4}, {"efo_term": "CONSTIPATION", "stage": 4}, {"efo_term": "OPIOID DEPENDENCE", "stage": 3}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 3}, {"efo_term": "HIV INFECTION", "stage": 2}], "max_phase": 4, "name": "LUBIPROSTONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201134", "mechanisms": ["Chloride channel protein 2 opener"], "genes": ["CLCN2"], "type": "Small molecule", "diseases": ["IRRITABLE BOWEL SYNDROME", "CONSTIPATION", "OPIOID DEPENDENCE", "COLORECTAL ADENOCARCINOMA", "HIV INFECTION"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 2}, {"efo_term": "SEIZURES", "stage": 2}, {"efo_term": "PAIN", "stage": 2}], "max_phase": 4, "name": "DIAZEPAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["EPILEPSY", "SEIZURES", "ANXIETY", "PAIN"]}, {"indications": [{"efo_term": "PANIC DISORDER", "stage": 4}, {"efo_term": "ANXIETY", "stage": 4}, {"efo_term": "ANXIETY DISORDER", "stage": 4}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}], "max_phase": 4, "name": "ALPRAZOLAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL661", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["PANIC DISORDER", "ANXIETY", "POST-TRAUMATIC STRESS DISORDER", "ANXIETY DISORDER"]}, {"indications": [{"efo_term": "INJURY", "stage": 3}, {"efo_term": "HEART DISEASE", "stage": 1}, {"efo_term": "DRUG DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "PENTOBARBITAL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL448", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["HEART DISEASE", "INJURY", "DRUG DEPENDENCE"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "NEUROPATHIC PAIN", "stage": 1}], "max_phase": 4, "name": "CLONAZEPAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL452", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN", "EPILEPSY", "MARIJUANA DEPENDENCE"]}, {"indications": [{"efo_term": "FEVER", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "CANCER", "stage": 3}], "max_phase": 4, "name": "METHOXYFLURANE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1341", "mechanisms": ["GABA-A receptor; anion channel positive modulator", "Glycine receptor (alpha-1/beta) agonist"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GLRB", "GABRG2", "GABRA6", "GABRB2", "GLRA1", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["FEVER", "PAIN", "CANCER"]}, {"indications": [{"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 2}, {"efo_term": "INSOMNIA", "stage": 1}], "max_phase": 4, "name": "FLUMAZENIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL407", "mechanisms": ["GABA-A receptor; anion channel allosteric antagonist"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["INSOMNIA", "OBSESSIVE-COMPULSIVE DISORDER"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "STROKE", "stage": 2}], "max_phase": 4, "name": "PRIMIDONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL856", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["EPILEPSY", "STROKE"]}, {"indications": [{"efo_term": "INGUINAL HERNIA", "stage": 3}, {"efo_term": "OPIOID DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "ISOFLURANE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator", "Glycine receptor (alpha-1/beta) positive modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GLRB", "GABRG2", "GABRA6", "GABRB2", "GLRA1", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["OPIOID DEPENDENCE", "INGUINAL HERNIA"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 4}, {"efo_term": "OBSTRUCTIVE SLEEP APNEA", "stage": 2}], "max_phase": 4, "name": "ESZOPICLONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1522", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["INSOMNIA", "OBSTRUCTIVE SLEEP APNEA"]}, {"indications": [{"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 2}, {"efo_term": "POST-OPERATIVE SIGN OR SYMPTOM", "stage": 1}], "max_phase": 4, "name": "DESFLURANE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200733", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator", "Glycine receptor (alpha-1/beta) positive modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GLRB", "GABRG2", "GABRA6", "GABRB2", "GLRA1", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["POST-OPERATIVE SIGN OR SYMPTOM", "COLORECTAL ADENOCARCINOMA"]}, {"indications": [{"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 2}, {"efo_term": "ANXIETY", "stage": 2}], "max_phase": 2, "name": "AZD7325", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1783282", "mechanisms": ["GABA receptor alpha-2 subunit positive allosteric modulator"], "genes": ["GABRA2"], "type": "Small molecule", "diseases": ["AUTISM SPECTRUM DISORDER", "ANXIETY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "METHARBITAL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL450", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 4}], "max_phase": 4, "name": "CHLORDIAZEPOXIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL451", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["ANXIETY"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 4}], "max_phase": 4, "name": "OXAZEPAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL568", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["ANXIETY"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 3}], "max_phase": 4, "name": "ETOMIDATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL681", "mechanisms": ["GABA-A receptor; anion channel positive modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["HYPERTENSION"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 4}], "max_phase": 4, "name": "TEMAZEPAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL967", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 4}], "max_phase": 4, "name": "PRAZEPAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL969", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["ANXIETY"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 4}], "max_phase": 4, "name": "HALAZEPAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL970", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["ANXIETY"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 4}], "max_phase": 4, "name": "MEPROBAMATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL979", "mechanisms": ["GABA-A receptor; anion channel agonist"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["ANXIETY"]}, {"indications": [{"efo_term": "ACUTE RESPIRATORY DISTRESS SYNDROME", "stage": 3}], "max_phase": 4, "name": "MIDAZOLAM HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200420", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["ACUTE RESPIRATORY DISTRESS SYNDROME"]}, {"indications": [{"efo_term": "PAIN", "stage": 2}], "max_phase": 2, "name": "PF-06372865", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707402", "mechanisms": ["GABA-A receptor; anion channel agonist"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 2}], "max_phase": 2, "name": "ADIPIPLON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103791", "mechanisms": ["GABA-A receptor; benzodiazepine site partial agonist"], "genes": ["GABRA1", "GABRA4", "GABRG2", "GABRA6", "GABRA2", "GABRG1", "GABRG3", "GABRA5"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}], "max_phase": 2, "name": "RESEQUINIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107801", "mechanisms": ["GABA-A receptor; benzodiazepine site inverse agonist"], "genes": ["GABRA1", "GABRA4", "GABRG2", "GABRA6", "GABRA2", "GABRG1", "GABRG3", "GABRA5"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 2}], "max_phase": 4, "name": "ZALEPLON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1521", "mechanisms": ["GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator"], "genes": ["GABRA1", "GABRG2", "GABRB1"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 4}], "max_phase": 4, "name": "ZOLPIDEM TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1723343", "mechanisms": ["GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator"], "genes": ["GABRA1", "GABRG2", "GABRB1"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}], "max_phase": 2, "name": "ETAZOLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL356388", "mechanisms": ["GABA receptor beta-3 subunit positive allosteric modulator"], "genes": ["GABRB3"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "PORTAL HYPERTENSION", "stage": 2}], "max_phase": 2, "name": "COBIPROSTONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103799", "mechanisms": ["Chloride channel protein 2 activator"], "genes": ["CLCN2"], "type": "Small molecule", "diseases": ["PORTAL HYPERTENSION"]}, {"indications": [], "max_phase": 3, "name": "INDIPLON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL262075", "mechanisms": ["GABA receptor alpha-1 subunit positive allosteric modulator"], "genes": ["GABRA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BUTALBITAL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL454", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ETHCHLORVYNOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL591", "mechanisms": ["GABA-A receptor; anion channel positive modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIAZOLAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL646", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THIOPENTAL SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL738", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METHOHEXITAL SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL30219", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ESTAZOLAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL285674", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HALOTHANE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL931", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator", "Glycine receptor (alpha-1/beta) positive modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GLRB", "GABRG2", "GABRA6", "GABRB2", "GLRA1", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PENTOBARBITAL SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL971", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "GLUTETHIMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1102", "mechanisms": ["GABA-A receptor; anion channel positive modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ENFLURANE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1257", "mechanisms": ["GABA-A receptor; anion channel positive modulator", "Glycine receptor (alpha-1/beta) positive modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GLRB", "GABRG2", "GABRA6", "GABRB2", "GLRA1", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "QUAZEPAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200472", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "FLURAZEPAM HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200602", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CHLORDIAZEPOXIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200703", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRICLOFOS SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200789", "mechanisms": ["GABA-A receptor; anion channel positive modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METHYPRYLON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200790", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TALBUTAL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200802", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "SECOBARBITAL SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200903", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BUTABARBITAL SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200982", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THIAMYLAL SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201065", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ACAMPROSATE CALCIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2068724", "mechanisms": ["GABA-A receptor; anion channel positive modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CLORAZEPATE DIPOTASSIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2096631", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "Lorediplon", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707317", "mechanisms": ["GABA-A receptor; benzodiazepine site positive allosteric modulator"], "genes": ["GABRA1", "GABRA4", "GABRG2", "GABRA6", "GABRA2", "GABRG1", "GABRG3", "GABRA5"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "GABOXADOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL312443", "mechanisms": ["GABA-A receptor; agonist GABA site agonist"], "genes": ["GABRA1", "GABRA4", "GABRA6", "GABRB2", "GABRA2", "GABRB1", "GABRB3", "GABRA5"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "AZD6280", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1783256", "mechanisms": ["GABA receptor alpha-2 subunit positive allosteric modulator"], "genes": ["GABRA2"], "type": "Small molecule", "diseases": []}], "heat": 0.6666666666666666, "nodes": [{"assoc": 1.0, "id": "ENSG00000022355", "label": "GABRA1"}, {"assoc": 1.0, "id": "ENSG00000094755", "label": "GABRP"}, {"assoc": 1.0, "id": "ENSG00000102287", "label": "GABRE"}, {"assoc": 1.0, "id": "ENSG00000109158", "label": "GABRA4"}, {"assoc": 1.0, "id": "ENSG00000109738", "label": "GLRB"}, {"assoc": 1.0, "id": "ENSG00000113327", "label": "GABRG2"}, {"assoc": 1.0, "id": "ENSG00000145863", "label": "GABRA6"}, {"assoc": 1.0, "id": "ENSG00000145864", "label": "GABRB2"}, {"assoc": 1.0, "id": "ENSG00000145888", "label": "GLRA1"}, {"assoc": 1.0, "id": "ENSG00000151834", "label": "GABRA2"}, {"assoc": 1.0, "id": "ENSG00000163285", "label": "GABRG1"}, {"assoc": 1.0, "id": "ENSG00000163288", "label": "GABRB1"}, {"assoc": 1.0, "id": "ENSG00000166206", "label": "GABRB3"}, {"assoc": 1.0, "id": "ENSG00000182256", "label": "GABRG3"}, {"assoc": 1.0, "id": "ENSG00000186297", "label": "GABRA5"}, {"assoc": 1.0, "id": "ENSG00000187730", "label": "GABRD"}, {"assoc": 0, "id": "ENSG00000171723", "label": "GPHN"}, {"assoc": 0, "id": "ENSG00000114859", "label": "CLCN2"}, {"assoc": 0, "id": "ENSG00000139112", "label": "GABARAPL1"}, {"assoc": 0, "id": "ENSG00000115896", "label": "PLCL1"}, {"assoc": 0, "id": "ENSG00000170296", "label": "GABARAP"}, {"assoc": 0, "id": "ENSG00000073969", "label": "NSF"}, {"assoc": 0, "id": "ENSG00000034713", "label": "GABARAPL2"}, {"assoc": 0, "id": "ENSG00000115993", "label": "TRAK2"}], "size": 24}, {"diseases": ["HEMORRHAGE", "SPONTANEOUS ABORTION", "CYTOMEGALOVIRUS INFECTION", "INFECTION", "UTERINE FIBROID", "PEPTIC ULCER", "GASTROESOPHAGEAL REFLUX DISEASE", "PAIN", "MENORRHAGIA", "PREECLAMPSIA", "PREGNANCY", "UNIPOLAR DEPRESSION", "PSYCHOSIS", "SCHIZOPHRENIA", "AMYOTROPHIC LATERAL SCLEROSIS", "CARDIOVASCULAR DISEASE", "BIPOLAR DISORDER", "AGITATION", "POST-OPERATIVE SIGN OR SYMPTOM", "TOURETTE SYNDROME", "CONDUCT DISORDER", "ACUTE MYELOID LEUKEMIA", "NEONATAL ABSTINENCE SYNDROME", "EATING DISORDER", "HUNTINGTON DISEASE", "DIABETES MELLITUS", "GAMBLING BEHAVIOUR", "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "FISH-EYE DISEASE", "HIV INFECTION", "ALCOHOL DEPENDENCE", "AUTISM", "VOMITING", "INSULIN RESISTANCE", "POST OPERATIVE NAUSEA AND VOMITING", "CANCER", "LYMPHOID NEOPLASM", "BREAST CARCINOMA", "ASTHMA", "NICOTINE DEPENDENCE", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "NEUROPATHIC PAIN", "FIBROMYALGIA", "PARKINSON'S DISEASE", "RESTLESS LEGS SYNDROME", "TYPE II DIABETES MELLITUS", "INFERTILITY", "HYPERPROLACTINEMIA", "HYPOGONADISM", "GROWTH HORMONE EXCESS", "ACROMEGALY", "HEROIN DEPENDENCE", "OPIOID DEPENDENCE", "OSTEOARTHRITIS", "DRUG DEPENDENCE", "COCAINE DEPENDENCE", "LUMBAR DISC DEGENERATION", "CONSTIPATION", "EPILEPSY", "PRURITUS", "OBESITY", "CHRONIC KIDNEY DISEASE", "LIVER DISEASE", "ALCOHOL DRINKING", "METAMPHETAMINE DEPENDENCE", "CROHN'S DISEASE", "OBSESSIVE-COMPULSIVE DISORDER", "HAIR-PULLING", "MARIJUANA DEPENDENCE", "MULTIPLE SCLEROSIS", "BORDERLINE PERSONALITY DISORDER SYMPTOM", "TYPE I DIABETES MELLITUS", "COUGH", "OSTEOARTHRITIS, KNEE", "DIABETIC NEUROPATHY", "OTITIS MEDIA", "ADENOMA", "SUBARACHNOID HEMORRHAGE", "MORBID OBESITY", "OBSTRUCTIVE SLEEP APNEA", "HYPOTENSION", "IMMUNE SYSTEM DISEASE", "OCCLUSIVE ARTERIAL DISEASE", "KIDNEY STONE", "DYSPNEA", "DIGESTIVE SYSTEM DISEASE", "DIARRHEA", "SCOLIOSIS", "PREMATURE EJACULATION", "HALLUX VALGUS", "IRRITABLE BOWEL SYNDROME", "ANOREXIA NERVOSA", "NAUSEA", "ALZHEIMERS DISEASE", "SMOKING CESSATION", "ACUTE GRAFT VS. HOST DISEASE", "ANXIETY", "NEOPLASM", "SEIZURES", "LENNOX-GASTAUT SYNDROME", "POST-TRAUMATIC STRESS DISORDER", "PRADER-WILLI SYNDROME", "LUNG CARCINOMA", "DRAVET SYNDROME", "HEPATIC STEATOSIS", "ULCERATIVE COLITIS", "SPASTICITY", "MIGRAINE DISORDER", "MIGRAINE WITH AURA", "INJURY", "NAUSEA AND VOMITING", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "MENTAL OR BEHAVIOURAL DISORDER", "AGGRESSIVE BEHAVIOR", "AUTISM SPECTRUM DISORDER", "POSTPARTUM DEPRESSION", "SCHIZOAFFECTIVE DISORDER", "PSORIASIS", "OVARIAN HYPERSTIMULATION SYNDROME", "ENDOMETRIOSIS", "INSOMNIA", "HYPERTENSION", "GLAUCOMA", "SEPTIC SHOCK", "CEREBRAL ISCHEMIA", "BONE NEOPLASM", "OPEN-ANGLE GLAUCOMA", "RETINITIS PIGMENTOSA", "HYPEREMIA", "OCULAR HYPERTENSION", "ROSACEA", "INCREASED INTRAOCULAR PRESSURE", "AGE-RELATED MACULAR DEGENERATION", "ALLERGIC CONJUNCTIVITIS", "ALLERGIC RHINITIS", "EYE DISEASE", "RHINITIS", "GRAVES OPHTHALMOPATHY", "NASAL OBSTRUCTION", "SUDDEN CARDIAC ARREST", "BRONCHIOLITIS", "OBSTRUCTIVE LUNG DISEASE", "SEASONAL ALLERGIC RHINITIS", "URTICARIA", "ANGIOEDEMA", "SINUSITIS", "RENAL INSUFFICIENCY", "ORTHOSTATIC HYPOTENSION", "MULTIPLE SYSTEM ATROPHY", "STROKE", "HEART FAILURE", "CONGESTIVE HEART FAILURE", "ATRIAL FIBRILLATION", "ANGINA PECTORIS", "CORONARY ARTERY DISEASE", "MYOCARDIAL INFARCTION", "CHRONIC LYMPHOCYTIC LEUKEMIA", "CARDIOMYOPATHY", "WOLFF-PARKINSON-WHITE SYNDROME", "CORONARY STENOSIS", "AMBLYOPIA", "PREMATURE BIRTH", "RETINOPATHY OF PREMATURITY", "BLADDER CARCINOMA", "PULMONARY HYPERTENSION", "EMPHYSEMA", "ALTITUDE SICKNESS", "CHRONIC BRONCHITIS", "NEUROGENIC BLADDER", "HYPERHIDROSIS", "URINARY INCONTINENCE", "ENURESIS NOCTURNA", "OVERACTIVE BLADDER", "HYPOGLYCEMIA", "MYOPIA"], "links": [{"source": "ENSG00000050628", "target": "ENSG00000069696"}, {"source": "ENSG00000050628", "target": "ENSG00000082556"}, {"source": "ENSG00000050628", "target": "ENSG00000112038"}, {"source": "ENSG00000050628", "target": "ENSG00000116329"}, {"source": "ENSG00000050628", "target": "ENSG00000118432"}, {"source": "ENSG00000050628", "target": "ENSG00000135312"}, {"source": "ENSG00000050628", "target": "ENSG00000149295"}, {"source": "ENSG00000050628", "target": "ENSG00000150594"}, {"source": "ENSG00000050628", "target": "ENSG00000151577"}, {"source": "ENSG00000050628", "target": "ENSG00000163485"}, {"source": "ENSG00000050628", "target": "ENSG00000179097"}, {"source": "ENSG00000050628", "target": "ENSG00000181072"}, {"source": "ENSG00000050628", "target": "ENSG00000184160"}, {"source": "ENSG00000069696", "target": "ENSG00000082556"}, {"source": "ENSG00000069696", "target": "ENSG00000112038"}, {"source": "ENSG00000069696", "target": "ENSG00000116329"}, {"source": "ENSG00000069696", "target": "ENSG00000118432"}, {"source": "ENSG00000069696", "target": "ENSG00000135312"}, {"source": "ENSG00000069696", "target": "ENSG00000149295"}, {"source": "ENSG00000069696", "target": "ENSG00000150594"}, {"source": "ENSG00000069696", "target": "ENSG00000151577"}, {"source": "ENSG00000069696", "target": "ENSG00000163485"}, {"source": "ENSG00000069696", "target": "ENSG00000179097"}, {"source": "ENSG00000069696", "target": "ENSG00000181072"}, {"source": "ENSG00000069696", "target": "ENSG00000184160"}, {"source": "ENSG00000082556", "target": "ENSG00000112038"}, {"source": "ENSG00000082556", "target": "ENSG00000116329"}, {"source": "ENSG00000082556", "target": "ENSG00000118432"}, {"source": "ENSG00000082556", "target": "ENSG00000135312"}, {"source": "ENSG00000082556", "target": "ENSG00000149295"}, {"source": "ENSG00000082556", "target": "ENSG00000150594"}, {"source": "ENSG00000082556", "target": "ENSG00000151577"}, {"source": "ENSG00000082556", "target": "ENSG00000163485"}, {"source": "ENSG00000082556", "target": "ENSG00000179097"}, {"source": "ENSG00000082556", "target": "ENSG00000181072"}, {"source": "ENSG00000082556", "target": "ENSG00000184160"}, {"source": "ENSG00000112038", "target": "ENSG00000116329"}, {"source": "ENSG00000112038", "target": "ENSG00000118432"}, {"source": "ENSG00000112038", "target": "ENSG00000135312"}, {"source": "ENSG00000112038", "target": "ENSG00000149295"}, {"source": "ENSG00000112038", "target": "ENSG00000150594"}, {"source": "ENSG00000112038", "target": "ENSG00000151577"}, {"source": "ENSG00000112038", "target": "ENSG00000163485"}, {"source": "ENSG00000112038", "target": "ENSG00000179097"}, {"source": "ENSG00000112038", "target": "ENSG00000181072"}, {"source": "ENSG00000112038", "target": "ENSG00000184160"}, {"source": "ENSG00000116329", "target": "ENSG00000118432"}, {"source": "ENSG00000116329", "target": "ENSG00000135312"}, {"source": "ENSG00000116329", "target": "ENSG00000149295"}, {"source": "ENSG00000116329", "target": "ENSG00000150594"}, {"source": "ENSG00000116329", "target": "ENSG00000151577"}, {"source": "ENSG00000116329", "target": "ENSG00000163485"}, {"source": "ENSG00000116329", "target": "ENSG00000179097"}, {"source": "ENSG00000116329", "target": "ENSG00000181072"}, {"source": "ENSG00000116329", "target": "ENSG00000184160"}, {"source": "ENSG00000118432", "target": "ENSG00000135312"}, {"source": "ENSG00000118432", "target": "ENSG00000149295"}, {"source": "ENSG00000118432", "target": "ENSG00000150594"}, {"source": "ENSG00000118432", "target": "ENSG00000151577"}, {"source": "ENSG00000118432", "target": "ENSG00000163485"}, {"source": "ENSG00000118432", "target": "ENSG00000179097"}, {"source": "ENSG00000118432", "target": "ENSG00000181072"}, {"source": "ENSG00000118432", "target": "ENSG00000184160"}, {"source": "ENSG00000135312", "target": "ENSG00000149295"}, {"source": "ENSG00000135312", "target": "ENSG00000150594"}, {"source": "ENSG00000135312", "target": "ENSG00000151577"}, {"source": "ENSG00000135312", "target": "ENSG00000163485"}, {"source": "ENSG00000135312", "target": "ENSG00000179097"}, {"source": "ENSG00000135312", "target": "ENSG00000181072"}, {"source": "ENSG00000135312", "target": "ENSG00000184160"}, {"source": "ENSG00000149295", "target": "ENSG00000150594"}, {"source": "ENSG00000149295", "target": "ENSG00000151577"}, {"source": "ENSG00000149295", "target": "ENSG00000163485"}, {"source": "ENSG00000149295", "target": "ENSG00000179097"}, {"source": "ENSG00000149295", "target": "ENSG00000181072"}, {"source": "ENSG00000149295", "target": "ENSG00000184160"}, {"source": "ENSG00000150594", "target": "ENSG00000151577"}, {"source": "ENSG00000150594", "target": "ENSG00000163485"}, {"source": "ENSG00000150594", "target": "ENSG00000179097"}, {"source": "ENSG00000150594", "target": "ENSG00000181072"}, {"source": "ENSG00000150594", "target": "ENSG00000184160"}, {"source": "ENSG00000151577", "target": "ENSG00000163485"}, {"source": "ENSG00000151577", "target": "ENSG00000179097"}, {"source": "ENSG00000151577", "target": "ENSG00000181072"}, {"source": "ENSG00000151577", "target": "ENSG00000184160"}, {"source": "ENSG00000163485", "target": "ENSG00000179097"}, {"source": "ENSG00000163485", "target": "ENSG00000181072"}, {"source": "ENSG00000163485", "target": "ENSG00000184160"}, {"source": "ENSG00000179097", "target": "ENSG00000181072"}, {"source": "ENSG00000179097", "target": "ENSG00000184160"}, {"source": "ENSG00000181072", "target": "ENSG00000184160"}], "drugs": [{"indications": [{"efo_term": "ALCOHOL DEPENDENCE", "stage": 4}, {"efo_term": "OPIOID DEPENDENCE", "stage": 4}, {"efo_term": "HIV INFECTION", "stage": 3}, {"efo_term": "HEROIN DEPENDENCE", "stage": 3}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "BORDERLINE PERSONALITY DISORDER SYMPTOM", "stage": 3}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 2}, {"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 2}, {"efo_term": "CROHN'S DISEASE", "stage": 2}, {"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "HAIR-PULLING", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "ALCOHOL DRINKING", "stage": 1}, {"efo_term": "OBESITY", "stage": 1}, {"efo_term": "PAIN", "stage": 1}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 1}, {"efo_term": "SCHIZOPHRENIA", "stage": 1}], "max_phase": 4, "name": "NALTREXONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19019", "mechanisms": ["Opioid receptors; mu/kappa/delta antagonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["ALCOHOL DEPENDENCE", "GAMBLING BEHAVIOUR", "OPIOID DEPENDENCE", "ALCOHOL DRINKING", "HIV INFECTION", "OBESITY", "PAIN", "METAMPHETAMINE DEPENDENCE", "CROHN'S DISEASE", "HEROIN DEPENDENCE", "OBSESSIVE-COMPULSIVE DISORDER", "NICOTINE DEPENDENCE", "HAIR-PULLING", "MARIJUANA DEPENDENCE", "MULTIPLE SCLEROSIS", "COCAINE DEPENDENCE", "BORDERLINE PERSONALITY DISORDER SYMPTOM", "TYPE I DIABETES MELLITUS", "SCHIZOPHRENIA", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "EATING DISORDER", "stage": 3}, {"efo_term": "HUNTINGTON DISEASE", "stage": 3}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "LYMPHOID NEOPLASM", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "DIABETES MELLITUS", "stage": 2}, {"efo_term": "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "stage": 2}, {"efo_term": "AUTISM", "stage": 2}, {"efo_term": "VOMITING", "stage": 2}, {"efo_term": "INSULIN RESISTANCE", "stage": 2}, {"efo_term": "POST OPERATIVE NAUSEA AND VOMITING", "stage": 2}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}, {"efo_term": "HIV INFECTION", "stage": 1}], "max_phase": 4, "name": "OLANZAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL715", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "EATING DISORDER", "HUNTINGTON DISEASE", "SCHIZOPHRENIA", "DIABETES MELLITUS", "GAMBLING BEHAVIOUR", "UNIPOLAR DEPRESSION", "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "FISH-EYE DISEASE", "HIV INFECTION", "ALCOHOL DEPENDENCE", "AUTISM", "PSYCHOSIS", "VOMITING", "INSULIN RESISTANCE", "POST OPERATIVE NAUSEA AND VOMITING", "CANCER", "LYMPHOID NEOPLASM", "BREAST CARCINOMA"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 3}, {"efo_term": "SEIZURES", "stage": 3}, {"efo_term": "LENNOX-GASTAUT SYNDROME", "stage": 3}, {"efo_term": "DRAVET SYNDROME", "stage": 3}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "ANXIETY", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "DRUG DEPENDENCE", "stage": 2}, {"efo_term": "PRADER-WILLI SYNDROME", "stage": 2}, {"efo_term": "HEPATIC STEATOSIS", "stage": 2}, {"efo_term": "ULCERATIVE COLITIS", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "OPIOID DEPENDENCE", "stage": 2}, {"efo_term": "PAIN", "stage": 1}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 1}, {"efo_term": "LUNG CARCINOMA", "stage": 1}], "max_phase": 3, "name": "CANNABIDIOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190461", "mechanisms": ["Cannabinoid CB1 receptor Negative allosteric modulator"], "genes": ["CNR1"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "PAIN", "MARIJUANA DEPENDENCE", "ACUTE GRAFT VS. HOST DISEASE", "ANXIETY", "EPILEPSY", "NEOPLASM", "SEIZURES", "PARKINSON'S DISEASE", "LENNOX-GASTAUT SYNDROME", "POST-TRAUMATIC STRESS DISORDER", "DRUG DEPENDENCE", "PRADER-WILLI SYNDROME", "LUNG CARCINOMA", "DRAVET SYNDROME", "HEPATIC STEATOSIS", "ULCERATIVE COLITIS", "COCAINE DEPENDENCE", "OPIOID DEPENDENCE"]}, {"indications": [{"efo_term": "AUTISM", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "AGGRESSIVE BEHAVIOR", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "AGITATION", "stage": 4}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 3}, {"efo_term": "MENTAL OR BEHAVIOURAL DISORDER", "stage": 3}, {"efo_term": "TOURETTE SYNDROME", "stage": 3}, {"efo_term": "ANOREXIA NERVOSA", "stage": 3}, {"efo_term": "POSTPARTUM DEPRESSION", "stage": 3}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}, {"efo_term": "DIABETES MELLITUS", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "ARIPIPRAZOLE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1112", "mechanisms": ["Dopamine D2 receptor partial agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["ALCOHOL DEPENDENCE", "ALZHEIMERS DISEASE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "AUTISM", "BIPOLAR DISORDER", "SCHIZOPHRENIA", "UNIPOLAR DEPRESSION", "MENTAL OR BEHAVIOURAL DISORDER", "PSYCHOSIS", "TOURETTE SYNDROME", "DIABETES MELLITUS", "POST-TRAUMATIC STRESS DISORDER", "ANOREXIA NERVOSA", "AGGRESSIVE BEHAVIOR", "AGITATION", "AUTISM SPECTRUM DISORDER", "POSTPARTUM DEPRESSION", "COCAINE DEPENDENCE"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "OPIOID DEPENDENCE", "stage": 4}, {"efo_term": "DRUG DEPENDENCE", "stage": 4}, {"efo_term": "NEONATAL ABSTINENCE SYNDROME", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "HIV INFECTION", "stage": 3}, {"efo_term": "LUMBAR DISC DEGENERATION", "stage": 3}, {"efo_term": "EPILEPSY", "stage": 3}, {"efo_term": "HEROIN DEPENDENCE", "stage": 2}, {"efo_term": "CONSTIPATION", "stage": 2}, {"efo_term": "EATING DISORDER", "stage": 2}, {"efo_term": "PRURITUS", "stage": 2}, {"efo_term": "OBESITY", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "BUPRENORPHINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL511142", "mechanisms": ["Kappa opioid receptor agonist", "Mu opioid receptor agonist"], "genes": ["OPRK1", "OPRM1"], "type": "Small molecule", "diseases": ["HEROIN DEPENDENCE", "PAIN", "OPIOID DEPENDENCE", "NEONATAL ABSTINENCE SYNDROME", "OSTEOARTHRITIS", "UNIPOLAR DEPRESSION", "DRUG DEPENDENCE", "HIV INFECTION", "COCAINE DEPENDENCE", "LUMBAR DISC DEGENERATION", "CONSTIPATION", "EPILEPSY", "EATING DISORDER", "PRURITUS", "OBESITY"]}, {"indications": [{"efo_term": "GLAUCOMA", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "MIGRAINE DISORDER", "stage": 4}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 3}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 3}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "NEONATAL ABSTINENCE SYNDROME", "stage": 2}, {"efo_term": "SEPTIC SHOCK", "stage": 2}, {"efo_term": "ANXIETY", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 2}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 2}, {"efo_term": "OPIOID DEPENDENCE", "stage": 1}, {"efo_term": "CEREBRAL ISCHEMIA", "stage": 1}], "max_phase": 4, "name": "CLONIDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL134", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "GLAUCOMA", "HYPERTENSION", "PAIN", "CARDIOVASCULAR DISEASE", "MIGRAINE DISORDER", "NEONATAL ABSTINENCE SYNDROME", "SEPTIC SHOCK", "ANXIETY", "OPIOID DEPENDENCE", "MARIJUANA DEPENDENCE", "AUTISM SPECTRUM DISORDER", "CEREBRAL ISCHEMIA", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "NASAL OBSTRUCTION", "stage": 4}, {"efo_term": "GLAUCOMA", "stage": 4}, {"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "HEMORRHAGE", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "URTICARIA", "stage": 4}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 4}, {"efo_term": "ANGIOEDEMA", "stage": 4}, {"efo_term": "SINUSITIS", "stage": 4}, {"efo_term": "ASTHMA", "stage": 3}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 3}, {"efo_term": "BRONCHIOLITIS", "stage": 3}], "max_phase": 4, "name": "EPINEPHRINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["ASTHMA", "NASAL OBSTRUCTION", "SUDDEN CARDIAC ARREST", "BRONCHIOLITIS", "GLAUCOMA", "OBSTRUCTIVE LUNG DISEASE", "HEMORRHAGE", "CARDIOVASCULAR DISEASE", "SEASONAL ALLERGIC RHINITIS", "ALLERGIC RHINITIS", "URTICARIA", "ANGIOEDEMA", "SINUSITIS"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "WOLFF-PARKINSON-WHITE SYNDROME", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "CORONARY STENOSIS", "stage": 3}, {"efo_term": "ANGINA PECTORIS", "stage": 3}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 2}, {"efo_term": "CARDIOMYOPATHY", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 1}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 1}, {"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 1}], "max_phase": 4, "name": "ADENOSINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477", "mechanisms": ["Adenosine receptor agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": ["CORONARY ARTERY DISEASE", "PAIN", "NEOPLASM", "MYOCARDIAL INFARCTION", "CARDIOVASCULAR DISEASE", "ACUTE MYELOID LEUKEMIA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "ATRIAL FIBRILLATION", "CARDIOMYOPATHY", "WOLFF-PARKINSON-WHITE SYNDROME", "CORONARY STENOSIS", "ANGINA PECTORIS"]}, {"indications": [{"efo_term": "PEPTIC ULCER", "stage": 4}, {"efo_term": "GASTROESOPHAGEAL REFLUX DISEASE", "stage": 4}, {"efo_term": "HEMORRHAGE", "stage": 3}, {"efo_term": "SPONTANEOUS ABORTION", "stage": 3}, {"efo_term": "UTERINE FIBROID", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "MENORRHAGIA", "stage": 3}, {"efo_term": "PREECLAMPSIA", "stage": 3}, {"efo_term": "PREGNANCY", "stage": 3}, {"efo_term": "CYTOMEGALOVIRUS INFECTION", "stage": 2}, {"efo_term": "INFECTION", "stage": 0}], "max_phase": 4, "name": "MISOPROSTOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL606", "mechanisms": ["Prostanoid EP3 receptor agonist"], "genes": ["PTGER3"], "type": "Small molecule", "diseases": ["HEMORRHAGE", "SPONTANEOUS ABORTION", "CYTOMEGALOVIRUS INFECTION", "INFECTION", "UTERINE FIBROID", "PEPTIC ULCER", "GASTROESOPHAGEAL REFLUX DISEASE", "PAIN", "MENORRHAGIA", "PREECLAMPSIA", "PREGNANCY"]}, {"indications": [{"efo_term": "CANCER", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "ADENOMA", "stage": 3}, {"efo_term": "MORBID OBESITY", "stage": 3}, {"efo_term": "OBSTRUCTIVE SLEEP APNEA", "stage": 3}, {"efo_term": "OCCLUSIVE ARTERIAL DISEASE", "stage": 3}, {"efo_term": "OTITIS MEDIA", "stage": 2}, {"efo_term": "SUBARACHNOID HEMORRHAGE", "stage": 2}, {"efo_term": "HYPOTENSION", "stage": 2}, {"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 1}, {"efo_term": "OPIOID DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "FENTANYL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL596", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["CANCER", "OTITIS MEDIA", "PAIN", "ADENOMA", "SUBARACHNOID HEMORRHAGE", "MORBID OBESITY", "OBSTRUCTIVE SLEEP APNEA", "HYPOTENSION", "IMMUNE SYSTEM DISEASE", "OPIOID DEPENDENCE", "OCCLUSIVE ARTERIAL DISEASE"]}, {"indications": [{"efo_term": "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "stage": 4}, {"efo_term": "NAUSEA", "stage": 4}, {"efo_term": "ANOREXIA NERVOSA", "stage": 3}, {"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "OBSTRUCTIVE SLEEP APNEA", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 1}, {"efo_term": "DRUG DEPENDENCE", "stage": 1}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "DRONABINOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL465", "mechanisms": ["Cannabinoid CB1 receptor agonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": ["IRRITABLE BOWEL SYNDROME", "MARIJUANA DEPENDENCE", "SCHIZOPHRENIA", "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "OBSTRUCTIVE SLEEP APNEA", "ANOREXIA NERVOSA", "DRUG DEPENDENCE", "NAUSEA", "ALCOHOL DEPENDENCE", "ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "CANCER", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "KIDNEY STONE", "stage": 3}, {"efo_term": "PRURITUS", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "OPIOID DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "OXYCODONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL656", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN", "CANCER", "OSTEOARTHRITIS", "OSTEOARTHRITIS, KNEE", "PARKINSON'S DISEASE", "DIABETIC NEUROPATHY", "KIDNEY STONE", "PRURITUS", "OPIOID DEPENDENCE"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "AUTISM", "stage": 4}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "DIABETES MELLITUS", "stage": 2}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}], "max_phase": 4, "name": "RISPERIDONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "PSYCHOSIS", "SCHIZOPHRENIA", "AUTISM", "COCAINE DEPENDENCE", "DIABETES MELLITUS", "UNIPOLAR DEPRESSION", "FISH-EYE DISEASE", "INJURY"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "DYSPNEA", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "AMBLYOPIA", "stage": 1}, {"efo_term": "PAIN", "stage": 1}], "max_phase": 4, "name": "CAFFEINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL113", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": ["CORONARY ARTERY DISEASE", "DYSPNEA", "MIGRAINE DISORDER", "PARKINSON'S DISEASE", "ATRIAL FIBRILLATION", "COCAINE DEPENDENCE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "AMBLYOPIA", "PAIN"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "BORDERLINE PERSONALITY DISORDER SYMPTOM", "stage": 3}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 1}], "max_phase": 4, "name": "QUETIAPINE FUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200911", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "BORDERLINE PERSONALITY DISORDER SYMPTOM", "FISH-EYE DISEASE", "POST-TRAUMATIC STRESS DISORDER", "SCHIZOPHRENIA", "UNIPOLAR DEPRESSION", "MULTIPLE SCLEROSIS", "ALCOHOL DEPENDENCE"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "RESTLESS LEGS SYNDROME", "stage": 3}, {"efo_term": "OVARIAN HYPERSTIMULATION SYNDROME", "stage": 3}, {"efo_term": "INFERTILITY", "stage": 2}, {"efo_term": "ENDOMETRIOSIS", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 1}, {"efo_term": "OBESITY", "stage": 1}, {"efo_term": "BREAST CARCINOMA", "stage": 0}], "max_phase": 4, "name": "CABERGOLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201087", "mechanisms": ["Dopamine D2 receptor agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "INFERTILITY", "RESTLESS LEGS SYNDROME", "OVARIAN HYPERSTIMULATION SYNDROME", "COCAINE DEPENDENCE", "BREAST CARCINOMA", "OBESITY", "ENDOMETRIOSIS"]}, {"indications": [{"efo_term": "OPEN-ANGLE GLAUCOMA", "stage": 4}, {"efo_term": "OCULAR HYPERTENSION", "stage": 4}, {"efo_term": "ROSACEA", "stage": 4}, {"efo_term": "INCREASED INTRAOCULAR PRESSURE", "stage": 4}, {"efo_term": "HYPEREMIA", "stage": 3}, {"efo_term": "AGE-RELATED MACULAR DEGENERATION", "stage": 2}, {"efo_term": "ALLERGIC CONJUNCTIVITIS", "stage": 2}, {"efo_term": "RETINITIS PIGMENTOSA", "stage": 1}], "max_phase": 4, "name": "BRIMONIDINE TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062257", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["OPEN-ANGLE GLAUCOMA", "RETINITIS PIGMENTOSA", "HYPEREMIA", "OCULAR HYPERTENSION", "ROSACEA", "INCREASED INTRAOCULAR PRESSURE", "AGE-RELATED MACULAR DEGENERATION", "ALLERGIC CONJUNCTIVITIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "TOURETTE SYNDROME", "stage": 4}, {"efo_term": "CONDUCT DISORDER", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "AGITATION", "stage": 3}, {"efo_term": "POST-OPERATIVE SIGN OR SYMPTOM", "stage": 3}], "max_phase": 4, "name": "HALOPERIDOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54", "mechanisms": ["D2-like dopamine receptor inverse agonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "PSYCHOSIS", "SCHIZOPHRENIA", "AGITATION", "POST-OPERATIVE SIGN OR SYMPTOM", "TOURETTE SYNDROME", "CONDUCT DISORDER"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}, {"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}, {"efo_term": "ASTHMA", "stage": 1}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 1}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 1}], "max_phase": 4, "name": "LOXAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL831", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": ["ASTHMA", "NICOTINE DEPENDENCE", "PSYCHOSIS", "SCHIZOPHRENIA", "BIPOLAR DISORDER", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 4}, {"efo_term": "INFERTILITY", "stage": 4}, {"efo_term": "HYPERPROLACTINEMIA", "stage": 4}, {"efo_term": "HYPOGONADISM", "stage": 4}, {"efo_term": "GROWTH HORMONE EXCESS", "stage": 4}, {"efo_term": "ACROMEGALY", "stage": 4}], "max_phase": 4, "name": "BROMOCRIPTINE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200503", "mechanisms": ["D2-like dopamine receptor agonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "TYPE II DIABETES MELLITUS", "INFERTILITY", "HYPERPROLACTINEMIA", "HYPOGONADISM", "GROWTH HORMONE EXCESS", "ACROMEGALY"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 3}, {"efo_term": "HEROIN DEPENDENCE", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "FIBROMYALGIA", "stage": 2}, {"efo_term": "CANCER", "stage": 2}], "max_phase": 4, "name": "MIRTAZAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL654", "mechanisms": ["Adrenergic receptor alpha-2 antagonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION", "AUTISM SPECTRUM DISORDER", "ALCOHOL DEPENDENCE", "COCAINE DEPENDENCE", "HEROIN DEPENDENCE", "FIBROMYALGIA", "CANCER"]}, {"indications": [{"efo_term": "ORTHOSTATIC HYPOTENSION", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HYPOTENSION", "stage": 2}, {"efo_term": "FIBROMYALGIA", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "MULTIPLE SYSTEM ATROPHY", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 1}], "max_phase": 4, "name": "DROXIDOPA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103827", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["HYPOTENSION", "ORTHOSTATIC HYPOTENSION", "FIBROMYALGIA", "CARDIOVASCULAR DISEASE", "CHRONIC KIDNEY DISEASE", "PARKINSON'S DISEASE", "MULTIPLE SYSTEM ATROPHY"]}, {"indications": [{"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}, {"efo_term": "CHRONIC BRONCHITIS", "stage": 4}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 1}, {"efo_term": "ALTITUDE SICKNESS", "stage": 1}, {"efo_term": "BLADDER CARCINOMA", "stage": 0}], "max_phase": 4, "name": "AMINOPHYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1370561", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": ["OBSTRUCTIVE LUNG DISEASE", "ASTHMA", "BLADDER CARCINOMA", "PULMONARY HYPERTENSION", "EMPHYSEMA", "ALTITUDE SICKNESS", "CHRONIC BRONCHITIS"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "SCHIZOAFFECTIVE DISORDER", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "AUTISM", "stage": 3}, {"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 2}], "max_phase": 4, "name": "PALIPERIDONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1621", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "SCHIZOPHRENIA", "SCHIZOAFFECTIVE DISORDER", "OBSESSIVE-COMPULSIVE DISORDER", "PSYCHOSIS", "AUTISM"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "INSOMNIA", "stage": 3}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 3}], "max_phase": 4, "name": "BREXPIPRAZOLE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105760", "mechanisms": ["Dopamine D2 receptor partial agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "UNIPOLAR DEPRESSION", "INSOMNIA", "PSYCHOSIS", "POST-TRAUMATIC STRESS DISORDER"]}, {"indications": [{"efo_term": "EYE DISEASE", "stage": 3}, {"efo_term": "RHINITIS", "stage": 3}, {"efo_term": "ROSACEA", "stage": 3}, {"efo_term": "ALLERGIC CONJUNCTIVITIS", "stage": 2}, {"efo_term": "GRAVES OPHTHALMOPATHY", "stage": 2}, {"efo_term": "ALLERGIC RHINITIS", "stage": 1}], "max_phase": 4, "name": "OXYMETAZOLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200791", "mechanisms": ["Adrenergic receptor alpha agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["ALLERGIC RHINITIS", "EYE DISEASE", "ALLERGIC CONJUNCTIVITIS", "RHINITIS", "ROSACEA", "GRAVES OPHTHALMOPATHY"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 4}, {"efo_term": "NEUROGENIC BLADDER", "stage": 3}, {"efo_term": "HYPERHIDROSIS", "stage": 3}, {"efo_term": "URINARY INCONTINENCE", "stage": 3}, {"efo_term": "ENURESIS NOCTURNA", "stage": 3}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 2}], "max_phase": 4, "name": "OXYBUTYNIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1231", "mechanisms": ["Muscarinic acetylcholine receptor M2 antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": ["NEUROGENIC BLADDER", "HYPERHIDROSIS", "URINARY INCONTINENCE", "ENURESIS NOCTURNA", "OVERACTIVE BLADDER", "SEASONAL ALLERGIC RHINITIS"]}, {"indications": [{"efo_term": "DIGESTIVE SYSTEM DISEASE", "stage": 4}, {"efo_term": "AMBLYOPIA", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "MYOPIA", "stage": 3}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 2}, {"efo_term": "HYPOGLYCEMIA", "stage": 0}], "max_phase": 4, "name": "ATROPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL517712", "mechanisms": ["Muscarinic acetylcholine receptor M2 antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": ["AMBLYOPIA", "SEASONAL ALLERGIC RHINITIS", "PAIN", "DIGESTIVE SYSTEM DISEASE", "HYPOGLYCEMIA", "MYOPIA"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}, {"efo_term": "PRURITUS", "stage": 3}, {"efo_term": "NEONATAL ABSTINENCE SYNDROME", "stage": 2}, {"efo_term": "HALLUX VALGUS", "stage": 2}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 2}], "max_phase": 4, "name": "MORPHINE SULFATE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103744", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["NEONATAL ABSTINENCE SYNDROME", "PAIN", "HALLUX VALGUS", "PRURITUS", "OSTEOARTHRITIS, KNEE"]}, {"indications": [{"efo_term": "NAUSEA", "stage": 4}, {"efo_term": "POST OPERATIVE NAUSEA AND VOMITING", "stage": 2}, {"efo_term": "SPASTICITY", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 1}], "max_phase": 4, "name": "NABILONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2218896", "mechanisms": ["Cannabinoid CB1 receptor agonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": ["NAUSEA", "POST OPERATIVE NAUSEA AND VOMITING", "SPASTICITY", "MARIJUANA DEPENDENCE", "OBSESSIVE-COMPULSIVE DISORDER"]}, {"indications": [{"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 3}, {"efo_term": "PREMATURE BIRTH", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 2}], "max_phase": 4, "name": "THEOPHYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "OBSTRUCTIVE LUNG DISEASE", "ASTHMA", "PREMATURE BIRTH", "CHRONIC KIDNEY DISEASE"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "NEUROPATHIC PAIN", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "HYDROCODONE BITARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062267", "mechanisms": ["Opioid receptors; mu/kappa/delta agonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN", "PAIN", "LIVER DISEASE", "OSTEOARTHRITIS"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "NEUROPATHIC PAIN", "stage": 4}, {"efo_term": "PAIN", "stage": 4}], "max_phase": 4, "name": "TAPENTADOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201777", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN", "NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "ILOPERIDONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14376", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "LIVER DISEASE", "POST-TRAUMATIC STRESS DISORDER", "PSYCHOSIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "NAUSEA AND VOMITING", "stage": 2}], "max_phase": 4, "name": "PROCHLORPERAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL728", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["MIGRAINE DISORDER", "NAUSEA AND VOMITING", "PSYCHOSIS", "PAIN"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "RESTLESS LEGS SYNDROME", "stage": 3}, {"efo_term": "STROKE", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "LEVODOPA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1009", "mechanisms": ["Dopamine D3 receptor agonist"], "genes": ["DRD3"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "COCAINE DEPENDENCE", "RESTLESS LEGS SYNDROME", "STROKE"]}, {"indications": [{"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "PEPTIC ULCER", "stage": 4}, {"efo_term": "PARKINSON'S DISEASE", "stage": 4}], "max_phase": 4, "name": "ATROPINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2146146", "mechanisms": ["Muscarinic acetylcholine receptor M2 antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": ["SEASONAL ALLERGIC RHINITIS", "ALLERGIC RHINITIS", "PEPTIC ULCER", "PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "AMYOTROPHIC LATERAL SCLEROSIS", "stage": 2}], "max_phase": 4, "name": "PIMOZIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1423", "mechanisms": ["Dopamine receptor antagonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": ["PSYCHOSIS", "SCHIZOPHRENIA", "AMYOTROPHIC LATERAL SCLEROSIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}, {"efo_term": "NEONATAL ABSTINENCE SYNDROME", "stage": 3}], "max_phase": 4, "name": "CHLORPROMAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": ["PSYCHOSIS", "SCHIZOPHRENIA", "NEONATAL ABSTINENCE SYNDROME"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "RESTLESS LEGS SYNDROME", "stage": 4}, {"efo_term": "FIBROMYALGIA", "stage": 2}], "max_phase": 4, "name": "ROTIGOTINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1303", "mechanisms": ["D2-like dopamine receptor agonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": ["FIBROMYALGIA", "PARKINSON'S DISEASE", "RESTLESS LEGS SYNDROME"]}, {"indications": [{"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 2}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 2}], "max_phase": 3, "name": "CEBRANOPADOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2364605", "mechanisms": ["Opioid receptors; mu/kappa/delta agonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["OSTEOARTHRITIS, KNEE", "PAIN", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "CANCER", "stage": 4}, {"efo_term": "DYSPNEA", "stage": 0}], "max_phase": 4, "name": "FENTANYL CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL688", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN", "CANCER", "DYSPNEA"]}, {"indications": [{"efo_term": "CONSTIPATION", "stage": 3}, {"efo_term": "DIGESTIVE SYSTEM DISEASE", "stage": 3}, {"efo_term": "CANCER", "stage": 2}], "max_phase": 4, "name": "ALVIMOPAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL270190", "mechanisms": ["Mu opioid receptor antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["CONSTIPATION", "CANCER", "DIGESTIVE SYSTEM DISEASE"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "PREMATURE EJACULATION", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 2}], "max_phase": 4, "name": "TRAMADOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237065", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN", "PREMATURE EJACULATION", "BREAST CARCINOMA"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 3}], "max_phase": 4, "name": "ASENAPINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544974", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "SCHIZOPHRENIA", "PSYCHOSIS"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 1}], "max_phase": 3, "name": "ITI-007", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545044", "mechanisms": ["Dopamine D2 receptor partial agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "BIPOLAR DISORDER", "SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "PREMATURE BIRTH", "stage": 3}, {"efo_term": "RETINOPATHY OF PREMATURITY", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "CAFFEINE, CITRATED", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200569", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": ["PREMATURE BIRTH", "LIVER DISEASE", "RETINOPATHY OF PREMATURITY"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}, {"efo_term": "PREGNANCY", "stage": 3}], "max_phase": 4, "name": "DINOPROSTONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL548", "mechanisms": ["Prostaglandin E2 receptor agonist"], "genes": ["PTGER3"], "type": "Small molecule", "diseases": ["PAIN", "PREGNANCY"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 1}], "max_phase": 4, "name": "THIORIDAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL479", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": ["PSYCHOSIS", "ACUTE MYELOID LEUKEMIA"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "RESTLESS LEGS SYNDROME", "stage": 2}], "max_phase": 4, "name": "PRAMIPEXOLE DIHYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL542257", "mechanisms": ["D2-like dopamine receptor agonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "RESTLESS LEGS SYNDROME"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "CANCER", "stage": 2}], "max_phase": 4, "name": "HALOPERIDOL DECANOATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200986", "mechanisms": ["D2-like dopamine receptor inverse agonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": ["CANCER", "PSYCHOSIS"]}, {"indications": [{"efo_term": "LIVER DISEASE", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 1}], "max_phase": 3, "name": "NALFURAFINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL490665", "mechanisms": ["Kappa opioid receptor agonist"], "genes": ["OPRK1"], "type": "Small molecule", "diseases": ["CHRONIC KIDNEY DISEASE", "LIVER DISEASE"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "OPIOID DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "NALOXONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1718", "mechanisms": ["Opioid receptors; mu/kappa/delta antagonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["OPIOID DEPENDENCE", "PAIN"]}, {"indications": [{"efo_term": "EATING DISORDER", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 1}], "max_phase": 2, "name": "SAMIDORPHAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL426084", "mechanisms": ["Mu opioid receptor antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["COCAINE DEPENDENCE", "EATING DISORDER"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "OPIOID DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "OXYCODONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200890", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN", "OPIOID DEPENDENCE"]}, {"indications": [{"efo_term": "OBESITY", "stage": 3}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 3}], "max_phase": 3, "name": "TARANABANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220360", "mechanisms": ["Cannabinoid CB1 receptor inverse agonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": ["OBESITY", "TYPE II DIABETES MELLITUS"]}, {"indications": [{"efo_term": "OBESITY", "stage": 2}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 2}], "max_phase": 2, "name": "IBIPINABANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL412262", "mechanisms": ["Cannabinoid CB1 receptor antagonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": ["OBESITY", "TYPE II DIABETES MELLITUS"]}, {"indications": [{"efo_term": "MIGRAINE WITH AURA", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 1}], "max_phase": 4, "name": "SUMATRIPTAN SUCCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201150", "mechanisms": ["Serotonin 1b (5-HT1b) receptor agonist"], "genes": ["HTR1B"], "type": "Small molecule", "diseases": ["MIGRAINE DISORDER", "MIGRAINE WITH AURA"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "CLOZAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "PSYCHOSIS"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 3}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}], "max_phase": 3, "name": "BIFEPRUNOX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL218166", "mechanisms": ["Dopamine D2 receptor partial agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "PSORIASIS", "stage": 2}], "max_phase": 4, "name": "FLUPHENAZINE DECANOATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200854", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSORIASIS", "PSYCHOSIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "PSORIASIS", "stage": 2}], "max_phase": 4, "name": "FLUPHENAZINE ENANTHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200951", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS", "PSORIASIS"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "SCHIZOAFFECTIVE DISORDER", "stage": 4}], "max_phase": 4, "name": "PALIPERIDONE PALMITATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201732", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "SCHIZOAFFECTIVE DISORDER"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 4}], "max_phase": 4, "name": "LURASIDONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1615372", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "BIPOLAR DISORDER"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}], "max_phase": 4, "name": "CARIPRAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2024517", "mechanisms": ["Dopamine D2 receptor modulator", "Dopamine D3 receptor modulator"], "genes": ["DRD2", "DRD3"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "PREECLAMPSIA", "stage": 2}], "max_phase": 4, "name": "METHYLDOPA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL459", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["PREECLAMPSIA", "HYPERTENSION"]}, {"indications": [{"efo_term": "HEART FAILURE", "stage": 3}, {"efo_term": "CONGESTIVE HEART FAILURE", "stage": 3}], "max_phase": 3, "name": "ROLOFYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103819", "mechanisms": ["Adenosine A1 receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": ["HEART FAILURE", "CONGESTIVE HEART FAILURE"]}, {"indications": [{"efo_term": "ATRIAL FIBRILLATION", "stage": 2}, {"efo_term": "ANGINA PECTORIS", "stage": 2}], "max_phase": 2, "name": "Capadenoson", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3235279", "mechanisms": ["Adenosine A1 receptor partial agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION", "ANGINA PECTORIS"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}, {"efo_term": "ASTHMA", "stage": 2}], "max_phase": 2, "name": "ASM-024", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707249", "mechanisms": ["Muscarinic acetylcholine receptor M2 antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ASTHMA"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}], "max_phase": 4, "name": "AMOXAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1113", "mechanisms": ["Dopamine receptor antagonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}], "max_phase": 4, "name": "ERGOLOID MESYLATES", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2311030", "mechanisms": ["Dopamine receptor agonist", "Serotonin 1b (5-HT1b) receptor agonist", "Adrenergic receptor alpha antagonist"], "genes": ["DRD4", "HTR1B", "DRD2", "ADRA2A", "DRD3", "ADRA2C"], "type": "Small molecule", "diseases": ["CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "DROPERIDOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1108", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}], "max_phase": 4, "name": "APOMORPHINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1616", "mechanisms": ["D2-like dopamine receptor agonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "LEVOMEPROMAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1764", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}], "max_phase": 4, "name": "ROPINIROLE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200411", "mechanisms": ["D2-like dopamine receptor agonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 3}], "max_phase": 4, "name": "OLANZAPINE PAMOATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201741", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}], "max_phase": 4, "name": "DEZOCINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1685", "mechanisms": ["Kappa opioid receptor antagonist", "Mu opioid receptor partial agonist"], "genes": ["OPRK1", "OPRM1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "PAIN", "stage": 2}], "max_phase": 2, "name": "AXOMADOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107731", "mechanisms": ["Kappa opioid receptor agonist", "Mu opioid receptor agonist", "Delta opioid receptor agonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "OPIOID DEPENDENCE", "stage": 4}], "max_phase": 4, "name": "Buprenorphine Hydrochloride", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2368861", "mechanisms": ["Kappa opioid receptor agonist", "Mu opioid receptor agonist"], "genes": ["OPRK1", "OPRM1"], "type": "Small molecule", "diseases": ["OPIOID DEPENDENCE"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}], "max_phase": 4, "name": "CODEINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL284671", "mechanisms": ["Opioid receptors; mu/kappa/delta agonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}], "max_phase": 4, "name": "OXYMORPHONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200794", "mechanisms": ["Opioid receptors; mu/kappa/delta agonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}], "max_phase": 4, "name": "CODEINE PHOSPHATE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201099", "mechanisms": ["Opioid receptors; mu/kappa/delta agonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "PAIN", "stage": 2}], "max_phase": 4, "name": "NALBUPHINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201132", "mechanisms": ["Opioid receptors; mu/kappa/delta agonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "BREAST CARCINOMA", "stage": 2}], "max_phase": 4, "name": "NALTREXONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201149", "mechanisms": ["Opioid receptors; mu/kappa/delta antagonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["BREAST CARCINOMA"]}, {"indications": [{"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}], "max_phase": 4, "name": "NALMEFENE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201152", "mechanisms": ["Opioid receptors; mu/kappa/delta antagonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["ALCOHOL DEPENDENCE"]}, {"indications": [{"efo_term": "COUGH", "stage": 4}], "max_phase": 4, "name": "CODEINE POLISTIREX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201463", "mechanisms": ["Opioid receptors; mu/kappa/delta agonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["COUGH"]}, {"indications": [{"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}], "max_phase": 2, "name": "ODELEPRAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103878", "mechanisms": ["Opioid receptors; mu/kappa/delta antagonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": ["ALCOHOL DEPENDENCE"]}, {"indications": [{"efo_term": "PAIN", "stage": 2}], "max_phase": 4, "name": "MEPERIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1701", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "DIARRHEA", "stage": 3}], "max_phase": 4, "name": "LOPERAMIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1707", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["DIARRHEA"]}, {"indications": [{"efo_term": "SCOLIOSIS", "stage": 2}], "max_phase": 4, "name": "METHADONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200825", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["SCOLIOSIS"]}, {"indications": [{"efo_term": "CONSTIPATION", "stage": 4}], "max_phase": 4, "name": "METHYLNALTREXONE BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201770", "mechanisms": ["Mu opioid receptor antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["CONSTIPATION"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}], "max_phase": 4, "name": "HYDROMORPHONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237055", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "CONSTIPATION", "stage": 3}], "max_phase": 4, "name": "NALDEMEDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105755", "mechanisms": ["Mu opioid receptor antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["CONSTIPATION"]}, {"indications": [{"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 4}], "max_phase": 4, "name": "ELUXADOLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2159122", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["IRRITABLE BOWEL SYNDROME"]}, {"indications": [{"efo_term": "CONSTIPATION", "stage": 2}], "max_phase": 2, "name": "METHYLSAMIDORPHAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2364619", "mechanisms": ["Mu opioid receptor antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["CONSTIPATION"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}], "max_phase": 3, "name": "OLICERIDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2443262", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "CONSTIPATION", "stage": 4}], "max_phase": 4, "name": "NALDEMEDINE TOSYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039508", "mechanisms": ["Mu opioid receptor antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["CONSTIPATION"]}, {"indications": [{"efo_term": "CONSTIPATION", "stage": 2}], "max_phase": 2, "name": "AXELOPRAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3137313", "mechanisms": ["Mu opioid receptor antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": ["CONSTIPATION"]}, {"indications": [{"efo_term": "SMOKING CESSATION", "stage": 2}], "max_phase": 2, "name": "SURINABANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL189676", "mechanisms": ["Cannabinoid CB1 receptor antagonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": ["SMOKING CESSATION"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}], "max_phase": 2, "name": "Drinabant", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545166", "mechanisms": ["Cannabinoid CB1 receptor antagonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "MIGRAINE DISORDER", "stage": 4}], "max_phase": 4, "name": "SUMATRIPTAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL128", "mechanisms": ["Serotonin 1b (5-HT1b) receptor agonist"], "genes": ["HTR1B"], "type": "Small molecule", "diseases": ["MIGRAINE DISORDER"]}, {"indications": [{"efo_term": "MIGRAINE DISORDER", "stage": 4}], "max_phase": 4, "name": "ZOLMITRIPTAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1185", "mechanisms": ["Serotonin 1b (5-HT1b) receptor agonist"], "genes": ["HTR1B"], "type": "Small molecule", "diseases": ["MIGRAINE DISORDER"]}, {"indications": [{"efo_term": "MIGRAINE DISORDER", "stage": 4}], "max_phase": 4, "name": "ALMOTRIPTAN MALATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200521", "mechanisms": ["Serotonin 1b (5-HT1b) receptor agonist", "Serotonin 1f (5-HT1f) receptor agonist"], "genes": ["HTR1B", "HTR1F"], "type": "Small molecule", "diseases": ["MIGRAINE DISORDER"]}, {"indications": [{"efo_term": "MIGRAINE DISORDER", "stage": 4}], "max_phase": 4, "name": "RIZATRIPTAN BENZOATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201032", "mechanisms": ["Serotonin 1b (5-HT1b) receptor agonist"], "genes": ["HTR1B"], "type": "Small molecule", "diseases": ["MIGRAINE DISORDER"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}], "max_phase": 2, "name": "GSK163090", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1631540", "mechanisms": ["Serotonin 1b (5-HT1b) receptor antagonist"], "genes": ["HTR1B"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "PERPHENAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL567", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "TRIFLUPROMAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL570", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "CHLORPROTHIXENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL908", "mechanisms": ["Dopamine D2 receptor antagonist", "Dopamine D3 receptor antagonist"], "genes": ["DRD2", "DRD3"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "THIOTHIXENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "HUNTINGTON DISEASE", "stage": 3}], "max_phase": 3, "name": "PRIDOPIDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL596802", "mechanisms": ["Dopamine D2 receptor modulator"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["HUNTINGTON DISEASE"]}, {"indications": [{"efo_term": "POST OPERATIVE NAUSEA AND VOMITING", "stage": 4}], "max_phase": 4, "name": "METOCLOPRAMIDE HYDROCHLORIDE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200940", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["POST OPERATIVE NAUSEA AND VOMITING"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 3}], "max_phase": 4, "name": "ZIPRASIDONE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200997", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}], "max_phase": 4, "name": "ARIPIPRAZOLE LAUROXIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2219425", "mechanisms": ["Dopamine D2 receptor partial agonist"], "genes": ["DRD2"], "type": "Unknown", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}], "max_phase": 3, "name": "PARDOPRUNOX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103832", "mechanisms": ["Dopamine receptors; D2 & D3 partial agonist"], "genes": ["DRD2", "DRD3"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}], "max_phase": 4, "name": "CLONIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1705", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "SPASTICITY", "stage": 4}], "max_phase": 4, "name": "TIZANIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200329", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["SPASTICITY"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}], "max_phase": 4, "name": "GUANFACINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200494", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "BONE NEOPLASM", "stage": 1}], "max_phase": 4, "name": "GUANABENZ ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200560", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["BONE NEOPLASM"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 3}], "max_phase": 3, "name": "ESMIRTAZAPINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107339", "mechanisms": ["Adrenergic receptor alpha-2 antagonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}], "max_phase": 4, "name": "RAUWOLFIA SERPENTINA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3559672", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["HYPERTENSION"]}, {"indications": [{"efo_term": "PREECLAMPSIA", "stage": 2}], "max_phase": 4, "name": "LABETALOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200323", "mechanisms": ["Adrenergic receptor antagonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["PREECLAMPSIA"]}, {"indications": [{"efo_term": "RENAL INSUFFICIENCY", "stage": 0}], "max_phase": 4, "name": "NORADRENALINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356607", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": ["RENAL INSUFFICIENCY"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 2}], "max_phase": 2, "name": "PBF-680", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545162", "mechanisms": ["Adenosine A1 receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": ["ASTHMA"]}, {"indications": [{"efo_term": "HEART FAILURE", "stage": 2}], "max_phase": 2, "name": "BAY1067197", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545405", "mechanisms": ["Adenosine A1 receptor agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": ["HEART FAILURE"]}, {"indications": [{"efo_term": "OCULAR HYPERTENSION", "stage": 3}], "max_phase": 3, "name": "Trabodenoson", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545407", "mechanisms": ["Adenosine A1 receptor agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": ["OCULAR HYPERTENSION"]}, {"indications": [{"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}], "max_phase": 4, "name": "OXTRIPHYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": ["OBSTRUCTIVE LUNG DISEASE"]}, {"indications": [{"efo_term": "MIGRAINE DISORDER", "stage": 3}], "max_phase": 3, "name": "LASMIDITAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039520", "mechanisms": ["Serotonin 1f (5-HT1f) receptor agonist"], "genes": ["HTR1F"], "type": "Small molecule", "diseases": ["MIGRAINE DISORDER"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 1}], "max_phase": 4, "name": "PROPANTHELINE BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1240", "mechanisms": ["Muscarinic acetylcholine receptor M2 antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": ["OVERACTIVE BLADDER"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 4}], "max_phase": 4, "name": "SOLIFENACIN SUCCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200803", "mechanisms": ["Muscarinic acetylcholine receptor M2 antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": ["OVERACTIVE BLADDER"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 4}], "max_phase": 4, "name": "FESOTERODINE FUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201765", "mechanisms": ["Muscarinic acetylcholine receptor M2 antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": ["OVERACTIVE BLADDER"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 4}], "max_phase": 4, "name": "TOLTERODINE TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1722209", "mechanisms": ["Muscarinic acetylcholine receptor M2 antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": ["OVERACTIVE BLADDER"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}], "max_phase": 2, "name": "BATEFENTEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039518", "mechanisms": ["Muscarinic acetylcholine receptor M2 antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 1}], "max_phase": 4, "name": "TROSPIUM CHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3084748", "mechanisms": ["Muscarinic acetylcholine receptor M2 antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [], "max_phase": 3, "name": "SARIZOTAN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2146110", "mechanisms": ["Dopamine D4 receptor agonist", "Dopamine D2 receptor partial agonist", "Dopamine D3 receptor agonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PERGOLIDE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1275", "mechanisms": ["Dopamine receptor agonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIFLUOPERAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1710", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CHLORPROMAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1713", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROMAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200469", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THIORIDAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200916", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LOXAPINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201060", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LOXAPINE SUCCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201155", "mechanisms": ["D2-like dopamine receptor antagonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HALOPERIDOL LACTATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2096643", "mechanisms": ["D2-like dopamine receptor inverse agonist"], "genes": ["DRD4", "DRD2", "DRD3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BUTORPHANOL TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL299400", "mechanisms": ["Kappa opioid receptor partial agonist", "Mu opioid receptor partial agonist"], "genes": ["OPRK1", "OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ANILERIDINE PHOSPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200543", "mechanisms": ["Kappa opioid receptor agonist", "Mu opioid receptor agonist"], "genes": ["OPRK1", "OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ANILERIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201047", "mechanisms": ["Kappa opioid receptor agonist", "Mu opioid receptor agonist"], "genes": ["OPRK1", "OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LEVALLORPHAN TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062276", "mechanisms": ["Kappa opioid receptor partial agonist", "Mu opioid receptor antagonist"], "genes": ["OPRK1", "OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HYDROCODONE POLISTIREX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201470", "mechanisms": ["Opioid receptors; mu/kappa/delta agonist"], "genes": ["OPRK1", "OPRM1", "OPRD1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ALFENTANIL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200531", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIFENOXIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200599", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "OXYCODONE TEREPHTHALATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200611", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIPHENOXYLATE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200665", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LEVOMETHADYL ACETATE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200817", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "REMIFENTANIL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201120", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "FENTANYL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201159", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "SUFENTANIL CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201163", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPOXYPHENE NAPSYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237085", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPOXYPHENE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237104", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LEVORPHANOL TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062261", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIHYDROCODEINE BITARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062266", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "FAXELADOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103829", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "FRAKEFAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105081", "mechanisms": ["Mu opioid receptor agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "NALOXEGOL OXALATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2219416", "mechanisms": ["Mu opioid receptor antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "BEVENOPRAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039511", "mechanisms": ["Mu opioid receptor antagonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Naltalimide", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545408", "mechanisms": ["Mu opioid receptor partial agonist"], "genes": ["OPRM1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "OTENABANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL562668", "mechanisms": ["Cannabinoid CB1 receptor antagonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "NONABINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2106841", "mechanisms": ["Cannabinoid CB1 receptor agonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "AZD2207", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545289", "mechanisms": ["Cannabinoid CB1 receptor antagonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "SAD448", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545387", "mechanisms": ["Cannabinoid CB1 receptor agonist"], "genes": ["CNR1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "FROVATRIPTAN SUCCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200371", "mechanisms": ["Serotonin 1b (5-HT1b) receptor agonist"], "genes": ["HTR1B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "NARATRIPTAN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200601", "mechanisms": ["Serotonin 1b (5-HT1b) receptor agonist"], "genes": ["HTR1B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ELETRIPTAN HYDROBROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201003", "mechanisms": ["Serotonin 1b (5-HT1b) receptor agonist", "Serotonin 1f (5-HT1f) receptor agonist"], "genes": ["HTR1B", "HTR1F"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "DONITRIPTAN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1742428", "mechanisms": ["Serotonin 1b (5-HT1b) receptor agonist"], "genes": ["HTR1B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "ELZASONAN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2106698", "mechanisms": ["Serotonin 1b (5-HT1b) receptor antagonist"], "genes": ["HTR1B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Trelanserin", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3183740", "mechanisms": ["Serotonin 1b (5-HT1b) receptor antagonist"], "genes": ["HTR1B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ZIPRASIDONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1712", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MOLINDONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200419", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROCHLORPERAZINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200587", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BENZQUINAMIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200707", "mechanisms": ["Dopamine D2 receptor modulator"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "FLUPHENAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200792", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THIETHYLPERAZINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200856", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THIOTHIXENE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200902", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIMIPRAMINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200948", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MESORIDAZINE BESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201052", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THIETHYLPERAZINE MALATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201074", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIFLUPROMAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201102", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROCHLORPERAZINE EDISYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201154", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "APLINDORE FUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104864", "mechanisms": ["Dopamine D2 receptor partial agonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CARPHENAZINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2358147", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ACETOPHENAZINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2360079", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "Ordopidine", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545010", "mechanisms": ["Dopamine D2 receptor modulator"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "SB-773812", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545102", "mechanisms": ["Dopamine D2 receptor antagonist"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "Seridopidine", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545388", "mechanisms": ["Dopamine D2 receptor modulator"], "genes": ["DRD2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LEVONORDEFRIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL677", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "APRACLONIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200379", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METHYLDOPATE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200432", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DEXMEDETOMIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2106195", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "FADOLMIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2106710", "mechanisms": ["Adrenergic receptor alpha-2 agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TOLAZOLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1689", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "NAPHAZOLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1706", "mechanisms": ["Adrenergic receptor alpha agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TETRAHYDROZOLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200413", "mechanisms": ["Adrenergic receptor alpha agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENOXYBENZAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200787", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENTOLAMINE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200873", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ALSEROXYLON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201454", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ERGOTAMINE TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062265", "mechanisms": ["Adrenergic receptor alpha agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HYDROXYAMPHETAMINE HYDROBROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200705", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIPIVEFRIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200833", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MEPHENTERMINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200996", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "EPINEPHRINE BITARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256958", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA2A", "ADRA2C"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "ETILEVODOPA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1823681", "mechanisms": ["Dopamine D3 receptor agonist"], "genes": ["DRD3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "FK453", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL440115", "mechanisms": ["Adenosine A1 receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "TONAPOFYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL414157", "mechanisms": ["Adenosine A1 receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "TECADENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL392149", "mechanisms": ["Adenosine A1 receptor agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Derenofylline", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL592435", "mechanisms": ["Adenosine A1 receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "SELODENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107371", "mechanisms": ["Adenosine A1 receptor agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "NAXIFYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107805", "mechanisms": ["Adenosine A1 receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "GS-9667", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545011", "mechanisms": ["Adenosine A1 receptor partial agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "AMP579", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545163", "mechanisms": ["Adenosine A1 receptor agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "GW493838", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545223", "mechanisms": ["Adenosine A1 receptor agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "RPR749", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545331", "mechanisms": ["Adenosine A1 receptor agonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THEOPHYLLINE SODIUM GLYCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200578", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "OXYBUTYNIN CHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1133", "mechanisms": ["Muscarinic acetylcholine receptor M2 antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BETHANECHOL CHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1768", "mechanisms": ["Muscarinic acetylcholine receptor M2 agonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DARIFENACIN HYDROBROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200935", "mechanisms": ["Muscarinic acetylcholine receptor M2 antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "DAROTROPIUM BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103803", "mechanisms": ["Muscarinic acetylcholine receptor antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Afacifenacin", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545165", "mechanisms": ["Muscarinic acetylcholine receptor antagonist"], "genes": ["CHRM2"], "type": "Small molecule", "diseases": []}], "heat": 0.9946656138645714, "nodes": [{"assoc": 0.925318594104, "id": "ENSG00000050628", "label": "PTGER3"}, {"assoc": 1.0, "id": "ENSG00000069696", "label": "DRD4"}, {"assoc": 1.0, "id": "ENSG00000082556", "label": "OPRK1"}, {"assoc": 1.0, "id": "ENSG00000112038", "label": "OPRM1"}, {"assoc": 1.0, "id": "ENSG00000116329", "label": "OPRD1"}, {"assoc": 1.0, "id": "ENSG00000118432", "label": "CNR1"}, {"assoc": 1.0, "id": "ENSG00000135312", "label": "HTR1B"}, {"assoc": 1.0, "id": "ENSG00000149295", "label": "DRD2"}, {"assoc": 1.0, "id": "ENSG00000150594", "label": "ADRA2A"}, {"assoc": 1.0, "id": "ENSG00000151577", "label": "DRD3"}, {"assoc": 1.0, "id": "ENSG00000163485", "label": "ADORA1"}, {"assoc": 1.0, "id": "ENSG00000179097", "label": "HTR1F"}, {"assoc": 1.0, "id": "ENSG00000181072", "label": "CHRM2"}, {"assoc": 1.0, "id": "ENSG00000184160", "label": "ADRA2C"}], "size": 14}, {"diseases": ["ANGINA PECTORIS", "HYPERTENSION", "MYOCARDIAL INFARCTION", "MARFAN SYNDROME", "HEART DISEASE", "CARDIOVASCULAR DISEASE", "HEMANGIOMA", "GLAUCOMA", "OPEN-ANGLE GLAUCOMA", "OCULAR HYPERTENSION", "SKIN ULCER", "UNIPOLAR DEPRESSION", "ASTHMA", "SMOKING CESSATION", "PARKINSON'S DISEASE", "TYPE II DIABETES MELLITUS", "CUTANEOUS MELANOMA", "AORTIC STENOSIS", "HEART FAILURE", "CONGESTIVE HEART FAILURE", "FISH-EYE DISEASE", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "VENTRICULAR ARRHYTHMIA", "ANTERIOR ISCHEMIC OPTIC NEUROPATHY", "OVARIAN CYST", "DIABETIC FOOT", "OBESITY", "PULMONARY HYPERTENSION", "CANCER", "EPILEPSY", "ATRIAL FIBRILLATION", "POST-TRAUMATIC STRESS DISORDER", "BREAST CARCINOMA", "COCAINE DEPENDENCE", "NICOTINE DEPENDENCE", "PROSTATE CARCINOMA", "NASAL OBSTRUCTION", "SUDDEN CARDIAC ARREST", "BRONCHIOLITIS", "OBSTRUCTIVE LUNG DISEASE", "HEMORRHAGE", "SEASONAL ALLERGIC RHINITIS", "ALLERGIC RHINITIS", "URTICARIA", "ANGIOEDEMA", "SINUSITIS", "PREECLAMPSIA", "RENAL INSUFFICIENCY", "HYPOTENSION", "ORTHOSTATIC HYPOTENSION", "FIBROMYALGIA", "CHRONIC KIDNEY DISEASE", "MULTIPLE SYSTEM ATROPHY", "AGE-RELATED MACULAR DEGENERATION", "ERECTILE DYSFUNCTION", "SEXUAL DYSFUNCTION", "ACUTE RESPIRATORY DISTRESS SYNDROME", "PAIN", "PREGNANCY", "LIVER DISEASE", "DRUG DEPENDENCE", "CORONARY ARTERY DISEASE", "SICKLE CELL ANEMIA", "CORONARY HEART DISEASE", "MYOCARDIAL ISCHEMIA", "HUNTINGTON DISEASE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "NEUROPATHIC PAIN", "NON-SMALL CELL LUNG CARCINOMA", "BILIARY ATRESIA", "DUCHENNE MUSCULAR DYSTROPHY", "CUTANEOUS LEISHMANIASIS", "ENDOMETRIOSIS", "NECROTIZING ENTEROCOLITIS", "PATENT DUCTUS ARTERIOSUS", "HEPATITIS, ALCOHOLIC", "ACUTE KIDNEY INJURY", "HEPATIC STEATOSIS", "NEOPLASM", "ACUTE MYELOID LEUKEMIA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "CARDIOMYOPATHY", "WOLFF-PARKINSON-WHITE SYNDROME", "CORONARY STENOSIS", "DYSPNEA", "MIGRAINE DISORDER", "AMBLYOPIA", "PREMATURE BIRTH", "RETINOPATHY OF PREMATURITY", "BLADDER CARCINOMA", "EMPHYSEMA", "ALTITUDE SICKNESS", "CHRONIC BRONCHITIS", "GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY", "CONGENITAL MYASTHENIC SYNDROME", "IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION", "MEMORY IMPAIRMENT", "IDIOPATHIC PULMONARY FIBROSIS", "FAMILIAL DYSAUTONOMIA", "RESPIRATORY FAILURE", "INFLAMMATION", "OVERACTIVE BLADDER", "NEUROGENIC BLADDER", "LEFT VENTRICULAR HYPERTROPHY", "CHRONIC INTERSTITIAL CYSTITIS"], "links": [{"source": "ENSG00000043591", "target": "ENSG00000125384"}, {"source": "ENSG00000043591", "target": "ENSG00000128271"}, {"source": "ENSG00000043591", "target": "ENSG00000169252"}, {"source": "ENSG00000043591", "target": "ENSG00000170425"}, {"source": "ENSG00000043591", "target": "ENSG00000171522"}, {"source": "ENSG00000043591", "target": "ENSG00000175868"}, {"source": "ENSG00000043591", "target": "ENSG00000188778"}, {"source": "ENSG00000125384", "target": "ENSG00000128271"}, {"source": "ENSG00000125384", "target": "ENSG00000169252"}, {"source": "ENSG00000125384", "target": "ENSG00000170425"}, {"source": "ENSG00000125384", "target": "ENSG00000171522"}, {"source": "ENSG00000125384", "target": "ENSG00000175868"}, {"source": "ENSG00000125384", "target": "ENSG00000188778"}, {"source": "ENSG00000128271", "target": "ENSG00000169252"}, {"source": "ENSG00000128271", "target": "ENSG00000170425"}, {"source": "ENSG00000128271", "target": "ENSG00000171522"}, {"source": "ENSG00000128271", "target": "ENSG00000175868"}, {"source": "ENSG00000128271", "target": "ENSG00000188778"}, {"source": "ENSG00000169252", "target": "ENSG00000170425"}, {"source": "ENSG00000169252", "target": "ENSG00000171522"}, {"source": "ENSG00000169252", "target": "ENSG00000175868"}, {"source": "ENSG00000169252", "target": "ENSG00000188778"}, {"source": "ENSG00000170425", "target": "ENSG00000171522"}, {"source": "ENSG00000170425", "target": "ENSG00000175868"}, {"source": "ENSG00000170425", "target": "ENSG00000188778"}, {"source": "ENSG00000171522", "target": "ENSG00000175868"}, {"source": "ENSG00000171522", "target": "ENSG00000188778"}, {"source": "ENSG00000175868", "target": "ENSG00000188778"}], "drugs": [{"indications": [{"efo_term": "HEART FAILURE", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "CONGESTIVE HEART FAILURE", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 2}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "EPILEPSY", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}], "max_phase": 4, "name": "CARVEDILOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL723", "mechanisms": ["Adrenergic receptor beta antagonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["HEART FAILURE", "HYPERTENSION", "PULMONARY HYPERTENSION", "CANCER", "EPILEPSY", "ATRIAL FIBRILLATION", "CONGESTIVE HEART FAILURE", "POST-TRAUMATIC STRESS DISORDER", "BREAST CARCINOMA", "CARDIOVASCULAR DISEASE", "COCAINE DEPENDENCE", "NICOTINE DEPENDENCE", "PROSTATE CARCINOMA"]}, {"indications": [{"efo_term": "NASAL OBSTRUCTION", "stage": 4}, {"efo_term": "GLAUCOMA", "stage": 4}, {"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "HEMORRHAGE", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "URTICARIA", "stage": 4}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 4}, {"efo_term": "ANGIOEDEMA", "stage": 4}, {"efo_term": "SINUSITIS", "stage": 4}, {"efo_term": "ASTHMA", "stage": 3}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 3}, {"efo_term": "BRONCHIOLITIS", "stage": 3}], "max_phase": 4, "name": "EPINEPHRINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["ASTHMA", "NASAL OBSTRUCTION", "SUDDEN CARDIAC ARREST", "BRONCHIOLITIS", "GLAUCOMA", "OBSTRUCTIVE LUNG DISEASE", "HEMORRHAGE", "CARDIOVASCULAR DISEASE", "SEASONAL ALLERGIC RHINITIS", "ALLERGIC RHINITIS", "URTICARIA", "ANGIOEDEMA", "SINUSITIS"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CONGESTIVE HEART FAILURE", "stage": 3}, {"efo_term": "FAMILIAL DYSAUTONOMIA", "stage": 3}, {"efo_term": "IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION", "stage": 2}, {"efo_term": "MEMORY IMPAIRMENT", "stage": 2}, {"efo_term": "RESPIRATORY FAILURE", "stage": 2}, {"efo_term": "GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY", "stage": 1}, {"efo_term": "CONGENITAL MYASTHENIC SYNDROME", "stage": 1}, {"efo_term": "IDIOPATHIC PULMONARY FIBROSIS", "stage": 1}, {"efo_term": "INFLAMMATION", "stage": 1}], "max_phase": 4, "name": "ALBUTEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL714", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "CONGESTIVE HEART FAILURE", "GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY", "CONGENITAL MYASTHENIC SYNDROME", "IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION", "MEMORY IMPAIRMENT", "IDIOPATHIC PULMONARY FIBROSIS", "OBSTRUCTIVE LUNG DISEASE", "FAMILIAL DYSAUTONOMIA", "RESPIRATORY FAILURE", "INFLAMMATION"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "WOLFF-PARKINSON-WHITE SYNDROME", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "CORONARY STENOSIS", "stage": 3}, {"efo_term": "ANGINA PECTORIS", "stage": 3}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 2}, {"efo_term": "CARDIOMYOPATHY", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 1}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 1}, {"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 1}], "max_phase": 4, "name": "ADENOSINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL477", "mechanisms": ["Adenosine receptor agonist"], "genes": ["ADORA2A", "ADORA2B"], "type": "Small molecule", "diseases": ["CORONARY ARTERY DISEASE", "PAIN", "NEOPLASM", "MYOCARDIAL INFARCTION", "CARDIOVASCULAR DISEASE", "ACUTE MYELOID LEUKEMIA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "ATRIAL FIBRILLATION", "CARDIOMYOPATHY", "WOLFF-PARKINSON-WHITE SYNDROME", "CORONARY STENOSIS", "ANGINA PECTORIS"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "ENDOMETRIOSIS", "stage": 3}, {"efo_term": "HEPATITIS, ALCOHOLIC", "stage": 3}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "BILIARY ATRESIA", "stage": 2}, {"efo_term": "CUTANEOUS LEISHMANIASIS", "stage": 2}, {"efo_term": "NECROTIZING ENTEROCOLITIS", "stage": 2}, {"efo_term": "PATENT DUCTUS ARTERIOSUS", "stage": 2}, {"efo_term": "ACUTE KIDNEY INJURY", "stage": 2}, {"efo_term": "HEPATIC STEATOSIS", "stage": 2}, {"efo_term": "DUCHENNE MUSCULAR DYSTROPHY", "stage": 1}], "max_phase": 4, "name": "PENTOXIFYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL628", "mechanisms": ["Adenosine A2 receptor antagonist"], "genes": ["ADORA2A", "ADORA2B"], "type": "Small molecule", "diseases": ["NON-SMALL CELL LUNG CARCINOMA", "BILIARY ATRESIA", "DUCHENNE MUSCULAR DYSTROPHY", "CUTANEOUS LEISHMANIASIS", "ENDOMETRIOSIS", "NECROTIZING ENTEROCOLITIS", "PATENT DUCTUS ARTERIOSUS", "CARDIOVASCULAR DISEASE", "HEPATITIS, ALCOHOLIC", "ACUTE KIDNEY INJURY", "HEPATIC STEATOSIS"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "DYSPNEA", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "AMBLYOPIA", "stage": 1}, {"efo_term": "PAIN", "stage": 1}], "max_phase": 4, "name": "CAFFEINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL113", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A", "ADORA2B"], "type": "Small molecule", "diseases": ["CORONARY ARTERY DISEASE", "DYSPNEA", "MIGRAINE DISORDER", "PARKINSON'S DISEASE", "ATRIAL FIBRILLATION", "COCAINE DEPENDENCE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "AMBLYOPIA", "PAIN"]}, {"indications": [{"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "MARFAN SYNDROME", "stage": 3}, {"efo_term": "HEART DISEASE", "stage": 3}, {"efo_term": "HEMANGIOMA", "stage": 3}], "max_phase": 4, "name": "ATENOLOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["ANGINA PECTORIS", "HYPERTENSION", "MYOCARDIAL INFARCTION", "MARFAN SYNDROME", "HEART DISEASE", "CARDIOVASCULAR DISEASE", "HEMANGIOMA"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "HEART FAILURE", "stage": 4}, {"efo_term": "CONGESTIVE HEART FAILURE", "stage": 4}, {"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 3}, {"efo_term": "AORTIC STENOSIS", "stage": 2}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}], "max_phase": 4, "name": "METOPROLOL SUCCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200337", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["HYPERTENSION", "AORTIC STENOSIS", "HEART FAILURE", "CONGESTIVE HEART FAILURE", "FISH-EYE DISEASE", "ANGINA PECTORIS", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "ORTHOSTATIC HYPOTENSION", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HYPOTENSION", "stage": 2}, {"efo_term": "FIBROMYALGIA", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "MULTIPLE SYSTEM ATROPHY", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 1}], "max_phase": 4, "name": "DROXIDOPA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103827", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["HYPOTENSION", "ORTHOSTATIC HYPOTENSION", "FIBROMYALGIA", "CARDIOVASCULAR DISEASE", "CHRONIC KIDNEY DISEASE", "PARKINSON'S DISEASE", "MULTIPLE SYSTEM ATROPHY"]}, {"indications": [{"efo_term": "ERECTILE DYSFUNCTION", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "AGE-RELATED MACULAR DEGENERATION", "stage": 3}, {"efo_term": "HEART FAILURE", "stage": 3}, {"efo_term": "OBESITY", "stage": 2}, {"efo_term": "ACUTE RESPIRATORY DISTRESS SYNDROME", "stage": 2}, {"efo_term": "SEXUAL DYSFUNCTION", "stage": 1}], "max_phase": 4, "name": "ALPROSTADIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL495", "mechanisms": ["Prostanoid EP2 receptor agonist"], "genes": ["PTGER2"], "type": "Small molecule", "diseases": ["AGE-RELATED MACULAR DEGENERATION", "ERECTILE DYSFUNCTION", "CARDIOVASCULAR DISEASE", "SEXUAL DYSFUNCTION", "OBESITY", "HEART FAILURE", "ACUTE RESPIRATORY DISTRESS SYNDROME"]}, {"indications": [{"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}, {"efo_term": "CHRONIC BRONCHITIS", "stage": 4}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 1}, {"efo_term": "ALTITUDE SICKNESS", "stage": 1}, {"efo_term": "BLADDER CARCINOMA", "stage": 0}], "max_phase": 4, "name": "AMINOPHYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1370561", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A", "ADORA2B"], "type": "Small molecule", "diseases": ["OBSTRUCTIVE LUNG DISEASE", "ASTHMA", "BLADDER CARCINOMA", "PULMONARY HYPERTENSION", "EMPHYSEMA", "ALTITUDE SICKNESS", "CHRONIC BRONCHITIS"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 4}, {"efo_term": "CHRONIC INTERSTITIAL CYSTITIS", "stage": 3}, {"efo_term": "HEART FAILURE", "stage": 2}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "NEUROGENIC BLADDER", "stage": 2}, {"efo_term": "LEFT VENTRICULAR HYPERTROPHY", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "MIRABEGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2095212", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": ["HEART FAILURE", "PAIN", "LIVER DISEASE", "OVERACTIVE BLADDER", "NEUROGENIC BLADDER", "LEFT VENTRICULAR HYPERTROPHY", "CHRONIC INTERSTITIAL CYSTITIS"]}, {"indications": [{"efo_term": "GLAUCOMA", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "OCULAR HYPERTENSION", "stage": 4}, {"efo_term": "OPEN-ANGLE GLAUCOMA", "stage": 2}, {"efo_term": "HEMANGIOMA", "stage": 2}, {"efo_term": "SKIN ULCER", "stage": 2}], "max_phase": 4, "name": "TIMOLOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL499", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": ["GLAUCOMA", "OPEN-ANGLE GLAUCOMA", "CARDIOVASCULAR DISEASE", "HEMANGIOMA", "OCULAR HYPERTENSION", "SKIN ULCER"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 2}, {"efo_term": "MYOCARDIAL ISCHEMIA", "stage": 2}, {"efo_term": "CORONARY HEART DISEASE", "stage": 0}], "max_phase": 4, "name": "REGADENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL317052", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["CORONARY ARTERY DISEASE", "SICKLE CELL ANEMIA", "CORONARY HEART DISEASE", "CARDIOVASCULAR DISEASE", "MYOCARDIAL ISCHEMIA"]}, {"indications": [{"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 3}, {"efo_term": "PREMATURE BIRTH", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 2}], "max_phase": 4, "name": "THEOPHYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A", "ADORA2B"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "OBSTRUCTIVE LUNG DISEASE", "ASTHMA", "PREMATURE BIRTH", "CHRONIC KIDNEY DISEASE"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}, {"efo_term": "CHRONIC BRONCHITIS", "stage": 4}, {"efo_term": "OBESITY", "stage": 2}], "max_phase": 4, "name": "SALMETEROL XINAFOATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1082607", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "OBESITY", "EMPHYSEMA", "CHRONIC BRONCHITIS"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "ACUTE RESPIRATORY DISTRESS SYNDROME", "stage": 2}], "max_phase": 4, "name": "ALBUTEROL SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201026", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ACUTE RESPIRATORY DISTRESS SYNDROME"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HEMANGIOMA", "stage": 3}, {"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "SMOKING CESSATION", "stage": 2}], "max_phase": 4, "name": "NADOLOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL649", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CARDIOVASCULAR DISEASE", "SMOKING CESSATION", "HEMANGIOMA"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}, {"efo_term": "CHRONIC BRONCHITIS", "stage": 4}], "max_phase": 4, "name": "VILANTEROL TRIFENATATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1084172", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "EMPHYSEMA", "CHRONIC BRONCHITIS"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}, {"efo_term": "CHRONIC BRONCHITIS", "stage": 4}, {"efo_term": "ASTHMA", "stage": 2}], "max_phase": 4, "name": "INDACATEROL MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789842", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ASTHMA", "EMPHYSEMA", "CHRONIC BRONCHITIS"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 2}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 1}], "max_phase": 4, "name": "PROPRANOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1671", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": ["TYPE II DIABETES MELLITUS", "HYPERTENSION", "CUTANEOUS MELANOMA"]}, {"indications": [{"efo_term": "GLAUCOMA", "stage": 3}, {"efo_term": "HEMANGIOMA", "stage": 3}, {"efo_term": "ANTERIOR ISCHEMIC OPTIC NEUROPATHY", "stage": 1}], "max_phase": 4, "name": "TIMOLOL MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200870", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": ["GLAUCOMA", "HEMANGIOMA", "ANTERIOR ISCHEMIC OPTIC NEUROPATHY"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "BREAST CARCINOMA", "stage": 2}], "max_phase": 4, "name": "CARVEDILOL PHOSPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201167", "mechanisms": ["Adrenergic receptor beta antagonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["HYPERTENSION", "BREAST CARCINOMA"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "LIVER DISEASE", "stage": 1}, {"efo_term": "DRUG DEPENDENCE", "stage": 1}], "max_phase": 3, "name": "ISTRADEFYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL431770", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "LIVER DISEASE", "DRUG DEPENDENCE"]}, {"indications": [{"efo_term": "PREMATURE BIRTH", "stage": 3}, {"efo_term": "RETINOPATHY OF PREMATURITY", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "CAFFEINE, CITRATED", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200569", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A", "ADORA2B"], "type": "Small molecule", "diseases": ["PREMATURE BIRTH", "LIVER DISEASE", "RETINOPATHY OF PREMATURITY"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 4, "name": "PINDOLOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL500", "mechanisms": ["Beta-1 adrenergic receptor partial agonist", "Beta-2 adrenergic receptor partial agonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": ["CARDIOVASCULAR DISEASE", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "OPEN-ANGLE GLAUCOMA", "stage": 4}, {"efo_term": "OCULAR HYPERTENSION", "stage": 4}], "max_phase": 4, "name": "BETAXOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1691", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["OPEN-ANGLE GLAUCOMA", "OCULAR HYPERTENSION"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}], "max_phase": 4, "name": "BISOPROLOL FUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200708", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["HYPERTENSION", "FISH-EYE DISEASE"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "VENTRICULAR ARRHYTHMIA", "stage": 4}], "max_phase": 4, "name": "ACEBUTOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200813", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["HYPERTENSION", "VENTRICULAR ARRHYTHMIA"]}, {"indications": [{"efo_term": "OVARIAN CYST", "stage": 1}, {"efo_term": "DIABETIC FOOT", "stage": 1}], "max_phase": 4, "name": "ESMOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201115", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": ["OVARIAN CYST", "DIABETIC FOOT"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}, {"efo_term": "PREGNANCY", "stage": 3}], "max_phase": 4, "name": "DINOPROSTONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL548", "mechanisms": ["Prostaglandin E2 receptor agonist"], "genes": ["PTGER2", "PTGER4"], "type": "Small molecule", "diseases": ["PAIN", "PREGNANCY"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 3, "name": "PRELADENANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL240624", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "LIVER DISEASE"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 0}], "max_phase": 3, "name": "TOZADENANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105747", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "COCAINE DEPENDENCE"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 1}, {"efo_term": "PARKINSON'S DISEASE", "stage": 1}], "max_phase": 2, "name": "V81444", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545288", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 3}], "max_phase": 4, "name": "TERBUTALINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1160544", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "DRUG DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "METAPROTERENOL SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200812", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "DRUG DEPENDENCE"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}], "max_phase": 4, "name": "ARFORMOTEROL TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1951071", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "EMPHYSEMA"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}], "max_phase": 4, "name": "OLODATEROL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105743", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "EMPHYSEMA"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 1}], "max_phase": 2, "name": "BEDORADRINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2218893", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ASTHMA"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}], "max_phase": 4, "name": "FORMOTEROL FUMARATE DIHYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2303638", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}], "max_phase": 2, "name": "ABEDITEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039530", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}], "max_phase": 2, "name": "AZD3199", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545103", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}], "max_phase": 4, "name": "DOPAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1557", "mechanisms": ["Beta-1 adrenergic receptor agonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}], "max_phase": 4, "name": "NEBIVOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201731", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": ["HYPERTENSION"]}, {"indications": [{"efo_term": "MYOCARDIAL INFARCTION", "stage": 4}], "max_phase": 4, "name": "METOPROLOL TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256957", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["MYOCARDIAL INFARCTION"]}, {"indications": [{"efo_term": "OBESITY", "stage": 2}], "max_phase": 2, "name": "LY377604", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2012520", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist", "Beta-3 adrenergic receptor agonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["OBESITY"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}], "max_phase": 4, "name": "ISOPROTERENOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1711", "mechanisms": ["Adrenergic receptor beta agonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["ASTHMA"]}, {"indications": [{"efo_term": "OPEN-ANGLE GLAUCOMA", "stage": 4}], "max_phase": 4, "name": "CARTEOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201002", "mechanisms": ["Adrenergic receptor beta antagonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["OPEN-ANGLE GLAUCOMA"]}, {"indications": [{"efo_term": "PREECLAMPSIA", "stage": 2}], "max_phase": 4, "name": "LABETALOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200323", "mechanisms": ["Adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["PREECLAMPSIA"]}, {"indications": [{"efo_term": "RENAL INSUFFICIENCY", "stage": 0}], "max_phase": 4, "name": "NORADRENALINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356607", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["RENAL INSUFFICIENCY"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 2}], "max_phase": 2, "name": "VIPADENANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL447664", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "DIABETIC FOOT", "stage": 2}], "max_phase": 2, "name": "SONEDENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1950553", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["DIABETIC FOOT"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 1}], "max_phase": 1, "name": "PBF-509", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545009", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "HUNTINGTON DISEASE", "stage": 1}], "max_phase": 1, "name": "PBF-999", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545271", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["HUNTINGTON DISEASE"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 2, "name": "BVT.115959", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545409", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}], "max_phase": 4, "name": "OXTRIPHYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A", "ADORA2B"], "type": "Small molecule", "diseases": ["OBSTRUCTIVE LUNG DISEASE"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}], "max_phase": 2, "name": "CARMOTEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1094785", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}], "max_phase": 4, "name": "PIRBUTEROL ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200444", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 3}], "max_phase": 4, "name": "LEVALBUTEROL TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062258", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}], "max_phase": 2, "name": "BATEFENTEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039518", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "MIGRAINE DISORDER", "stage": 3}], "max_phase": 0, "name": "EPTINEZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3833320", "mechanisms": ["Calcitonin gene-related peptide_UNCURATED inhibitor"], "genes": ["CALCB"], "type": "Antibody", "diseases": ["MIGRAINE DISORDER"]}, {"indications": [{"efo_term": "NEUROGENIC BLADDER", "stage": 1}], "max_phase": 3, "name": "RITOBEGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107773", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": ["NEUROGENIC BLADDER"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 2}], "max_phase": 2, "name": "VIBEGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107826", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": ["OVERACTIVE BLADDER"]}, {"indications": [], "max_phase": 4, "name": "SOTALOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1700", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PENBUTOLOL SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200363", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DOBUTAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200418", "mechanisms": ["Beta-1 adrenergic receptor agonist", "Beta-2 adrenergic receptor agonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "OXPRENOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200745", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LEVOBETAXOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200837", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METOPROLOL FUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200898", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METIPRANOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200947", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPAFENONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201063", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LEVOBUNOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201177", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ISOPROTERENOL SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200447", "mechanisms": ["Adrenergic receptor beta agonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HYDROXYAMPHETAMINE HYDROBROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200705", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIPIVEFRIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200833", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MEPHENTERMINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200996", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "EPINEPHRINE BITARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256958", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "ST1535", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL197669", "mechanisms": ["Adenosine A2a receptor antagonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "UK432097", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1096896", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "BINODENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1950554", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "APADENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1950649", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "EVODENOSON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1950651", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "AMP579", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545163", "mechanisms": ["Adenosine A2a receptor agonist"], "genes": ["ADORA2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THEOPHYLLINE SODIUM GLYCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200578", "mechanisms": ["Adenosine receptor antagonist"], "genes": ["ADORA2A", "ADORA2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BITOLTEROL MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200405", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROTOKYLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200893", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ISOETHARINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200920", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LEVALBUTEROL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201061", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ISOETHARINE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201153", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "RITODRINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201160", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "MILVETEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1940832", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "GSK159802", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545087", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "LAS190792", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545272", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "GS 6201", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL260933", "mechanisms": ["Adenosine A2b receptor antagonist"], "genes": ["ADORA2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "LAS101057", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1672627", "mechanisms": ["Adenosine A2b receptor antagonist"], "genes": ["ADORA2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "QAF805", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545204", "mechanisms": ["Adenosine A2b receptor antagonist"], "genes": ["ADORA2B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "RIVENPROST", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL303960", "mechanisms": ["Prostanoid EP4 receptor agonist"], "genes": ["PTGER4"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "RAFABEGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL279260", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "SOLABEGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL208427", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "AMIBEGRON HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL545437", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": []}], "heat": 0.9205053472222501, "nodes": [{"assoc": 1.0, "id": "ENSG00000043591", "label": "ADRB1"}, {"assoc": 0.7, "id": "ENSG00000125384", "label": "PTGER2"}, {"assoc": 1.0, "id": "ENSG00000128271", "label": "ADORA2A"}, {"assoc": 1.0, "id": "ENSG00000169252", "label": "ADRB2"}, {"assoc": 1.0, "id": "ENSG00000170425", "label": "ADORA2B"}, {"assoc": 0.706965, "id": "ENSG00000171522", "label": "PTGER4"}, {"assoc": 0.957077777778, "id": "ENSG00000175868", "label": "CALCB"}, {"assoc": 1.0, "id": "ENSG00000188778", "label": "ADRB3"}], "size": 8}, {"diseases": ["PARKINSON'S DISEASE", "NICOTINE DEPENDENCE", "BORDERLINE PERSONALITY DISORDER SYMPTOM", "LIVER DISEASE", "MARIJUANA DEPENDENCE", "MULTIPLE SYSTEM ATROPHY", "PAIN", "NEUROPATHIC PAIN", "PROSTATE ADENOCARCINOMA", "UNIPOLAR DEPRESSION", "METAMPHETAMINE DEPENDENCE", "EPILEPSY", "OBESITY", "GAMBLING BEHAVIOUR", "PICK DISEASE", "ALCOHOL DEPENDENCE", "MYELODYSPLASTIC SYNDROME", "CANCER", "FAMILIAL DYSAUTONOMIA", "FIBROMYALGIA", "SECONDARY PARKINSON DISEASE", "POSTENCEPHALITIC PARKINSON DISEASE", "CARCINOID SYNDROME", "DIARRHEA"], "links": [{"source": "ENSG00000069535", "target": "ENSG00000093010"}, {"source": "ENSG00000069535", "target": "ENSG00000123454"}, {"source": "ENSG00000069535", "target": "ENSG00000130066"}, {"source": "ENSG00000069535", "target": "ENSG00000131203"}, {"source": "ENSG00000069535", "target": "ENSG00000132437"}, {"source": "ENSG00000093010", "target": "ENSG00000123454"}, {"source": "ENSG00000093010", "target": "ENSG00000132437"}, {"source": "ENSG00000093010", "target": "ENSG00000189221"}, {"source": "ENSG00000123454", "target": "ENSG00000132437"}, {"source": "ENSG00000123454", "target": "ENSG00000189221"}, {"source": "ENSG00000130066", "target": "ENSG00000189221"}, {"source": "ENSG00000131203", "target": "ENSG00000132437"}, {"source": "ENSG00000131203", "target": "ENSG00000139287"}, {"source": "ENSG00000131203", "target": "ENSG00000189221"}, {"source": "ENSG00000132437", "target": "ENSG00000139287"}, {"source": "ENSG00000132437", "target": "ENSG00000189221"}], "drugs": [{"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "SECONDARY PARKINSON DISEASE", "stage": 4}, {"efo_term": "POSTENCEPHALITIC PARKINSON DISEASE", "stage": 4}, {"efo_term": "FAMILIAL DYSAUTONOMIA", "stage": 3}, {"efo_term": "FIBROMYALGIA", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "CARBIDOPA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200748", "mechanisms": ["DOPA decarboxylase inhibitor"], "genes": ["DDC"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "FAMILIAL DYSAUTONOMIA", "FIBROMYALGIA", "SECONDARY PARKINSON DISEASE", "POSTENCEPHALITIC PARKINSON DISEASE", "NICOTINE DEPENDENCE"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 2}, {"efo_term": "PICK DISEASE", "stage": 2}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "TOLCAPONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1324", "mechanisms": ["Catechol O-methyltransferase inhibitor"], "genes": ["COMT"], "type": "Small molecule", "diseases": ["NICOTINE DEPENDENCE", "PARKINSON'S DISEASE", "GAMBLING BEHAVIOUR", "PICK DISEASE", "ALCOHOL DEPENDENCE"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 1}, {"efo_term": "OBESITY", "stage": 1}, {"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 0}], "max_phase": 4, "name": "ENTACAPONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL953", "mechanisms": ["Catechol O-methyltransferase inhibitor"], "genes": ["COMT"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "METAMPHETAMINE DEPENDENCE", "EPILEPSY", "OBESITY"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "BORDERLINE PERSONALITY DISORDER SYMPTOM", "stage": 3}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "SELEGILINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL972", "mechanisms": ["Monoamine oxidase B inhibitor"], "genes": ["MAOB"], "type": "Small molecule", "diseases": ["NICOTINE DEPENDENCE", "PARKINSON'S DISEASE", "BORDERLINE PERSONALITY DISORDER SYMPTOM"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "SAFINAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL396778", "mechanisms": ["Monoamine oxidase B inhibitor"], "genes": ["MAOB"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "LIVER DISEASE"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "MULTIPLE SYSTEM ATROPHY", "stage": 2}], "max_phase": 4, "name": "RASAGILINE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201142", "mechanisms": ["Monoamine oxidase B inhibitor"], "genes": ["MAOB"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "MULTIPLE SYSTEM ATROPHY"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 3, "name": "RALFINAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107771", "mechanisms": ["Monoamine oxidase B inhibitor"], "genes": ["MAOB"], "type": "Small molecule", "diseases": ["PAIN", "NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "MYELODYSPLASTIC SYNDROME", "stage": 2}, {"efo_term": "CANCER", "stage": 1}], "max_phase": 3, "name": "EPACADOSTAT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545369", "mechanisms": ["Indoleamine 2,3-dioxygenase inhibitor"], "genes": ["IDO1"], "type": "Small molecule", "diseases": ["MYELODYSPLASTIC SYNDROME", "CANCER"]}, {"indications": [{"efo_term": "CARCINOID SYNDROME", "stage": 3}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 3, "name": "TELOTRISTAT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103855", "mechanisms": ["Tryptophan 5-hydroxylase inhibitor"], "genes": ["TPH2"], "type": "Small molecule", "diseases": ["CARCINOID SYNDROME", "LIVER DISEASE"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}], "max_phase": 4, "name": "SAFINAMIDE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL48582", "mechanisms": ["Monoamine oxidase B inhibitor"], "genes": ["MAOB"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "SELEGILINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200904", "mechanisms": ["Monoamine oxidase B inhibitor"], "genes": ["MAOB"], "type": "Small molecule", "diseases": ["MARIJUANA DEPENDENCE"]}, {"indications": [{"efo_term": "PROSTATE ADENOCARCINOMA", "stage": 2}], "max_phase": 4, "name": "PHENELZINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200895", "mechanisms": ["Monoamine oxidase inhibitor"], "genes": ["MAOB", "MAOA"], "type": "Small molecule", "diseases": ["PROSTATE ADENOCARCINOMA"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}], "max_phase": 4, "name": "ISOCARBOXAZID", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201168", "mechanisms": ["Monoamine oxidase inhibitor"], "genes": ["MAOB", "MAOA"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "DIARRHEA", "stage": 4}], "max_phase": 4, "name": "TELOTRISTAT ETHYL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105695", "mechanisms": ["Tryptophan 5-hydroxylase inhibitor"], "genes": ["TPH2"], "type": "Small molecule", "diseases": ["DIARRHEA"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 2, "name": "Indantadol", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707400", "mechanisms": ["Monoamine oxidase A inhibitor"], "genes": ["MAOA"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN"]}, {"indications": [], "max_phase": 4, "name": "PARGYLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200425", "mechanisms": ["Monoamine oxidase inhibitor"], "genes": ["MAOB", "MAOA"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRANYLCYPROMINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2218887", "mechanisms": ["Monoamine oxidase inhibitor"], "genes": ["MAOB", "MAOA"], "type": "Small molecule", "diseases": []}], "heat": 0.2606602034297875, "nodes": [{"assoc": 0.759512285016, "id": "ENSG00000069535", "label": "MAOB"}, {"assoc": 0.275427403746, "id": "ENSG00000093010", "label": "COMT"}, {"assoc": 0.0739868819955, "id": "ENSG00000123454", "label": "DBH"}, {"assoc": 0.210811347222, "id": "ENSG00000130066", "label": "SAT1"}, {"assoc": 0.209004010747, "id": "ENSG00000131203", "label": "IDO1"}, {"assoc": 0.2033, "id": "ENSG00000132437", "label": "DDC"}, {"assoc": 0.0864175277778, "id": "ENSG00000139287", "label": "TPH2"}, {"assoc": 0.266822170934, "id": "ENSG00000189221", "label": "MAOA"}], "size": 8}, {"diseases": ["NICOTINE DEPENDENCE", "SMOKING CESSATION", "MEMORY IMPAIRMENT", "PARKINSON'S DISEASE", "POST OPERATIVE NAUSEA AND VOMITING", "SARCOIDOSIS", "ALCOHOL DRINKING", "HEART FAILURE", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "CERVICAL CARCINOMA", "COGNITIVE IMPAIRMENT", "LUNG CARCINOMA", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "INJURY", "DRUG DEPENDENCE", "ALZHEIMERS DISEASE", "SCHIZOPHRENIA", "NEUROPATHIC PAIN", "UNIPOLAR DEPRESSION", "HYPERTENSION", "OVERACTIVE BLADDER", "GASTROPARESIS", "IRRITABLE BOWEL SYNDROME", "LIVER DISEASE"], "links": [{"source": "ENSG00000101204", "target": "ENSG00000108556"}, {"source": "ENSG00000101204", "target": "ENSG00000135902"}, {"source": "ENSG00000101204", "target": "ENSG00000160716"}, {"source": "ENSG00000101204", "target": "ENSG00000163032"}, {"source": "ENSG00000101204", "target": "ENSG00000170175"}, {"source": "ENSG00000101204", "target": "ENSG00000196811"}, {"source": "ENSG00000108556", "target": "ENSG00000135902"}, {"source": "ENSG00000108556", "target": "ENSG00000138435"}, {"source": "ENSG00000108556", "target": "ENSG00000160716"}, {"source": "ENSG00000108556", "target": "ENSG00000170175"}, {"source": "ENSG00000135902", "target": "ENSG00000138435"}, {"source": "ENSG00000135902", "target": "ENSG00000160716"}, {"source": "ENSG00000135902", "target": "ENSG00000170175"}, {"source": "ENSG00000138435", "target": "ENSG00000196811"}, {"source": "ENSG00000160716", "target": "ENSG00000170175"}, {"source": "ENSG00000170175", "target": "ENSG00000196811"}], "drugs": [{"indications": [{"efo_term": "NICOTINE DEPENDENCE", "stage": 4}, {"efo_term": "SMOKING CESSATION", "stage": 3}, {"efo_term": "HEART FAILURE", "stage": 3}, {"efo_term": "CERVICAL CARCINOMA", "stage": 3}, {"efo_term": "LUNG CARCINOMA", "stage": 3}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "POST OPERATIVE NAUSEA AND VOMITING", "stage": 2}, {"efo_term": "ALCOHOL DRINKING", "stage": 2}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}, {"efo_term": "COGNITIVE IMPAIRMENT", "stage": 2}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "DRUG DEPENDENCE", "stage": 2}, {"efo_term": "MEMORY IMPAIRMENT", "stage": 1}, {"efo_term": "SARCOIDOSIS", "stage": 1}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 1}], "max_phase": 4, "name": "NICOTINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["NICOTINE DEPENDENCE", "SMOKING CESSATION", "MEMORY IMPAIRMENT", "PARKINSON'S DISEASE", "POST OPERATIVE NAUSEA AND VOMITING", "SARCOIDOSIS", "ALCOHOL DRINKING", "HEART FAILURE", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "CERVICAL CARCINOMA", "COGNITIVE IMPAIRMENT", "LUNG CARCINOMA", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "INJURY", "DRUG DEPENDENCE"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}], "max_phase": 2, "name": "ISPRONICLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL188462", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 partial agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "SCHIZOPHRENIA", "ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "OVERACTIVE BLADDER", "stage": 2}, {"efo_term": "HYPERTENSION", "stage": 1}], "max_phase": 3, "name": "DEXMECAMYLAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103881", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 antagonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["HYPERTENSION", "OVERACTIVE BLADDER", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}], "max_phase": 2, "name": "POZANICLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL127071", "mechanisms": ["Nicotinic acetylcholine receptor alpha4/beta2/alpha5 partial agonist", "Neuronal acetylcholine receptor; alpha6/beta2 partial agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "NICOTINE DEPENDENCE"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 2}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}], "max_phase": 2, "name": "SOFINICLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL238465", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN", "ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "NICOTINE DEPENDENCE", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}], "max_phase": 4, "name": "NICOTINE POLACRILEX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201536", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["NICOTINE DEPENDENCE", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "SMOKING CESSATION", "stage": 1}], "max_phase": 4, "name": "VARENICLINE TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062259", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["NICOTINE DEPENDENCE", "SMOKING CESSATION"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}], "max_phase": 2, "name": "AZD1446", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2179529", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 2}, {"efo_term": "GASTROPARESIS", "stage": 1}], "max_phase": 2, "name": "TC-6499", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545353", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["GASTROPARESIS", "IRRITABLE BOWEL SYNDROME"]}, {"indications": [{"efo_term": "LIVER DISEASE", "stage": 2}], "max_phase": 4, "name": "MIVACURIUM CHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL984", "mechanisms": ["Muscle-type nicotinic acetylcholine receptor antagonist"], "genes": ["CHRNE", "CHRND", "CHRNA1", "CHRNB1", "CHRNG"], "type": "Small molecule", "diseases": ["LIVER DISEASE"]}, {"indications": [], "max_phase": 2, "name": "TEBANICLINE TOSYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL430497", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "ALTINICLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL111659", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "TC-2216", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL504652", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 antagonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "CP-601927", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707250", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 partial agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "ABT-560", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707354", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 modulator"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "SUCCINYLCHOLINE CHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL983", "mechanisms": ["Muscle-type nicotinic acetylcholine receptor agonist"], "genes": ["CHRNE", "CHRND", "CHRNA1", "CHRNB1", "CHRNG"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DECAMETHONIUM BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1134", "mechanisms": ["Muscle-type nicotinic acetylcholine receptor partial agonist"], "genes": ["CHRNE", "CHRND", "CHRNA1", "CHRNB1", "CHRNG"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TUBOCURARINE CHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1687", "mechanisms": ["Muscle-type nicotinic acetylcholine receptor antagonist"], "genes": ["CHRNE", "CHRND", "CHRNA1", "CHRNB1", "CHRNG"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METOCURINE IODIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1739", "mechanisms": ["Muscle-type nicotinic acetylcholine receptor antagonist"], "genes": ["CHRNE", "CHRND", "CHRNA1", "CHRNB1", "CHRNG"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ATRACURIUM BESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200527", "mechanisms": ["Muscle-type nicotinic acetylcholine receptor antagonist"], "genes": ["CHRNE", "CHRND", "CHRNA1", "CHRNB1", "CHRNG"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "RAPACURONIUM BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200549", "mechanisms": ["Muscle-type nicotinic acetylcholine receptor antagonist"], "genes": ["CHRNE", "CHRND", "CHRNA1", "CHRNB1", "CHRNG"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "VECURONIUM BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200629", "mechanisms": ["Muscle-type nicotinic acetylcholine receptor antagonist"], "genes": ["CHRNE", "CHRND", "CHRNA1", "CHRNB1", "CHRNG"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CISATRACURIUM BESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200641", "mechanisms": ["Muscle-type nicotinic acetylcholine receptor antagonist"], "genes": ["CHRNE", "CHRND", "CHRNA1", "CHRNB1", "CHRNG"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ROCURONIUM BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200648", "mechanisms": ["Muscle-type nicotinic acetylcholine receptor antagonist"], "genes": ["CHRNE", "CHRND", "CHRNA1", "CHRNB1", "CHRNG"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PIPECURONIUM BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200722", "mechanisms": ["Muscle-type nicotinic acetylcholine receptor antagonist"], "genes": ["CHRNE", "CHRND", "CHRNA1", "CHRNB1", "CHRNG"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PANCURONIUM BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200757", "mechanisms": ["Muscle-type nicotinic acetylcholine receptor antagonist"], "genes": ["CHRNE", "CHRND", "CHRNA1", "CHRNB1", "CHRNG"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "GALLAMINE TRIETHIODIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200993", "mechanisms": ["Muscle-type nicotinic acetylcholine receptor antagonist"], "genes": ["CHRNE", "CHRND", "CHRNA1", "CHRNB1", "CHRNG"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DOXACURIUM CHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237099", "mechanisms": ["Muscle-type nicotinic acetylcholine receptor antagonist"], "genes": ["CHRNE", "CHRND", "CHRNA1", "CHRNB1", "CHRNG"], "type": "Small molecule", "diseases": []}], "heat": 0.8817815, "nodes": [{"assoc": 1.0, "id": "ENSG00000101204", "label": "CHRNA4"}, {"assoc": 1.0, "id": "ENSG00000108556", "label": "CHRNE"}, {"assoc": 1.0, "id": "ENSG00000135902", "label": "CHRND"}, {"assoc": 1.0, "id": "ENSG00000138435", "label": "CHRNA1"}, {"assoc": 1.0, "id": "ENSG00000160716", "label": "CHRNB2"}, {"assoc": 0.054252, "id": "ENSG00000163032", "label": "VSNL1"}, {"assoc": 1.0, "id": "ENSG00000170175", "label": "CHRNB1"}, {"assoc": 1.0, "id": "ENSG00000196811", "label": "CHRNG"}], "size": 8}, {"diseases": ["SCHIZOPHRENIA", "PSYCHOSIS", "BIPOLAR DISORDER", "AGITATION", "POST-OPERATIVE SIGN OR SYMPTOM", "TOURETTE SYNDROME", "CONDUCT DISORDER", "ACUTE MYELOID LEUKEMIA", "NEONATAL ABSTINENCE SYNDROME", "AUTISM", "COCAINE DEPENDENCE", "DIABETES MELLITUS", "UNIPOLAR DEPRESSION", "FISH-EYE DISEASE", "INJURY", "LIVER DISEASE", "POST-TRAUMATIC STRESS DISORDER", "AUTISM SPECTRUM DISORDER", "ALCOHOL DEPENDENCE", "HEROIN DEPENDENCE", "FIBROMYALGIA", "CANCER", "EATING DISORDER", "HUNTINGTON DISEASE", "GAMBLING BEHAVIOUR", "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "HIV INFECTION", "VOMITING", "INSULIN RESISTANCE", "POST OPERATIVE NAUSEA AND VOMITING", "LYMPHOID NEOPLASM", "BREAST CARCINOMA", "ASTHMA", "NICOTINE DEPENDENCE", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "NEUROPATHIC PAIN", "INSOMNIA", "ALZHEIMERS DISEASE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "MENTAL OR BEHAVIOURAL DISORDER", "ANOREXIA NERVOSA", "AGGRESSIVE BEHAVIOR", "POSTPARTUM DEPRESSION", "AMYOTROPHIC LATERAL SCLEROSIS", "SCHIZOAFFECTIVE DISORDER", "OBSESSIVE-COMPULSIVE DISORDER", "ACUTE CORONARY SYNDROME", "MIGRAINE DISORDER", "SPASTICITY", "CEREBRAL PALSY", "MYALGIA", "PAIN", "BORDERLINE PERSONALITY DISORDER SYMPTOM", "MULTIPLE SCLEROSIS", "PARKINSON'S DISEASE", "BENIGN PROSTATIC HYPERPLASIA", "KIDNEY STONE", "PREMATURE EJACULATION", "PROSTATE CARCINOMA", "PROSTATITIS", "HEART FAILURE", "HYPERTENSION", "PULMONARY HYPERTENSION", "EPILEPSY", "ATRIAL FIBRILLATION", "CONGESTIVE HEART FAILURE", "CARDIOVASCULAR DISEASE", "CATARACT", "CARDIAC ARRHYTHMIA", "STROKE", "HYPERPLASIA", "NEUROGENIC BLADDER", "ALLERGIC RHINITIS", "EYE DISEASE", "ALLERGIC CONJUNCTIVITIS", "RHINITIS", "ROSACEA", "GRAVES OPHTHALMOPATHY", "NASAL OBSTRUCTION", "SUDDEN CARDIAC ARREST", "BRONCHIOLITIS", "GLAUCOMA", "OBSTRUCTIVE LUNG DISEASE", "HEMORRHAGE", "SEASONAL ALLERGIC RHINITIS", "URTICARIA", "ANGIOEDEMA", "SINUSITIS", "PREECLAMPSIA", "RENAL INSUFFICIENCY", "HYPOTENSION", "ORTHOSTATIC HYPOTENSION", "CHRONIC KIDNEY DISEASE", "MULTIPLE SYSTEM ATROPHY", "URINARY INCONTINENCE", "HYPERHIDROSIS", "ENURESIS NOCTURNA", "OVERACTIVE BLADDER", "AMBLYOPIA", "DIGESTIVE SYSTEM DISEASE", "HYPOGLYCEMIA", "MYOPIA", "EMPHYSEMA", "CHRONIC BRONCHITIS", "DROOLING", "FAMILIAL DYSAUTONOMIA", "PEPTIC ULCER", "CYSTIC FIBROSIS", "ALLERGY", "RHINITIS, ALLERGIC, PERENNIAL", "ATOPIC ECZEMA", "ECZEMA", "PRURITUS", "SKIN DISEASE", "NEUROTIC DISORDER", "VASOMOTOR RHINITIS", "EYE ALLERGY"], "links": [{"source": "ENSG00000102468", "target": "ENSG00000120907"}, {"source": "ENSG00000102468", "target": "ENSG00000133019"}, {"source": "ENSG00000102468", "target": "ENSG00000170214"}, {"source": "ENSG00000102468", "target": "ENSG00000171873"}, {"source": "ENSG00000102468", "target": "ENSG00000196639"}, {"source": "ENSG00000120907", "target": "ENSG00000133019"}, {"source": "ENSG00000120907", "target": "ENSG00000170214"}, {"source": "ENSG00000120907", "target": "ENSG00000171873"}, {"source": "ENSG00000120907", "target": "ENSG00000196639"}, {"source": "ENSG00000133019", "target": "ENSG00000170214"}, {"source": "ENSG00000133019", "target": "ENSG00000171873"}, {"source": "ENSG00000133019", "target": "ENSG00000196639"}, {"source": "ENSG00000170214", "target": "ENSG00000171873"}, {"source": "ENSG00000170214", "target": "ENSG00000196639"}, {"source": "ENSG00000171873", "target": "ENSG00000196639"}], "drugs": [{"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "EATING DISORDER", "stage": 3}, {"efo_term": "HUNTINGTON DISEASE", "stage": 3}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "LYMPHOID NEOPLASM", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "DIABETES MELLITUS", "stage": 2}, {"efo_term": "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "stage": 2}, {"efo_term": "AUTISM", "stage": 2}, {"efo_term": "VOMITING", "stage": 2}, {"efo_term": "INSULIN RESISTANCE", "stage": 2}, {"efo_term": "POST OPERATIVE NAUSEA AND VOMITING", "stage": 2}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}, {"efo_term": "HIV INFECTION", "stage": 1}], "max_phase": 4, "name": "OLANZAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL715", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "EATING DISORDER", "HUNTINGTON DISEASE", "SCHIZOPHRENIA", "DIABETES MELLITUS", "GAMBLING BEHAVIOUR", "UNIPOLAR DEPRESSION", "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "FISH-EYE DISEASE", "HIV INFECTION", "ALCOHOL DEPENDENCE", "AUTISM", "PSYCHOSIS", "VOMITING", "INSULIN RESISTANCE", "POST OPERATIVE NAUSEA AND VOMITING", "CANCER", "LYMPHOID NEOPLASM", "BREAST CARCINOMA"]}, {"indications": [{"efo_term": "AUTISM", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "AGGRESSIVE BEHAVIOR", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "AGITATION", "stage": 4}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 3}, {"efo_term": "MENTAL OR BEHAVIOURAL DISORDER", "stage": 3}, {"efo_term": "TOURETTE SYNDROME", "stage": 3}, {"efo_term": "ANOREXIA NERVOSA", "stage": 3}, {"efo_term": "POSTPARTUM DEPRESSION", "stage": 3}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}, {"efo_term": "DIABETES MELLITUS", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "ARIPIPRAZOLE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1112", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["ALCOHOL DEPENDENCE", "ALZHEIMERS DISEASE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "AUTISM", "BIPOLAR DISORDER", "SCHIZOPHRENIA", "UNIPOLAR DEPRESSION", "MENTAL OR BEHAVIOURAL DISORDER", "PSYCHOSIS", "TOURETTE SYNDROME", "DIABETES MELLITUS", "POST-TRAUMATIC STRESS DISORDER", "ANOREXIA NERVOSA", "AGGRESSIVE BEHAVIOR", "AGITATION", "AUTISM SPECTRUM DISORDER", "POSTPARTUM DEPRESSION", "COCAINE DEPENDENCE"]}, {"indications": [{"efo_term": "HEART FAILURE", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "CONGESTIVE HEART FAILURE", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 2}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "EPILEPSY", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}], "max_phase": 4, "name": "CARVEDILOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL723", "mechanisms": ["Adrenergic receptor alpha-1 antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["HEART FAILURE", "HYPERTENSION", "PULMONARY HYPERTENSION", "CANCER", "EPILEPSY", "ATRIAL FIBRILLATION", "CONGESTIVE HEART FAILURE", "POST-TRAUMATIC STRESS DISORDER", "BREAST CARCINOMA", "CARDIOVASCULAR DISEASE", "COCAINE DEPENDENCE", "NICOTINE DEPENDENCE", "PROSTATE CARCINOMA"]}, {"indications": [{"efo_term": "NASAL OBSTRUCTION", "stage": 4}, {"efo_term": "GLAUCOMA", "stage": 4}, {"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "HEMORRHAGE", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "URTICARIA", "stage": 4}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 4}, {"efo_term": "ANGIOEDEMA", "stage": 4}, {"efo_term": "SINUSITIS", "stage": 4}, {"efo_term": "ASTHMA", "stage": 3}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 3}, {"efo_term": "BRONCHIOLITIS", "stage": 3}], "max_phase": 4, "name": "EPINEPHRINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["ASTHMA", "NASAL OBSTRUCTION", "SUDDEN CARDIAC ARREST", "BRONCHIOLITIS", "GLAUCOMA", "OBSTRUCTIVE LUNG DISEASE", "HEMORRHAGE", "CARDIOVASCULAR DISEASE", "SEASONAL ALLERGIC RHINITIS", "ALLERGIC RHINITIS", "URTICARIA", "ANGIOEDEMA", "SINUSITIS"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "AUTISM", "stage": 4}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "DIABETES MELLITUS", "stage": 2}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}], "max_phase": 4, "name": "RISPERIDONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "PSYCHOSIS", "SCHIZOPHRENIA", "AUTISM", "COCAINE DEPENDENCE", "DIABETES MELLITUS", "UNIPOLAR DEPRESSION", "FISH-EYE DISEASE", "INJURY"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "BORDERLINE PERSONALITY DISORDER SYMPTOM", "stage": 3}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 1}], "max_phase": 4, "name": "QUETIAPINE FUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200911", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "BORDERLINE PERSONALITY DISORDER SYMPTOM", "FISH-EYE DISEASE", "POST-TRAUMATIC STRESS DISORDER", "SCHIZOPHRENIA", "UNIPOLAR DEPRESSION", "MULTIPLE SCLEROSIS", "ALCOHOL DEPENDENCE"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "TOURETTE SYNDROME", "stage": 4}, {"efo_term": "CONDUCT DISORDER", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "AGITATION", "stage": 3}, {"efo_term": "POST-OPERATIVE SIGN OR SYMPTOM", "stage": 3}], "max_phase": 4, "name": "HALOPERIDOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "PSYCHOSIS", "SCHIZOPHRENIA", "AGITATION", "POST-OPERATIVE SIGN OR SYMPTOM", "TOURETTE SYNDROME", "CONDUCT DISORDER"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 3}, {"efo_term": "HEROIN DEPENDENCE", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "FIBROMYALGIA", "stage": 2}, {"efo_term": "CANCER", "stage": 2}], "max_phase": 4, "name": "MIRTAZAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL654", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION", "AUTISM SPECTRUM DISORDER", "ALCOHOL DEPENDENCE", "COCAINE DEPENDENCE", "HEROIN DEPENDENCE", "FIBROMYALGIA", "CANCER"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}, {"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}, {"efo_term": "ASTHMA", "stage": 1}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 1}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 1}], "max_phase": 4, "name": "LOXAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL831", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["ASTHMA", "NICOTINE DEPENDENCE", "PSYCHOSIS", "SCHIZOPHRENIA", "BIPOLAR DISORDER", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "ORTHOSTATIC HYPOTENSION", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HYPOTENSION", "stage": 2}, {"efo_term": "FIBROMYALGIA", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "MULTIPLE SYSTEM ATROPHY", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 1}], "max_phase": 4, "name": "DROXIDOPA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103827", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["HYPOTENSION", "ORTHOSTATIC HYPOTENSION", "FIBROMYALGIA", "CARDIOVASCULAR DISEASE", "CHRONIC KIDNEY DISEASE", "PARKINSON'S DISEASE", "MULTIPLE SYSTEM ATROPHY"]}, {"indications": [{"efo_term": "ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "ALLERGY", "stage": 4}, {"efo_term": "URTICARIA", "stage": 3}, {"efo_term": "ATOPIC ECZEMA", "stage": 3}, {"efo_term": "RHINITIS, ALLERGIC, PERENNIAL", "stage": 3}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}], "max_phase": 4, "name": "DESLORATADINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1172", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["ALLERGIC RHINITIS", "URTICARIA", "ATOPIC ECZEMA", "SEASONAL ALLERGIC RHINITIS", "FISH-EYE DISEASE", "ALLERGY", "RHINITIS, ALLERGIC, PERENNIAL"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "SCHIZOAFFECTIVE DISORDER", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "AUTISM", "stage": 3}, {"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 2}], "max_phase": 4, "name": "PALIPERIDONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1621", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "SCHIZOPHRENIA", "SCHIZOAFFECTIVE DISORDER", "OBSESSIVE-COMPULSIVE DISORDER", "PSYCHOSIS", "AUTISM"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "INSOMNIA", "stage": 3}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 3}], "max_phase": 4, "name": "BREXPIPRAZOLE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105760", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "UNIPOLAR DEPRESSION", "INSOMNIA", "PSYCHOSIS", "POST-TRAUMATIC STRESS DISORDER"]}, {"indications": [{"efo_term": "EYE DISEASE", "stage": 3}, {"efo_term": "RHINITIS", "stage": 3}, {"efo_term": "ROSACEA", "stage": 3}, {"efo_term": "ALLERGIC CONJUNCTIVITIS", "stage": 2}, {"efo_term": "GRAVES OPHTHALMOPATHY", "stage": 2}, {"efo_term": "ALLERGIC RHINITIS", "stage": 1}], "max_phase": 4, "name": "OXYMETAZOLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200791", "mechanisms": ["Adrenergic receptor alpha agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["ALLERGIC RHINITIS", "EYE DISEASE", "ALLERGIC CONJUNCTIVITIS", "RHINITIS", "ROSACEA", "GRAVES OPHTHALMOPATHY"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 4}, {"efo_term": "NEUROGENIC BLADDER", "stage": 3}, {"efo_term": "HYPERHIDROSIS", "stage": 3}, {"efo_term": "URINARY INCONTINENCE", "stage": 3}, {"efo_term": "ENURESIS NOCTURNA", "stage": 3}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 2}], "max_phase": 4, "name": "OXYBUTYNIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1231", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["NEUROGENIC BLADDER", "HYPERHIDROSIS", "URINARY INCONTINENCE", "ENURESIS NOCTURNA", "OVERACTIVE BLADDER", "SEASONAL ALLERGIC RHINITIS"]}, {"indications": [{"efo_term": "DIGESTIVE SYSTEM DISEASE", "stage": 4}, {"efo_term": "AMBLYOPIA", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "MYOPIA", "stage": 3}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 2}, {"efo_term": "HYPOGLYCEMIA", "stage": 0}], "max_phase": 4, "name": "ATROPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL517712", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["AMBLYOPIA", "SEASONAL ALLERGIC RHINITIS", "PAIN", "DIGESTIVE SYSTEM DISEASE", "HYPOGLYCEMIA", "MYOPIA"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "NASAL OBSTRUCTION", "stage": 4}, {"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}, {"efo_term": "CHRONIC BRONCHITIS", "stage": 4}, {"efo_term": "FAMILIAL DYSAUTONOMIA", "stage": 3}], "max_phase": 4, "name": "IPRATROPIUM BROMIDE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2134724", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "NASAL OBSTRUCTION", "OBSTRUCTIVE LUNG DISEASE", "EMPHYSEMA", "FAMILIAL DYSAUTONOMIA", "CHRONIC BRONCHITIS"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "CHRONIC BRONCHITIS", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}, {"efo_term": "ASTHMA", "stage": 3}, {"efo_term": "CYSTIC FIBROSIS", "stage": 3}], "max_phase": 4, "name": "TIOTROPIUM BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545181", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "CYSTIC FIBROSIS", "OBSTRUCTIVE LUNG DISEASE", "CHRONIC BRONCHITIS", "EMPHYSEMA"]}, {"indications": [{"efo_term": "SPASTICITY", "stage": 4}, {"efo_term": "CEREBRAL PALSY", "stage": 4}, {"efo_term": "MYALGIA", "stage": 4}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "PAIN", "stage": 3}], "max_phase": 4, "name": "CYCLOBENZAPRINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200636", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["MIGRAINE DISORDER", "SPASTICITY", "CEREBRAL PALSY", "MYALGIA", "PAIN"]}, {"indications": [{"efo_term": "BENIGN PROSTATIC HYPERPLASIA", "stage": 4}, {"efo_term": "KIDNEY STONE", "stage": 3}, {"efo_term": "PROSTATE CARCINOMA", "stage": 3}, {"efo_term": "PREMATURE EJACULATION", "stage": 2}, {"efo_term": "PROSTATITIS", "stage": 2}], "max_phase": 4, "name": "SILODOSIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24778", "mechanisms": ["Alpha-1a adrenergic receptor antagonist"], "genes": ["ADRA1A"], "type": "Small molecule", "diseases": ["BENIGN PROSTATIC HYPERPLASIA", "KIDNEY STONE", "PREMATURE EJACULATION", "PROSTATE CARCINOMA", "PROSTATITIS"]}, {"indications": [{"efo_term": "ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "ALLERGIC CONJUNCTIVITIS", "stage": 4}, {"efo_term": "VASOMOTOR RHINITIS", "stage": 4}, {"efo_term": "RHINITIS, ALLERGIC, PERENNIAL", "stage": 3}], "max_phase": 4, "name": "AZELASTINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200809", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["ALLERGIC RHINITIS", "SEASONAL ALLERGIC RHINITIS", "ALLERGIC CONJUNCTIVITIS", "VASOMOTOR RHINITIS", "RHINITIS, ALLERGIC, PERENNIAL"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "ILOPERIDONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14376", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "LIVER DISEASE", "POST-TRAUMATIC STRESS DISORDER", "PSYCHOSIS"]}, {"indications": [{"efo_term": "BENIGN PROSTATIC HYPERPLASIA", "stage": 4}, {"efo_term": "POST-OPERATIVE SIGN OR SYMPTOM", "stage": 3}, {"efo_term": "HYPERPLASIA", "stage": 2}, {"efo_term": "NEUROGENIC BLADDER", "stage": 2}], "max_phase": 4, "name": "TAMSULOSIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200914", "mechanisms": ["Adrenergic receptor alpha-1 antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["BENIGN PROSTATIC HYPERPLASIA", "HYPERPLASIA", "POST-OPERATIVE SIGN OR SYMPTOM", "NEUROGENIC BLADDER"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}, {"efo_term": "CHRONIC BRONCHITIS", "stage": 4}], "max_phase": 4, "name": "UMECLIDINIUM BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL523299", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "OBSTRUCTIVE LUNG DISEASE", "EMPHYSEMA", "CHRONIC BRONCHITIS"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}, {"efo_term": "CHRONIC BRONCHITIS", "stage": 4}], "max_phase": 4, "name": "ACLIDINIUM BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL551466", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "OBSTRUCTIVE LUNG DISEASE", "EMPHYSEMA", "CHRONIC BRONCHITIS"]}, {"indications": [{"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 3}, {"efo_term": "DROOLING", "stage": 1}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}], "max_phase": 4, "name": "GLYCOPYRROLATE BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201027", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "OBSTRUCTIVE LUNG DISEASE", "DROOLING", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "PEPTIC ULCER", "stage": 4}, {"efo_term": "PARKINSON'S DISEASE", "stage": 4}], "max_phase": 4, "name": "ATROPINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2146146", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["SEASONAL ALLERGIC RHINITIS", "ALLERGIC RHINITIS", "PEPTIC ULCER", "PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "ALLERGY", "stage": 4}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 3}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "RHINITIS, ALLERGIC, PERENNIAL", "stage": 2}], "max_phase": 4, "name": "LORATADINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL998", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["SEASONAL ALLERGIC RHINITIS", "ALLERGY", "PAIN", "RHINITIS, ALLERGIC, PERENNIAL"]}, {"indications": [{"efo_term": "ATOPIC ECZEMA", "stage": 3}, {"efo_term": "ALLERGIC CONJUNCTIVITIS", "stage": 3}, {"efo_term": "ECZEMA", "stage": 3}, {"efo_term": "RHINITIS, ALLERGIC, PERENNIAL", "stage": 3}], "max_phase": 4, "name": "KETOTIFEN FUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1633", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["ATOPIC ECZEMA", "ALLERGIC CONJUNCTIVITIS", "ECZEMA", "RHINITIS, ALLERGIC, PERENNIAL"]}, {"indications": [{"efo_term": "ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "ALLERGIC CONJUNCTIVITIS", "stage": 4}, {"efo_term": "PRURITUS", "stage": 4}], "max_phase": 4, "name": "OLOPATADINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1719", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["ALLERGIC RHINITIS", "SEASONAL ALLERGIC RHINITIS", "ALLERGIC CONJUNCTIVITIS", "PRURITUS"]}, {"indications": [{"efo_term": "URTICARIA", "stage": 4}, {"efo_term": "SKIN DISEASE", "stage": 4}, {"efo_term": "NEUROTIC DISORDER", "stage": 4}, {"efo_term": "PRURITUS", "stage": 4}], "max_phase": 4, "name": "HYDROXYZINE PAMOATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200467", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["URTICARIA", "SKIN DISEASE", "NEUROTIC DISORDER", "PRURITUS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}, {"efo_term": "NEONATAL ABSTINENCE SYNDROME", "stage": 3}], "max_phase": 4, "name": "CHLORPROMAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["PSYCHOSIS", "SCHIZOPHRENIA", "NEONATAL ABSTINENCE SYNDROME"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "AMYOTROPHIC LATERAL SCLEROSIS", "stage": 2}], "max_phase": 4, "name": "PIMOZIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1423", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["PSYCHOSIS", "SCHIZOPHRENIA", "AMYOTROPHIC LATERAL SCLEROSIS"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 3}], "max_phase": 4, "name": "ASENAPINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544974", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "SCHIZOPHRENIA", "PSYCHOSIS"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 1}], "max_phase": 3, "name": "ITI-007", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545044", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "BIPOLAR DISORDER", "SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "BREAST CARCINOMA", "stage": 2}], "max_phase": 4, "name": "CARVEDILOL PHOSPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201167", "mechanisms": ["Adrenergic receptor alpha-1 antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["HYPERTENSION", "BREAST CARCINOMA"]}, {"indications": [{"efo_term": "ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "URTICARIA", "stage": 4}], "max_phase": 4, "name": "CETIRIZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201113", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["ALLERGIC RHINITIS", "SEASONAL ALLERGIC RHINITIS", "URTICARIA"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "CLOZAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "PSYCHOSIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 1}], "max_phase": 4, "name": "THIORIDAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL479", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["PSYCHOSIS", "ACUTE MYELOID LEUKEMIA"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "CANCER", "stage": 2}], "max_phase": 4, "name": "HALOPERIDOL DECANOATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200986", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["CANCER", "PSYCHOSIS"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "SCHIZOAFFECTIVE DISORDER", "stage": 4}], "max_phase": 4, "name": "PALIPERIDONE PALMITATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201732", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "SCHIZOAFFECTIVE DISORDER"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 4}], "max_phase": 4, "name": "LURASIDONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1615372", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "BIPOLAR DISORDER"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 2}], "max_phase": 4, "name": "PIMAVANSERIN TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2448613", "mechanisms": ["Serotonin 2a (5-HT2a) receptor inverse agonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "BENIGN PROSTATIC HYPERPLASIA", "stage": 4}, {"efo_term": "KIDNEY STONE", "stage": 3}], "max_phase": 4, "name": "ALFUZOSIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1723", "mechanisms": ["Adrenergic receptor alpha-1 agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["KIDNEY STONE", "BENIGN PROSTATIC HYPERPLASIA"]}, {"indications": [{"efo_term": "CATARACT", "stage": 3}, {"efo_term": "CARDIAC ARRHYTHMIA", "stage": 1}], "max_phase": 4, "name": "PHENYLEPHRINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200339", "mechanisms": ["Adrenergic receptor alpha-1 agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["CATARACT", "CARDIAC ARRHYTHMIA"]}, {"indications": [{"efo_term": "GLAUCOMA", "stage": 4}, {"efo_term": "URINARY INCONTINENCE", "stage": 1}], "max_phase": 4, "name": "PILOCARPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL550", "mechanisms": ["Muscarinic acetylcholine receptor M3 agonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["GLAUCOMA", "URINARY INCONTINENCE"]}, {"indications": [{"efo_term": "DROOLING", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}], "max_phase": 4, "name": "TROPICAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200604", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["DROOLING", "PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}, {"efo_term": "ASTHMA", "stage": 2}], "max_phase": 2, "name": "ASM-024", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707249", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ASTHMA"]}, {"indications": [{"efo_term": "ALLERGY", "stage": 1}, {"efo_term": "ALLERGIC RHINITIS", "stage": 1}], "max_phase": 4, "name": "DIPHENHYDRAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1620", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["ALLERGY", "ALLERGIC RHINITIS"]}, {"indications": [{"efo_term": "RHINITIS, ALLERGIC, PERENNIAL", "stage": 3}, {"efo_term": "ALLERGIC RHINITIS", "stage": 2}], "max_phase": 4, "name": "FEXOFENADINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200618", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["ALLERGIC RHINITIS", "RHINITIS, ALLERGIC, PERENNIAL"]}, {"indications": [{"efo_term": "URTICARIA", "stage": 4}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}], "max_phase": 4, "name": "LEVOCETIRIZINE DIHYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201190", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["FISH-EYE DISEASE", "URTICARIA"]}, {"indications": [{"efo_term": "EYE ALLERGY", "stage": 4}, {"efo_term": "ALLERGIC CONJUNCTIVITIS", "stage": 4}], "max_phase": 4, "name": "ALCAFTADINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201747", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["EYE ALLERGY", "ALLERGIC CONJUNCTIVITIS"]}, {"indications": [{"efo_term": "ALLERGIC CONJUNCTIVITIS", "stage": 4}, {"efo_term": "RHINITIS, ALLERGIC, PERENNIAL", "stage": 3}], "max_phase": 4, "name": "BEPOTASTINE BESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201759", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["ALLERGIC CONJUNCTIVITIS", "RHINITIS, ALLERGIC, PERENNIAL"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "CHLORPROTHIXENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL908", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 3}], "max_phase": 3, "name": "VOLINANSERIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL74355", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "DROPERIDOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1108", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "THIOTHIXENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 3}], "max_phase": 3, "name": "EPLIVANSERIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL257704", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 2}], "max_phase": 2, "name": "NELOTANSERIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL598172", "mechanisms": ["Serotonin 2a (5-HT2a) receptor inverse agonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "ACUTE CORONARY SYNDROME", "stage": 1}], "max_phase": 1, "name": "TEMANOGREL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1084617", "mechanisms": ["Serotonin 2a (5-HT2a) receptor inverse agonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["ACUTE CORONARY SYNDROME"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}], "max_phase": 4, "name": "TRAZODONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200798", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 3}], "max_phase": 4, "name": "ZIPRASIDONE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200997", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 3}], "max_phase": 4, "name": "OLANZAPINE PAMOATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201741", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "TEDATIOXETINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104986", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist", "Alpha-1a adrenergic receptor antagonist"], "genes": ["HTR2A", "ADRA1A"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 3}], "max_phase": 3, "name": "ESMIRTAZAPINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107339", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist", "Histamine H1 receptor antagonist"], "genes": ["HTR2A", "HRH1"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}], "max_phase": 4, "name": "ARIPIPRAZOLE LAUROXIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2219425", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Unknown", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "STROKE", "stage": 1}], "max_phase": 4, "name": "MIDODRINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200461", "mechanisms": ["Adrenergic receptor alpha-1 agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["STROKE"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}], "max_phase": 4, "name": "PHENYLEPHRINE BITARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062264", "mechanisms": ["Adrenergic receptor alpha-1 agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["ASTHMA"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}], "max_phase": 4, "name": "ERGOLOID MESYLATES", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2311030", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}], "max_phase": 4, "name": "RAUWOLFIA SERPENTINA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3559672", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["HYPERTENSION"]}, {"indications": [{"efo_term": "PREECLAMPSIA", "stage": 2}], "max_phase": 4, "name": "LABETALOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200323", "mechanisms": ["Adrenergic receptor antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["PREECLAMPSIA"]}, {"indications": [{"efo_term": "RENAL INSUFFICIENCY", "stage": 0}], "max_phase": 4, "name": "NORADRENALINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356607", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["RENAL INSUFFICIENCY"]}, {"indications": [{"efo_term": "GLAUCOMA", "stage": 4}], "max_phase": 4, "name": "CARBACHOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14", "mechanisms": ["Muscarinic acetylcholine receptor M3 agonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["GLAUCOMA"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 1}], "max_phase": 4, "name": "PROPANTHELINE BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1240", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["OVERACTIVE BLADDER"]}, {"indications": [{"efo_term": "BREAST CARCINOMA", "stage": 3}], "max_phase": 4, "name": "PILOCARPINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200330", "mechanisms": ["Muscarinic acetylcholine receptor M3 agonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["BREAST CARCINOMA"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}], "max_phase": 4, "name": "METHACHOLINE CHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200764", "mechanisms": ["Muscarinic acetylcholine receptor M3 agonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["ASTHMA"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 4}], "max_phase": 4, "name": "SOLIFENACIN SUCCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200803", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["OVERACTIVE BLADDER"]}, {"indications": [{"efo_term": "DIGESTIVE SYSTEM DISEASE", "stage": 4}], "max_phase": 4, "name": "CLIDINIUM BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200950", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["DIGESTIVE SYSTEM DISEASE"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 4}], "max_phase": 4, "name": "FESOTERODINE FUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201765", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["OVERACTIVE BLADDER"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 4}], "max_phase": 4, "name": "TOLTERODINE TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1722209", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["OVERACTIVE BLADDER"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 2}], "max_phase": 2, "name": "Tarafenacin", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1779046", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["OVERACTIVE BLADDER"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}], "max_phase": 2, "name": "BATEFENTEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039518", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 1}], "max_phase": 4, "name": "TROSPIUM CHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3084748", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}], "max_phase": 2, "name": "AZD8683", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545222", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "ALLERGY", "stage": 4}], "max_phase": 4, "name": "ASTEMIZOLE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL296419", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["ALLERGY"]}, {"indications": [{"efo_term": "ALLERGY", "stage": 4}], "max_phase": 4, "name": "ACRIVASTINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1224", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["ALLERGY"]}, {"indications": [{"efo_term": "ALLERGIC RHINITIS", "stage": 2}], "max_phase": 4, "name": "CHLORPHENIRAMINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1659", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["ALLERGIC RHINITIS"]}, {"indications": [{"efo_term": "CANCER", "stage": 3}], "max_phase": 4, "name": "CYPROHEPTADINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1716", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["CANCER"]}, {"indications": [{"efo_term": "ALLERGY", "stage": 1}], "max_phase": 4, "name": "PROMETHAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200750", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["ALLERGY"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}], "max_phase": 4, "name": "ORPHENADRINE (CHLORIDE)", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201023", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "RHINITIS, ALLERGIC, PERENNIAL", "stage": 3}], "max_phase": 4, "name": "LEVOCABASTINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237102", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["RHINITIS, ALLERGIC, PERENNIAL"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 1}], "max_phase": 2, "name": "LY2624803", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545287", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [], "max_phase": 4, "name": "TRIFLUOPERAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1710", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ZIPRASIDONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1712", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CHLORPROMAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1713", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MOLINDONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200419", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROMAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200469", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "NEFAZODONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200492", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THIOTHIXENE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200902", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THIORIDAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200916", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIMIPRAMINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200948", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist", "Adrenergic receptor alpha-1 antagonist", "Histamine H1 receptor antagonist"], "genes": ["HTR2A", "ADRA1A", "ADRA1B", "ADRA1D", "HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MESORIDAZINE BESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201052", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LOXAPINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201060", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LOXAPINE SUCCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201155", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "PRUVANSERIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1215661", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HALOPERIDOL LACTATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2096643", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "VABICASERIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104991", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "IFERANSERIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107754", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CARPHENAZINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2358147", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Trelanserin", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3183740", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "SB-773812", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545102", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "DABUZALGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL257978", "mechanisms": ["Alpha-1a adrenergic receptor partial agonist"], "genes": ["ADRA1A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENYLPROPANOLAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200695", "mechanisms": ["Alpha-1a adrenergic receptor agonist"], "genes": ["ADRA1A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DAPIPRAZOLE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201044", "mechanisms": ["Alpha-1a adrenergic receptor antagonist"], "genes": ["ADRA1A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENYLPROPANOLAMINE POLISTIREX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201535", "mechanisms": ["Alpha-1a adrenergic receptor agonist"], "genes": ["ADRA1A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PRAZOSIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1558", "mechanisms": ["Adrenergic receptor alpha-1 antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DOXAZOSIN MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200561", "mechanisms": ["Adrenergic receptor alpha-1 antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TERAZOSIN HYDROCHLORIDE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201091", "mechanisms": ["Adrenergic receptor alpha-1 antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METHOXAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201103", "mechanisms": ["Adrenergic receptor alpha-1 agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METARAMINOL BITARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062262", "mechanisms": ["Adrenergic receptor alpha-1 agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TOLAZOLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1689", "mechanisms": ["Adrenergic receptor alpha antagonist", "Histamine H1 receptor agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D", "HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "NAPHAZOLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1706", "mechanisms": ["Adrenergic receptor alpha agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TETRAHYDROZOLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200413", "mechanisms": ["Adrenergic receptor alpha agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENOXYBENZAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200787", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENTOLAMINE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200873", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ALSEROXYLON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201454", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ERGOTAMINE TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062265", "mechanisms": ["Adrenergic receptor alpha agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HYDROXYAMPHETAMINE HYDROBROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200705", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIPIVEFRIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200833", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MEPHENTERMINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200996", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "EPINEPHRINE BITARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256958", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "OXYBUTYNIN CHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1133", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ACETYLCHOLINE CHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1184", "mechanisms": ["Muscarinic acetylcholine receptor M3 agonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ANISOTROPINE METHYLBROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1578", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MEPENZOLATE BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1724", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BETHANECHOL CHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1768", "mechanisms": ["Muscarinic acetylcholine receptor M3 agonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ISOPROPAMIDE IODIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200347", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CYCLOPENTOLATE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200473", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DICYCLOMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200479", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIDIHEXETHYL CHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200771", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIPHEMANIL METHYLSULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200880", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "OXYPHENCYCLIMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200891", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "OXYPHENONIUM BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200906", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DARIFENACIN HYDROBROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200935", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METHSCOPOLAMINE BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201024", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HEXOCYCLIUM METHYLSULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1626570", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CEVIMELINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2218917", "mechanisms": ["Muscarinic acetylcholine receptor M3 agonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "LAS190792", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545272", "mechanisms": ["Muscarinic acetylcholine receptor M3 antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "DAROTROPIUM BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103803", "mechanisms": ["Muscarinic acetylcholine receptor antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Afacifenacin", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545165", "mechanisms": ["Muscarinic acetylcholine receptor antagonist"], "genes": ["CHRM3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIPHENYLPYRALINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1564", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENIRAMINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1653", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "VAPITADINE DIHYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL539843", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DOXYLAMINE SUCCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200392", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ORPHENADRINE CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200395", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BUCLIZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200403", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIMENHYDRINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200406", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIPELENNAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200446", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIPROLIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200450", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "EPINASTINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200491", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CYCLIZINE LACTATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200497", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METHDILAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200532", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ANTAZOLINE PHOSPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200550", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MECLIZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200590", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DEXBROMPHENIRAMINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200638", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIPELENNAMINE CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200769", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CLEMASTINE FUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200795", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HISTAMINE PHOSPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200801", "mechanisms": ["Histamine H1 receptor agonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DEXCHLORPHENIRAMINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200927", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METHDILAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200959", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BROMPHENIRAMINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200961", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BROMODIPHENHYDRAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200967", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CARBINOXAMINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200974", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PYRILAMINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201006", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HYDROXYZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201007", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPIOMAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201068", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIPHENHYDRAMINE CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201089", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CHLORPHENIRAMINE POLISTIREX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201659", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIMEPRAZINE TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1713082", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "EMEDASTINE DIFUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103739", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "AZATADINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544908", "mechanisms": ["Histamine H1 receptor antagonist"], "genes": ["HRH1"], "type": "Small molecule", "diseases": []}], "heat": 1.0, "nodes": [{"assoc": 1.0, "id": "ENSG00000102468", "label": "HTR2A"}, {"assoc": 1.0, "id": "ENSG00000120907", "label": "ADRA1A"}, {"assoc": 1.0, "id": "ENSG00000133019", "label": "CHRM3"}, {"assoc": 1.0, "id": "ENSG00000170214", "label": "ADRA1B"}, {"assoc": 1.0, "id": "ENSG00000171873", "label": "ADRA1D"}, {"assoc": 1.0, "id": "ENSG00000196639", "label": "HRH1"}], "size": 6}, {"diseases": ["EPILEPSY", "SEIZURES", "INJURY", "OPTIC NEURITIS", "OSTEOARTHRITIS, KNEE", "PAIN", "PERIPHERAL NEUROPATHY", "SUDDEN CARDIAC ARREST", "SYSTEMIC SCLERODERMA", "CARCINOMA", "PREMATURE BIRTH", "URINARY TRACT INFECTION", "BREAST CARCINOMA", "POST-OPERATIVE SIGN OR SYMPTOM", "CANCER", "CARPAL TUNNEL SYNDROME", "COUGH", "PRURITUS", "TINNITUS", "ANXIETY", "FIBROMYALGIA", "COCAINE DEPENDENCE", "DYSMENORRHEA", "NEUROPATHIC PAIN", "PARATHYROID DISEASE", "PREECLAMPSIA", "OSTEOARTHRITIS", "POSTMENOPAUSAL OSTEOPOROSIS", "PREMATURE EJACULATION", "TENDINOPATHY", "CARDIAC ARRHYTHMIA", "OBESITY", "UTERINE FIBROID", "AGE-RELATED MACULAR DEGENERATION", "FROZEN SHOULDER", "PULMONARY HYPERTENSION", "STROKE", "NUTRITIONAL DISORDER", "ARTHRITIS", "MYALGIA", "PREGNANCY", "OVERACTIVE BLADDER", "CHRONIC INTERSTITIAL CYSTITIS", "PARTIAL EPILEPSY", "BIPOLAR DISORDER", "TRIGEMINAL NEURALGIA", "CATARACT", "FISH-EYE DISEASE", "MENTAL OR BEHAVIOURAL DISORDER", "MOOD DISORDER", "UNIPOLAR DEPRESSION", "NEUROFIBROMATOSIS TYPE 1", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "LENNOX-GASTAUT SYNDROME", "GENERALIZED TONIC-CLONIC SEIZURES", "DRUG DEPENDENCE", "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "POST-TRAUMATIC STRESS DISORDER", "ATAXIA", "AUTISM SPECTRUM DISORDER", "ALZHEIMERS DISEASE", "CUTANEOUS MELANOMA", "PROXIMAL SPINAL MUSCULAR ATROPHY", "AMYOTROPHIC LATERAL SCLEROSIS", "OBSESSIVE-COMPULSIVE DISORDER", "ALCOHOL DEPENDENCE", "PARKINSON'S DISEASE", "EATING DISORDER", "ESSENTIAL TREMOR", "NICOTINE DEPENDENCE", "MIGRAINE DISORDER", "NEUROPATHY", "DIABETIC NEUROPATHY", "MULTIPLE SCLEROSIS", "SCHIZOPHRENIA", "COMPLEX PARTIAL EPILEPSY", "ALCOHOL DRINKING", "CONGENITAL HEART DISEASE", "METAMPHETAMINE DEPENDENCE", "GAMBLING BEHAVIOUR", "SMOKING CESSATION", "MARIJUANA DEPENDENCE", "PRADER-WILLI SYNDROME", "CEREBRAL ISCHEMIA", "DYSURIA", "ATRIAL FIBRILLATION", "HIP FRACTURE", "INGUINAL HERNIA", "BONE FRACTURE", "CORONARY ARTERY DISEASE", "DILATED CARDIOMYOPATHY", "TYPE II DIABETES MELLITUS", "ACUTE CORONARY SYNDROME", "IRRITABLE BOWEL SYNDROME", "PROLONGED QT INTERVAL", "CARDIOVASCULAR DISEASE", "VASCULAR DISEASE", "ANGINA PECTORIS", "MYOCARDIAL ISCHEMIA", "DIASTOLIC HEART FAILURE"], "links": [{"source": "ENSG00000136531", "target": "ENSG00000183873"}, {"source": "ENSG00000136531", "target": "ENSG00000185313"}, {"source": "ENSG00000136531", "target": "ENSG00000196876"}, {"source": "ENSG00000183873", "target": "ENSG00000185313"}, {"source": "ENSG00000183873", "target": "ENSG00000196876"}, {"source": "ENSG00000185313", "target": "ENSG00000196876"}, {"source": "ENSG00000169432", "type": "manual", "target": "ENSG00000149575"}, {"source": "ENSG00000149575", "type": "manual", "target": "ENSG00000196876"}, {"source": "ENSG00000169432", "type": "manual", "target": "ENSG00000105711"}, {"source": "ENSG00000105711", "type": "manual", "target": "ENSG00000196876"}, {"source": "ENSG00000153253", "type": "manual", "target": "ENSG00000166257"}, {"source": "ENSG00000166257", "type": "manual", "target": "ENSG00000196876"}, {"source": "ENSG00000153253", "type": "manual", "target": "ENSG00000149575"}, {"source": "ENSG00000153253", "type": "manual", "target": "ENSG00000105711"}], "drugs": [{"indications": [{"efo_term": "PRURITUS", "stage": 4}, {"efo_term": "TENDINOPATHY", "stage": 4}, {"efo_term": "CARDIAC ARRHYTHMIA", "stage": 4}, {"efo_term": "FROZEN SHOULDER", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "ARTHRITIS", "stage": 4}, {"efo_term": "MYALGIA", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "PERIPHERAL NEUROPATHY", "stage": 3}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "CARPAL TUNNEL SYNDROME", "stage": 3}, {"efo_term": "COUGH", "stage": 3}, {"efo_term": "FIBROMYALGIA", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 3}, {"efo_term": "PARATHYROID DISEASE", "stage": 3}, {"efo_term": "PREECLAMPSIA", "stage": 3}, {"efo_term": "POSTMENOPAUSAL OSTEOPOROSIS", "stage": 3}, {"efo_term": "PREMATURE EJACULATION", "stage": 3}, {"efo_term": "OBESITY", "stage": 3}, {"efo_term": "NUTRITIONAL DISORDER", "stage": 3}, {"efo_term": "PREGNANCY", "stage": 3}, {"efo_term": "OVERACTIVE BLADDER", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 2}, {"efo_term": "SYSTEMIC SCLERODERMA", "stage": 2}, {"efo_term": "CARCINOMA", "stage": 2}, {"efo_term": "URINARY TRACT INFECTION", "stage": 2}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "ANXIETY", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "DYSMENORRHEA", "stage": 2}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "UTERINE FIBROID", "stage": 2}, {"efo_term": "AGE-RELATED MACULAR DEGENERATION", "stage": 2}, {"efo_term": "STROKE", "stage": 2}, {"efo_term": "CHRONIC INTERSTITIAL CYSTITIS", "stage": 2}, {"efo_term": "PREMATURE BIRTH", "stage": 1}, {"efo_term": "POST-OPERATIVE SIGN OR SYMPTOM", "stage": 1}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 1}, {"efo_term": "TINNITUS", "stage": 0}], "max_phase": 4, "name": "LIDOCAINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL79", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["OSTEOARTHRITIS, KNEE", "PAIN", "PERIPHERAL NEUROPATHY", "SUDDEN CARDIAC ARREST", "SYSTEMIC SCLERODERMA", "CARCINOMA", "PREMATURE BIRTH", "URINARY TRACT INFECTION", "BREAST CARCINOMA", "POST-OPERATIVE SIGN OR SYMPTOM", "CANCER", "CARPAL TUNNEL SYNDROME", "COUGH", "PRURITUS", "TINNITUS", "ANXIETY", "FIBROMYALGIA", "COCAINE DEPENDENCE", "DYSMENORRHEA", "NEUROPATHIC PAIN", "PARATHYROID DISEASE", "PREECLAMPSIA", "OSTEOARTHRITIS", "POSTMENOPAUSAL OSTEOPOROSIS", "PREMATURE EJACULATION", "TENDINOPATHY", "CARDIAC ARRHYTHMIA", "OBESITY", "UTERINE FIBROID", "AGE-RELATED MACULAR DEGENERATION", "FROZEN SHOULDER", "PULMONARY HYPERTENSION", "STROKE", "NUTRITIONAL DISORDER", "ARTHRITIS", "MYALGIA", "PREGNANCY", "OVERACTIVE BLADDER", "CHRONIC INTERSTITIAL CYSTITIS"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "OBESITY", "stage": 3}, {"efo_term": "SMOKING CESSATION", "stage": 3}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 3}, {"efo_term": "PRADER-WILLI SYNDROME", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "ALCOHOL DRINKING", "stage": 2}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 2}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "CEREBRAL ISCHEMIA", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 1}, {"efo_term": "CONGENITAL HEART DISEASE", "stage": 1}], "max_phase": 4, "name": "TOPIRAMATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["COCAINE DEPENDENCE", "EPILEPSY", "ALCOHOL DRINKING", "BIPOLAR DISORDER", "MIGRAINE DISORDER", "ALCOHOL DEPENDENCE", "CONGENITAL HEART DISEASE", "METAMPHETAMINE DEPENDENCE", "GAMBLING BEHAVIOUR", "OBESITY", "SMOKING CESSATION", "NICOTINE DEPENDENCE", "MARIJUANA DEPENDENCE", "PRADER-WILLI SYNDROME", "CEREBRAL ISCHEMIA"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "LENNOX-GASTAUT SYNDROME", "stage": 4}, {"efo_term": "GENERALIZED TONIC-CLONIC SEIZURES", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 4}, {"efo_term": "MOOD DISORDER", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "NEUROFIBROMATOSIS TYPE 1", "stage": 2}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "DRUG DEPENDENCE", "stage": 2}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}, {"efo_term": "MENTAL OR BEHAVIOURAL DISORDER", "stage": 1}], "max_phase": 4, "name": "LAMOTRIGINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL741", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "EPILEPSY", "FISH-EYE DISEASE", "MENTAL OR BEHAVIOURAL DISORDER", "MOOD DISORDER", "UNIPOLAR DEPRESSION", "NEUROFIBROMATOSIS TYPE 1", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "SEIZURES", "LENNOX-GASTAUT SYNDROME", "GENERALIZED TONIC-CLONIC SEIZURES", "PARTIAL EPILEPSY", "DRUG DEPENDENCE"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 3}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "MYOCARDIAL ISCHEMIA", "stage": 3}, {"efo_term": "DILATED CARDIOMYOPATHY", "stage": 2}, {"efo_term": "ACUTE CORONARY SYNDROME", "stage": 2}, {"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 2}, {"efo_term": "PROLONGED QT INTERVAL", "stage": 2}, {"efo_term": "VASCULAR DISEASE", "stage": 2}, {"efo_term": "DIASTOLIC HEART FAILURE", "stage": 2}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 1}], "max_phase": 4, "name": "RANOLAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1404", "mechanisms": ["Sodium channel protein type V alpha subunit blocker"], "genes": ["SCN5A"], "type": "Small molecule", "diseases": ["CORONARY ARTERY DISEASE", "DILATED CARDIOMYOPATHY", "TYPE II DIABETES MELLITUS", "ATRIAL FIBRILLATION", "ACUTE CORONARY SYNDROME", "IRRITABLE BOWEL SYNDROME", "PROLONGED QT INTERVAL", "PULMONARY HYPERTENSION", "CARDIOVASCULAR DISEASE", "VASCULAR DISEASE", "ANGINA PECTORIS", "MYOCARDIAL ISCHEMIA", "DIASTOLIC HEART FAILURE"]}, {"indications": [{"efo_term": "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "ATAXIA", "stage": 2}, {"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 2}, {"efo_term": "PROXIMAL SPINAL MUSCULAR ATROPHY", "stage": 2}, {"efo_term": "AMYOTROPHIC LATERAL SCLEROSIS", "stage": 2}, {"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 1}, {"efo_term": "CANCER", "stage": 1}], "max_phase": 4, "name": "RILUZOLE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL744", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "POST-TRAUMATIC STRESS DISORDER", "ATAXIA", "AUTISM SPECTRUM DISORDER", "BIPOLAR DISORDER", "UNIPOLAR DEPRESSION", "ALZHEIMERS DISEASE", "CUTANEOUS MELANOMA", "PROXIMAL SPINAL MUSCULAR ATROPHY", "AMYOTROPHIC LATERAL SCLEROSIS", "CANCER", "OBSESSIVE-COMPULSIVE DISORDER"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "NEUROPATHY", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}, {"efo_term": "FIBROMYALGIA", "stage": 2}], "max_phase": 4, "name": "LACOSAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58323", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "OSTEOARTHRITIS", "PARTIAL EPILEPSY", "MIGRAINE DISORDER", "NEUROPATHY", "NEUROPATHIC PAIN", "FIBROMYALGIA", "SEIZURES", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "COMPLEX PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "FIBROMYALGIA", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 2}], "max_phase": 4, "name": "ESLICARBAZEPINE ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL87992", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "PARTIAL EPILEPSY", "FIBROMYALGIA", "MIGRAINE DISORDER", "BIPOLAR DISORDER", "COMPLEX PARTIAL EPILEPSY", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "EATING DISORDER", "stage": 3}, {"efo_term": "SEIZURES", "stage": 3}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "ESSENTIAL TREMOR", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "ZONISAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL750", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["ALCOHOL DEPENDENCE", "EPILEPSY", "PARKINSON'S DISEASE", "EATING DISORDER", "ESSENTIAL TREMOR", "SEIZURES", "NICOTINE DEPENDENCE"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "SEIZURES", "stage": 2}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}], "max_phase": 4, "name": "OXCARBAZEPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1068", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "SEIZURES", "PARTIAL EPILEPSY", "MULTIPLE SCLEROSIS", "SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "OPTIC NEURITIS", "stage": 2}], "max_phase": 4, "name": "PHENYTOIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "SEIZURES", "INJURY", "OPTIC NEURITIS"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "TRIGEMINAL NEURALGIA", "stage": 4}], "max_phase": 4, "name": "CARBAMAZEPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL108", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "PARTIAL EPILEPSY", "BIPOLAR DISORDER", "TRIGEMINAL NEURALGIA"]}, {"indications": [{"efo_term": "PRURITUS", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "CATARACT", "stage": 3}, {"efo_term": "PAIN", "stage": 2}], "max_phase": 4, "name": "TETRACAINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL698", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["CATARACT", "PAIN", "PRURITUS"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "LENNOX-GASTAUT SYNDROME", "stage": 4}, {"efo_term": "SEIZURES", "stage": 3}, {"efo_term": "PAIN", "stage": 2}], "max_phase": 4, "name": "RUFINAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201754", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["SEIZURES", "EPILEPSY", "LENNOX-GASTAUT SYNDROME", "PAIN"]}, {"indications": [{"efo_term": "HIP FRACTURE", "stage": 2}, {"efo_term": "BONE FRACTURE", "stage": 2}, {"efo_term": "INGUINAL HERNIA", "stage": 1}, {"efo_term": "PAIN", "stage": 0}], "max_phase": 4, "name": "ROPIVACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1889140", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["PAIN", "HIP FRACTURE", "INGUINAL HERNIA", "BONE FRACTURE"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "STROKE", "stage": 2}], "max_phase": 4, "name": "PRIMIDONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL856", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "STROKE"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 3, "name": "RALFINAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107771", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["PAIN", "NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "TRIGEMINAL NEURALGIA", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 1}], "max_phase": 2, "name": "RAXATRIGINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544913", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": ["TRIGEMINAL NEURALGIA", "BIPOLAR DISORDER"]}, {"indications": [{"efo_term": "PAIN", "stage": 2}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 2}], "max_phase": 2, "name": "PF-05089771", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545171", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": ["PAIN", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "MEPHENYTOIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL861", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "PHENACEMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL918", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "ESLICARBAZEPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL315985", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "ETHOTOIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1095", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "DYSURIA", "stage": 3}], "max_phase": 4, "name": "PHENAZOPYRIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201022", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["DYSURIA"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}], "max_phase": 4, "name": "ORPHENADRINE (CHLORIDE)", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201023", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "CARDIAC ARRHYTHMIA", "stage": 4}], "max_phase": 4, "name": "QUINIDINE POLYGALACTURONATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201486", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["CARDIAC ARRHYTHMIA"]}, {"indications": [{"efo_term": "ATRIAL FIBRILLATION", "stage": 4}], "max_phase": 4, "name": "DRONEDARONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201729", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION"]}, {"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}], "max_phase": 2, "name": "NERISPIRDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107762", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["MULTIPLE SCLEROSIS"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}], "max_phase": 2, "name": "NW-3509", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545207", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 1}], "max_phase": 1, "name": "AZD3161", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545208", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "ATRIAL FIBRILLATION", "stage": 2}], "max_phase": 2, "name": "AZD1305", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545169", "mechanisms": ["Sodium channel protein type V alpha subunit blocker"], "genes": ["SCN5A"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION"]}, {"indications": [{"efo_term": "PAIN", "stage": 2}], "max_phase": 2, "name": "PF-04531083", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544951", "mechanisms": ["Sodium channel protein type X alpha subunit blocker"], "genes": ["SCN10A"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [], "max_phase": 0, "name": "ELPETRIGINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29919", "mechanisms": ["Sodium channel protein type II alpha subunit blocker", "Sodium channel protein type III alpha subunit blocker"], "genes": ["SCN2A", "SCN3A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROCAINAMIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL605", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "IRAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29741", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "FOSPHENYTOIN SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL919", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CHLOROPROCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL944", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PRILOCAINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1194", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENYTOIN SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1611", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPOXYCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1769", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MORICIZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200334", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "INDECAINIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200341", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ORPHENADRINE CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200395", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LIDOCAINE HYDROCHLORIDE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200409", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "QUINIDINE GLUCONATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200437", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MEPIVACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200440", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MERETHOXYLLINE PROCAINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200443", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPARACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200464", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DYCLONINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200478", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PRILOCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200586", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ETIDOCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200597", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MEXILETINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200606", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BENOXINATE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200654", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HEXYLCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200715", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TOCAINIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200773", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ARTICAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200819", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200841", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DISOPYRAMIDE PHOSPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201020", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPAFENONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201063", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TETRACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1255654", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "NKTR-171", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545209", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "QUINIDINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707183", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "DSP-2230", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545012", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker", "Sodium channel protein type X alpha subunit blocker"], "genes": ["SCN9A", "SCN10A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "XEN403", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545091", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "RG7893", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707353", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "RG6029", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707380", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIBUCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200612", "mechanisms": ["Sodium channel protein type V alpha subunit blocker", "Sodium channel protein type X alpha subunit blocker"], "genes": ["SCN5A", "SCN10A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "FLECAINIDE ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200822", "mechanisms": ["Sodium channel protein type V alpha subunit blocker"], "genes": ["SCN5A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "AZD7009", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545040", "mechanisms": ["Sodium channel protein type V alpha subunit blocker"], "genes": ["SCN5A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Afacifenacin", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545165", "mechanisms": ["Sodium channel protein type X alpha subunit blocker"], "genes": ["SCN10A"], "type": "Small molecule", "diseases": []}], "heat": 0.6666666666666666, "nodes": [{"assoc": 1.0, "id": "ENSG00000136531", "label": "SCN2A"}, {"assoc": 1.0, "id": "ENSG00000153253", "label": "SCN3A"}, {"assoc": 1.0, "id": "ENSG00000169432", "label": "SCN9A"}, {"assoc": 1.0, "id": "ENSG00000183873", "label": "SCN5A"}, {"assoc": 1.0, "id": "ENSG00000185313", "label": "SCN10A"}, {"assoc": 1.0, "id": "ENSG00000196876", "label": "SCN8A"}, {"assoc": 0, "id": "ENSG00000149575", "label": "SCN2B"}, {"assoc": 0, "id": "ENSG00000105711", "label": "SCN1B"}, {"assoc": 0, "id": "ENSG00000166257", "label": "SCN3B"}], "size": 9}, {"diseases": ["UNIPOLAR DEPRESSION", "IRRITABLE BOWEL SYNDROME", "POST-TRAUMATIC STRESS DISORDER", "ALCOHOL DEPENDENCE"], "links": [{"source": "ENSG00000120088", "target": "ENSG00000163794"}, {"source": "ENSG00000120088", "target": "ENSG00000178473"}, {"source": "ENSG00000145708", "target": "ENSG00000163794"}], "drugs": [{"indications": [{"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "VERUCERFONT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1287935", "mechanisms": ["Corticotropin releasing factor receptor 1 antagonist"], "genes": ["CRHR1"], "type": "Small molecule", "diseases": ["POST-TRAUMATIC STRESS DISORDER", "ALCOHOL DEPENDENCE", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "SSR125543", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL291657", "mechanisms": ["Corticotropin releasing factor receptor 1 antagonist"], "genes": ["CRHR1"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 2}], "max_phase": 2, "name": "EMICERFONT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL514270", "mechanisms": ["Corticotropin releasing factor receptor 1 antagonist"], "genes": ["CRHR1"], "type": "Small molecule", "diseases": ["IRRITABLE BOWEL SYNDROME"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}], "max_phase": 3, "name": "PEXACERFONT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL482950", "mechanisms": ["Corticotropin releasing factor receptor 1 antagonist"], "genes": ["CRHR1"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "ONO-2333Ms", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545034", "mechanisms": ["Corticotropin releasing factor receptor 1 antagonist"], "genes": ["CRHR1"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}], "heat": 0.039265451852025, "nodes": [{"assoc": 0.0404277325782, "id": "ENSG00000120088", "label": "CRHR1"}, {"assoc": 0.039989, "id": "ENSG00000145708", "label": "CRHBP"}, {"assoc": 0.0422450748299, "id": "ENSG00000163794", "label": "UCN"}, {"assoc": 0.0344, "id": "ENSG00000178473", "label": "UCN3"}], "size": 4}, {"diseases": ["IRRITABLE BOWEL SYNDROME", "DIARRHEA", "BREAST CARCINOMA"], "links": [{"source": "ENSG00000047617", "target": "ENSG00000167995"}, {"source": "ENSG00000131620", "target": "ENSG00000167995"}], "drugs": [{"indications": [{"efo_term": "DIARRHEA", "stage": 4}, {"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}], "max_phase": 4, "name": "CROFELEMER", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2108184", "mechanisms": ["Anoctamin-1 blocker"], "genes": ["ANO1"], "type": "Small molecule", "diseases": ["IRRITABLE BOWEL SYNDROME", "DIARRHEA", "BREAST CARCINOMA"]}], "heat": 0.09776225787766667, "nodes": [{"assoc": 0.078, "id": "ENSG00000047617", "label": "ANO2"}, {"assoc": 0.163281500858, "id": "ENSG00000131620", "label": "ANO1"}, {"assoc": 0.052005272775, "id": "ENSG00000167995", "label": "BEST1"}], "size": 3}, {"diseases": ["DUCHENNE MUSCULAR DYSTROPHY", "ACUTE CORONARY SYNDROME", "CARDIOVASCULAR DISEASE", "CONGESTIVE HEART FAILURE", "DIABETIC FOOT", "PAIN", "STROKE", "OSTEOPOROSIS", "HYPERTENSION", "NON-SMALL CELL LUNG CARCINOMA", "CORONARY ARTERY DISEASE", "ERECTILE DYSFUNCTION", "RAYNAUD DISEASE", "RECTUM CANCER", "SCHIZOPHRENIA", "MYOCARDIAL INFARCTION", "AGING", "SARCOPENIA", "HEART FAILURE", "ANAL FISSURE", "BRONCHOPULMONARY DYSPLASIA", "CUTANEOUS LEISHMANIASIS", "BRONCHIOLITIS", "LUNG DISEASE", "PULMONARY EMBOLISM", "SEPSIS", "CYSTIC FIBROSIS", "NEUROPATHIC PAIN", "PULMONARY HYPERTENSION", "SICKLE CELL ANEMIA", "MALARIA", "ISCHEMIA REPERFUSION INJURY", "CONGENITAL HEART DISEASE", "OPIOID DEPENDENCE", "RESPIRATORY INSUFFICIENCY", "ACUTE RESPIRATORY DISTRESS SYNDROME", "ANEMIA", "TINEA PEDIS", "CEREBRAL ISCHEMIA", "INFLAMMATION", "DECUBITUS ULCER", "ACUTE KIDNEY INJURY", "ALOPECIA", "URINARY TRACT INFECTION", "IDIOPATHIC AND/OR FAMILIAL PULMONARY ARTERIAL HYPERTENSION"], "links": [{"source": "ENSG00000061918", "target": "ENSG00000152402"}, {"source": "ENSG00000061918", "target": "ENSG00000164116"}, {"source": "ENSG00000152402", "target": "ENSG00000164116"}], "drugs": [{"indications": [{"efo_term": "BRONCHOPULMONARY DYSPLASIA", "stage": 3}, {"efo_term": "CUTANEOUS LEISHMANIASIS", "stage": 3}, {"efo_term": "SEPSIS", "stage": 3}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 3}, {"efo_term": "ISCHEMIA REPERFUSION INJURY", "stage": 3}, {"efo_term": "RESPIRATORY INSUFFICIENCY", "stage": 3}, {"efo_term": "ACUTE RESPIRATORY DISTRESS SYNDROME", "stage": 3}, {"efo_term": "DIABETIC FOOT", "stage": 3}, {"efo_term": "ACUTE KIDNEY INJURY", "stage": 3}, {"efo_term": "CONGESTIVE HEART FAILURE", "stage": 2}, {"efo_term": "LUNG DISEASE", "stage": 2}, {"efo_term": "CYSTIC FIBROSIS", "stage": 2}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 2}, {"efo_term": "MALARIA", "stage": 2}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 2}, {"efo_term": "OPIOID DEPENDENCE", "stage": 2}, {"efo_term": "TINEA PEDIS", "stage": 2}, {"efo_term": "INFLAMMATION", "stage": 2}, {"efo_term": "BRONCHIOLITIS", "stage": 1}, {"efo_term": "PULMONARY EMBOLISM", "stage": 1}, {"efo_term": "CONGENITAL HEART DISEASE", "stage": 1}, {"efo_term": "ANEMIA", "stage": 1}, {"efo_term": "CEREBRAL ISCHEMIA", "stage": 1}, {"efo_term": "HYPERTENSION", "stage": 1}, {"efo_term": "DECUBITUS ULCER", "stage": 1}, {"efo_term": "ALOPECIA", "stage": 1}, {"efo_term": "URINARY TRACT INFECTION", "stage": 1}], "max_phase": 4, "name": "NITRIC OXIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200689", "mechanisms": ["Soluble guanylate cyclase activator"], "genes": ["GUCY1B3", "GUCY1A2", "GUCY1A3"], "type": "Small molecule", "diseases": ["BRONCHOPULMONARY DYSPLASIA", "CONGESTIVE HEART FAILURE", "CUTANEOUS LEISHMANIASIS", "BRONCHIOLITIS", "LUNG DISEASE", "PULMONARY EMBOLISM", "SEPSIS", "CYSTIC FIBROSIS", "NEUROPATHIC PAIN", "PULMONARY HYPERTENSION", "SICKLE CELL ANEMIA", "MALARIA", "MYOCARDIAL INFARCTION", "ISCHEMIA REPERFUSION INJURY", "CONGENITAL HEART DISEASE", "OPIOID DEPENDENCE", "RESPIRATORY INSUFFICIENCY", "ACUTE RESPIRATORY DISTRESS SYNDROME", "ANEMIA", "TINEA PEDIS", "DIABETIC FOOT", "CEREBRAL ISCHEMIA", "HYPERTENSION", "INFLAMMATION", "DECUBITUS ULCER", "ACUTE KIDNEY INJURY", "ALOPECIA", "URINARY TRACT INFECTION"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "STROKE", "stage": 3}, {"efo_term": "OSTEOPOROSIS", "stage": 3}, {"efo_term": "HYPERTENSION", "stage": 3}, {"efo_term": "RAYNAUD DISEASE", "stage": 3}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "ERECTILE DYSFUNCTION", "stage": 2}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 1}, {"efo_term": "RECTUM CANCER", "stage": 1}], "max_phase": 4, "name": "NITROGLYCERIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL730", "mechanisms": ["Soluble guanylate cyclase activator"], "genes": ["GUCY1B3", "GUCY1A2", "GUCY1A3"], "type": "Small molecule", "diseases": ["PAIN", "STROKE", "OSTEOPOROSIS", "HYPERTENSION", "NON-SMALL CELL LUNG CARCINOMA", "CARDIOVASCULAR DISEASE", "CORONARY ARTERY DISEASE", "ERECTILE DYSFUNCTION", "RAYNAUD DISEASE", "RECTUM CANCER"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "DIABETIC FOOT", "stage": 3}, {"efo_term": "CONGESTIVE HEART FAILURE", "stage": 2}, {"efo_term": "DUCHENNE MUSCULAR DYSTROPHY", "stage": 1}, {"efo_term": "ACUTE CORONARY SYNDROME", "stage": 0}], "max_phase": 4, "name": "ISOSORBIDE DINITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6622", "mechanisms": ["Soluble guanylate cyclase activator"], "genes": ["GUCY1B3", "GUCY1A2", "GUCY1A3"], "type": "Small molecule", "diseases": ["DUCHENNE MUSCULAR DYSTROPHY", "ACUTE CORONARY SYNDROME", "CARDIOVASCULAR DISEASE", "CONGESTIVE HEART FAILURE", "DIABETIC FOOT"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 3}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 2}, {"efo_term": "AGING", "stage": 1}, {"efo_term": "SARCOPENIA", "stage": 1}], "max_phase": 4, "name": "SODIUM NITROPRUSSIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL136478", "mechanisms": ["Soluble guanylate cyclase activator"], "genes": ["GUCY1B3", "GUCY1A2", "GUCY1A3"], "type": "Small molecule", "diseases": ["HYPERTENSION", "SCHIZOPHRENIA", "MYOCARDIAL INFARCTION", "AGING", "SARCOPENIA"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HEART FAILURE", "stage": 2}, {"efo_term": "HYPERTENSION", "stage": 1}, {"efo_term": "ANAL FISSURE", "stage": 1}], "max_phase": 4, "name": "ISOSORBIDE MONONITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1311", "mechanisms": ["Soluble guanylate cyclase activator"], "genes": ["GUCY1B3", "GUCY1A2", "GUCY1A3"], "type": "Small molecule", "diseases": ["HYPERTENSION", "CARDIOVASCULAR DISEASE", "HEART FAILURE", "ANAL FISSURE"]}, {"indications": [{"efo_term": "PULMONARY HYPERTENSION", "stage": 4}, {"efo_term": "IDIOPATHIC AND/OR FAMILIAL PULMONARY ARTERIAL HYPERTENSION", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 2}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 2}], "max_phase": 4, "name": "RIOCIGUAT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107834", "mechanisms": ["Soluble guanylate cyclase positive allosteric modulator"], "genes": ["GUCY1B3", "GUCY1A2", "GUCY1A3"], "type": "Small molecule", "diseases": ["CORONARY ARTERY DISEASE", "PULMONARY HYPERTENSION", "SICKLE CELL ANEMIA", "IDIOPATHIC AND/OR FAMILIAL PULMONARY ARTERIAL HYPERTENSION"]}], "heat": 0.772222222222, "nodes": [{"assoc": 0.772222222222, "id": "ENSG00000061918", "label": "GUCY1B3"}, {"assoc": 0.772222222222, "id": "ENSG00000152402", "label": "GUCY1A2"}, {"assoc": 0.772222222222, "id": "ENSG00000164116", "label": "GUCY1A3"}], "size": 3}, {"diseases": ["GLAUCOMA", "EPILEPSY", "KIDNEY DISEASE", "HELICOBACTER PYLORI INFECTION", "CARDIODYSRHYTHMIC POTASSIUM-SENSITIVE PERIODIC PARALYSIS", "ALTITUDE SICKNESS", "PULMONARY HYPERTENSION", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "MULTIPLE SCLEROSIS", "OSTEOARTHRITIS, HIP", "OSTEOARTHRITIS", "OPEN-ANGLE GLAUCOMA", "OCULAR HYPERTENSION", "COCAINE DEPENDENCE", "ALCOHOL DRINKING", "BIPOLAR DISORDER", "MIGRAINE DISORDER", "ALCOHOL DEPENDENCE", "CONGENITAL HEART DISEASE", "METAMPHETAMINE DEPENDENCE", "GAMBLING BEHAVIOUR", "OBESITY", "SMOKING CESSATION", "NICOTINE DEPENDENCE", "MARIJUANA DEPENDENCE", "PRADER-WILLI SYNDROME", "CEREBRAL ISCHEMIA"], "links": [{"source": "ENSG00000104267", "target": "ENSG00000114923"}, {"source": "ENSG00000114923", "target": "ENSG00000167434"}], "drugs": [{"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "OBESITY", "stage": 3}, {"efo_term": "SMOKING CESSATION", "stage": 3}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 3}, {"efo_term": "PRADER-WILLI SYNDROME", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "ALCOHOL DRINKING", "stage": 2}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 2}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "CEREBRAL ISCHEMIA", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 1}, {"efo_term": "CONGENITAL HEART DISEASE", "stage": 1}], "max_phase": 4, "name": "TOPIRAMATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492", "mechanisms": ["Carbonic anhydrase II inhibitor", "Carbonic anhydrase IV inhibitor"], "genes": ["CA2", "CA4"], "type": "Small molecule", "diseases": ["COCAINE DEPENDENCE", "EPILEPSY", "ALCOHOL DRINKING", "BIPOLAR DISORDER", "MIGRAINE DISORDER", "ALCOHOL DEPENDENCE", "CONGENITAL HEART DISEASE", "METAMPHETAMINE DEPENDENCE", "GAMBLING BEHAVIOUR", "OBESITY", "SMOKING CESSATION", "NICOTINE DEPENDENCE", "MARIJUANA DEPENDENCE", "PRADER-WILLI SYNDROME", "CEREBRAL ISCHEMIA"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "GLAUCOMA", "stage": 4}, {"efo_term": "ALTITUDE SICKNESS", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 3}, {"efo_term": "KIDNEY DISEASE", "stage": 2}, {"efo_term": "HELICOBACTER PYLORI INFECTION", "stage": 2}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 2}, {"efo_term": "CARDIODYSRHYTHMIC POTASSIUM-SENSITIVE PERIODIC PARALYSIS", "stage": 1}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 1}], "max_phase": 4, "name": "ACETAZOLAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL20", "mechanisms": ["Carbonic anhydrase II inhibitor", "Carbonic anhydrase IV inhibitor"], "genes": ["CA2", "CA4"], "type": "Small molecule", "diseases": ["EPILEPSY", "GLAUCOMA", "KIDNEY DISEASE", "HELICOBACTER PYLORI INFECTION", "CARDIODYSRHYTHMIC POTASSIUM-SENSITIVE PERIODIC PARALYSIS", "ALTITUDE SICKNESS", "PULMONARY HYPERTENSION", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "MULTIPLE SCLEROSIS"]}, {"indications": [{"efo_term": "OPEN-ANGLE GLAUCOMA", "stage": 4}, {"efo_term": "OCULAR HYPERTENSION", "stage": 4}, {"efo_term": "GLAUCOMA", "stage": 4}], "max_phase": 4, "name": "BRINZOLAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220491", "mechanisms": ["Carbonic anhydrase II inhibitor"], "genes": ["CA2"], "type": "Small molecule", "diseases": ["OPEN-ANGLE GLAUCOMA", "OCULAR HYPERTENSION", "GLAUCOMA"]}, {"indications": [{"efo_term": "OSTEOARTHRITIS, HIP", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}], "max_phase": 3, "name": "POLMACOXIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL166863", "mechanisms": ["Carbonic anhydrase II inhibitor"], "genes": ["CA2"], "type": "Small molecule", "diseases": ["OSTEOARTHRITIS, HIP", "OSTEOARTHRITIS"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "GLAUCOMA", "stage": 4}], "max_phase": 4, "name": "ACETAZOLAMIDE SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200814", "mechanisms": ["Carbonic anhydrase II inhibitor", "Carbonic anhydrase IV inhibitor"], "genes": ["CA2", "CA4"], "type": "Small molecule", "diseases": ["EPILEPSY", "GLAUCOMA"]}, {"indications": [{"efo_term": "GLAUCOMA", "stage": 4}], "max_phase": 4, "name": "DICHLORPHENAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17", "mechanisms": ["Carbonic anhydrase II inhibitor", "Carbonic anhydrase IV inhibitor"], "genes": ["CA2", "CA4"], "type": "Small molecule", "diseases": ["GLAUCOMA"]}, {"indications": [{"efo_term": "GLAUCOMA", "stage": 4}], "max_phase": 4, "name": "METHAZOLAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL19", "mechanisms": ["Carbonic anhydrase II inhibitor", "Carbonic anhydrase IV inhibitor"], "genes": ["CA2", "CA4"], "type": "Small molecule", "diseases": ["GLAUCOMA"]}, {"indications": [], "max_phase": 4, "name": "DORZOLAMIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201162", "mechanisms": ["Carbonic anhydrase II inhibitor"], "genes": ["CA2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ETHOXZOLAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL18", "mechanisms": ["Carbonic anhydrase inhibitor"], "genes": ["CA2", "CA4"], "type": "Small molecule", "diseases": []}], "heat": 0.6777273333333333, "nodes": [{"assoc": 1.0, "id": "ENSG00000104267", "label": "CA2"}, {"assoc": 0.033182, "id": "ENSG00000114923", "label": "SLC4A3"}, {"assoc": 1.0, "id": "ENSG00000167434", "label": "CA4"}], "size": 3}, {"diseases": ["OBSTRUCTIVE LUNG DISEASE", "ASTHMA", "BRONCHIECTASIS", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "NON-ALCOHOLIC FATTY LIVER DISEASE", "OBESITY", "TYPE II DIABETES MELLITUS", "DEMENTIA", "ECZEMA", "PSORIASIS", "SCHIZOPHRENIA", "ATOPIC ECZEMA", "PREMATURE BIRTH", "CHRONIC KIDNEY DISEASE", "ANKYLOSING SPONDYLITIS", "BEHCET'S SYNDROME", "PSORIATIC ARTHRITIS", "RHEUMATOID ARTHRITIS", "ACNE", "ULCERATIVE COLITIS", "SYSTEMIC LUPUS ERYTHEMATOSUS", "GOUT", "IMMUNE SYSTEM DISEASE", "PROSTATITIS", "ROSACEA", "HIDRADENITIS SUPPURATIVA", "LICHEN PLANUS", "UVEITIS", "BLADDER CARCINOMA", "PULMONARY HYPERTENSION", "EMPHYSEMA", "ALTITUDE SICKNESS", "CHRONIC BRONCHITIS", "NON-SMALL CELL LUNG CARCINOMA", "BILIARY ATRESIA", "DUCHENNE MUSCULAR DYSTROPHY", "CUTANEOUS LEISHMANIASIS", "ENDOMETRIOSIS", "NECROTIZING ENTEROCOLITIS", "PATENT DUCTUS ARTERIOSUS", "CARDIOVASCULAR DISEASE", "HEPATITIS, ALCOHOLIC", "ACUTE KIDNEY INJURY", "HEPATIC STEATOSIS", "HIV INFECTION", "RECURRENT THROMBOPHLEBITIS"], "links": [{"source": "ENSG00000105650", "target": "ENSG00000184588"}, {"source": "ENSG00000113448", "target": "ENSG00000184588"}], "drugs": [{"indications": [{"efo_term": "PSORIASIS", "stage": 4}, {"efo_term": "PSORIATIC ARTHRITIS", "stage": 4}, {"efo_term": "IMMUNE SYSTEM DISEASE", "stage": 4}, {"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 3}, {"efo_term": "BEHCET'S SYNDROME", "stage": 3}, {"efo_term": "ATOPIC ECZEMA", "stage": 2}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}, {"efo_term": "ACNE", "stage": 2}, {"efo_term": "ULCERATIVE COLITIS", "stage": 2}, {"efo_term": "GOUT", "stage": 2}, {"efo_term": "PROSTATITIS", "stage": 2}, {"efo_term": "ROSACEA", "stage": 2}, {"efo_term": "HIDRADENITIS SUPPURATIVA", "stage": 2}, {"efo_term": "LICHEN PLANUS", "stage": 2}, {"efo_term": "SYSTEMIC LUPUS ERYTHEMATOSUS", "stage": 1}, {"efo_term": "UVEITIS", "stage": 1}], "max_phase": 4, "name": "APREMILAST", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL514800", "mechanisms": ["Phosphodiesterase 4 inhibitor"], "genes": ["PDE4C", "PDE4D", "PDE4B"], "type": "Small molecule", "diseases": ["ATOPIC ECZEMA", "ANKYLOSING SPONDYLITIS", "BEHCET'S SYNDROME", "PSORIASIS", "PSORIATIC ARTHRITIS", "RHEUMATOID ARTHRITIS", "ACNE", "ULCERATIVE COLITIS", "SYSTEMIC LUPUS ERYTHEMATOSUS", "GOUT", "IMMUNE SYSTEM DISEASE", "PROSTATITIS", "ROSACEA", "HIDRADENITIS SUPPURATIVA", "LICHEN PLANUS", "UVEITIS"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "BRONCHIECTASIS", "stage": 2}, {"efo_term": "NON-ALCOHOLIC FATTY LIVER DISEASE", "stage": 2}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 2}, {"efo_term": "DEMENTIA", "stage": 2}, {"efo_term": "ECZEMA", "stage": 2}, {"efo_term": "PSORIASIS", "stage": 2}, {"efo_term": "ATOPIC ECZEMA", "stage": 2}, {"efo_term": "OBESITY", "stage": 1}, {"efo_term": "SCHIZOPHRENIA", "stage": 1}], "max_phase": 4, "name": "ROFLUMILAST", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193240", "mechanisms": ["Phosphodiesterase 4 inhibitor"], "genes": ["PDE4C", "PDE4D", "PDE4B"], "type": "Small molecule", "diseases": ["ASTHMA", "BRONCHIECTASIS", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "NON-ALCOHOLIC FATTY LIVER DISEASE", "OBSTRUCTIVE LUNG DISEASE", "OBESITY", "TYPE II DIABETES MELLITUS", "DEMENTIA", "ECZEMA", "PSORIASIS", "SCHIZOPHRENIA", "ATOPIC ECZEMA"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "ENDOMETRIOSIS", "stage": 3}, {"efo_term": "HEPATITIS, ALCOHOLIC", "stage": 3}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "BILIARY ATRESIA", "stage": 2}, {"efo_term": "CUTANEOUS LEISHMANIASIS", "stage": 2}, {"efo_term": "NECROTIZING ENTEROCOLITIS", "stage": 2}, {"efo_term": "PATENT DUCTUS ARTERIOSUS", "stage": 2}, {"efo_term": "ACUTE KIDNEY INJURY", "stage": 2}, {"efo_term": "HEPATIC STEATOSIS", "stage": 2}, {"efo_term": "DUCHENNE MUSCULAR DYSTROPHY", "stage": 1}], "max_phase": 4, "name": "PENTOXIFYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL628", "mechanisms": ["3',5'-cyclic phosphodiesterase inhibitor"], "genes": ["PDE4C", "PDE4D", "PDE4B"], "type": "Small molecule", "diseases": ["NON-SMALL CELL LUNG CARCINOMA", "BILIARY ATRESIA", "DUCHENNE MUSCULAR DYSTROPHY", "CUTANEOUS LEISHMANIASIS", "ENDOMETRIOSIS", "NECROTIZING ENTEROCOLITIS", "PATENT DUCTUS ARTERIOSUS", "CARDIOVASCULAR DISEASE", "HEPATITIS, ALCOHOLIC", "ACUTE KIDNEY INJURY", "HEPATIC STEATOSIS"]}, {"indications": [{"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}, {"efo_term": "CHRONIC BRONCHITIS", "stage": 4}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 1}, {"efo_term": "ALTITUDE SICKNESS", "stage": 1}, {"efo_term": "BLADDER CARCINOMA", "stage": 0}], "max_phase": 4, "name": "AMINOPHYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1370561", "mechanisms": ["Phosphodiesterase 4 inhibitor"], "genes": ["PDE4C", "PDE4D", "PDE4B"], "type": "Small molecule", "diseases": ["OBSTRUCTIVE LUNG DISEASE", "ASTHMA", "BLADDER CARCINOMA", "PULMONARY HYPERTENSION", "EMPHYSEMA", "ALTITUDE SICKNESS", "CHRONIC BRONCHITIS"]}, {"indications": [{"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 3}, {"efo_term": "PREMATURE BIRTH", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 2}], "max_phase": 4, "name": "THEOPHYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190", "mechanisms": ["Phosphodiesterase 4 inhibitor"], "genes": ["PDE4C", "PDE4D", "PDE4B"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "OBSTRUCTIVE LUNG DISEASE", "ASTHMA", "PREMATURE BIRTH", "CHRONIC KIDNEY DISEASE"]}, {"indications": [{"efo_term": "RECURRENT THROMBOPHLEBITIS", "stage": 4}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}, {"efo_term": "HIV INFECTION", "stage": 1}], "max_phase": 4, "name": "DIPYRIDAMOLE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL932", "mechanisms": ["3',5'-cyclic phosphodiesterase inhibitor"], "genes": ["PDE4C", "PDE4D", "PDE4B"], "type": "Small molecule", "diseases": ["RHEUMATOID ARTHRITIS", "HIV INFECTION", "RECURRENT THROMBOPHLEBITIS"]}, {"indications": [{"efo_term": "ATOPIC ECZEMA", "stage": 4}, {"efo_term": "PSORIASIS", "stage": 2}], "max_phase": 4, "name": "CRISABOROLE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL484785", "mechanisms": ["Phosphodiesterase 4 inhibitor"], "genes": ["PDE4C", "PDE4D", "PDE4B"], "type": "Small molecule", "diseases": ["ATOPIC ECZEMA", "PSORIASIS"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}], "max_phase": 4, "name": "DYPHYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1752", "mechanisms": ["Phosphodiesterase 4 inhibitor"], "genes": ["PDE4C", "PDE4D", "PDE4B"], "type": "Small molecule", "diseases": ["ASTHMA", "OBSTRUCTIVE LUNG DISEASE"]}, {"indications": [{"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}], "max_phase": 4, "name": "AMLEXANOX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1096", "mechanisms": ["Phosphodiesterase 4 inhibitor"], "genes": ["PDE4C", "PDE4D", "PDE4B"], "type": "Small molecule", "diseases": ["OBSTRUCTIVE LUNG DISEASE"]}, {"indications": [{"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}], "max_phase": 4, "name": "OXTRIPHYLLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200434", "mechanisms": ["Phosphodiesterase 4 inhibitor"], "genes": ["PDE4C", "PDE4D", "PDE4B"], "type": "Small molecule", "diseases": ["OBSTRUCTIVE LUNG DISEASE"]}, {"indications": [], "max_phase": 4, "name": "THEOPHYLLINE SODIUM GLYCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200578", "mechanisms": ["Phosphodiesterase 4 inhibitor"], "genes": ["PDE4C", "PDE4D", "PDE4B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "FLAVOXATE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200875", "mechanisms": ["Phosphodiesterase 4 inhibitor"], "genes": ["PDE4C", "PDE4D", "PDE4B"], "type": "Small molecule", "diseases": []}], "heat": 1.0, "nodes": [{"assoc": 1.0, "id": "ENSG00000105650", "label": "PDE4C"}, {"assoc": 1.0, "id": "ENSG00000113448", "label": "PDE4D"}, {"assoc": 1.0, "id": "ENSG00000184588", "label": "PDE4B"}], "size": 3}], "auto_delta": "0.00273139"}